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Abstract
Genetic and developmental studies have shown that upon the presence or absence of
the Y-linked sex-determining gene SRY, the bipotential gonad will develop either as
a testis or ovary. Since the discovery of SRY, several other genes (such as WT1, SF1,
DAX1 and SOX9) have been isolated which play an important role in gonadal
development and sex determination. Despite these advances our understanding of the
mammalian sex determination process remains incomplete.
To identify new genes involved in gonadal development, a differential screen using
Affymetrix GeneChip arrays was performed. Wild-type male and female gonads
were dissected from mouse embryos at El2.5 (during the differentiation process) and
subjected to microarray analysis. From this extensive analysis, several novel
transcripts were identified, which show a sex-specific expression pattern.
The validity of this approach was verified by analysing the expression of these novel
transcripts by in-situ hybridisation in male and female gonads at E12.5. Transcripts
with a confirmed sex-specific expression pattern where then selected for detailed in-
situ hybridisation ofmale and female gonads at El 1.5, E13.5 and E14.5. Moreover,
real-time PCR of these candidates was carried out to establish a sex-specific gene
expression profile during gonadal development, ranging from 17 to 36 tail somites.
This thesis also describes the novel approach of applying small interfering RNAs
(siRNAs) to a gonadal organ culture system. Several known sex determination genes
were successfully targeted and knocked-down by applying this technique.
Importantly, siRNA against Sry effectively blocked male gonad differentiation
resulting in a lack of expression of male specific markers. Taken together these
results suggest that the siRNA approach in gonad cultures can be used to efficiently
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1.1 Sex Determination and Sex Chromosomes
How an individual's sex is determined has been one of the intriguing questions of
life for many centuries. In 355 BC, Aristotle claimed that sex was determined by the
heat of the semen at the time of copulation: hot semen generated males, whereas cold
semen produced females. Since then, greater knowledge of the molecular events of
sex determination has been established. Mammalian sex determination is now
known to be controlled by genes, which are expressed in a sexually dimorphic
manner. In humans and other mammals, the presence of either a second X
chromosome or a Y chromosome determines whether the embryo is to be female
(XX) or male (XY). However, in birds, the situation is reversed: males have two
similar sex chromosomes (ZZ), while females have the unmatched pair (ZW).
Interestingly, the gonad is the only organ that can develop into two different organs:
either a testis or an ovary. Hence, the path of differentiation taken by this organ
determines the future sexual development of the organism.
1.2 Development ofthe Gonad
Mammalian gonads are formed by proliferation of the coelomic epithelium and
condensation of the underlying mesenchyme (Sadler 1995). Initially, these gonads
are indifferent or bipotential as they cannot be distinguished to be either testes or
ovaries (Gubbay et al., 1990; Sinclair et al., 1990). In humans, gonadal rudiments
appear in the intermediate mesoderm during week 4 and remain sexually indifferent
until week 7 (Francavilla et al., 1990). These gonadal rudiments form as paired
regions adjacent to the developing kidneys and the ventral parts constitute the genital
ridge epithelium. In the mouse, this formation begins at approximately E10.5
(Figure 1.1) and the gonads appear as a pair of longitudinal ridges on the





Figure 1.1 Structure of the Urogential System at E10.5
Schematic diagram illustrating the mouse urogenital system at El0.5. Epithelial
structures are shown in red and mesenchymal structures are shown in blue. The
striped region depicts the genital ridge (GR). The Wolffian duct (WD), mesonephric
tubules (MT), Miillerian duct (MD), ureteric bud (UB) and coelomic epithelia (CE)
are also shown (Figure adapted from Swain and Lovell-Badge 1999).
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(Karl and Capel, 1998). Interestingly, testes and ovaries have corresponding cell
types which display similar functions in reproduction. For example, Leydig cells (in
testes) and theca cells (in ovaries) are involved in steroidogenesis, Sertoli cells and
granulosa cells (from testes and ovaries, respectively) play an important role in germ
cell maturation. In the mouse, primordial germ cells (PGC) migrate from the base of
the allantois, via the gut mesentery, reaching the gonad between E10.5 and El 1.5
(Ginsburg et ah, 1990; Gomperts et ah, 1994). At approximately El 1.5, sexual
differentiation between the testis and the ovary commences.
During the early stages of gonad differentiation, the size of the male gonad increases
comparatively to the female gonad in mammals and in other vertebrates such as birds
and reptiles (Mittwoch, 1989; Schmahl et ah, 2003). In the mouse, the size increase
of the XY gonad results from increased cell proliferation (Schmahl et ah, 2000),
which is concentrated in the coelomic epithelium (Karl and Capel, 1998).
Throughout the early phase of proliferation, which occurs between El 1.0 - El 1.5,
both Sertoli and interstitial cells are derived from the division of SF1-expressing
cells in this layer. Subsequently, SF1 expression is lost from coelomic epithelial
cells. As proliferation continues, only interstitial cells are produced. Furthermore, in
a study where proliferation inhibitors were used to block cell division prior to the
stages of the XY gonad committing to the testicular pathway, the inhibitors stopped
proliferation of coelomic epithelial cells, blocked expression of the Sertoli cell
marker, Sox9, and prevented testis cord formation (Schmahl and Capel, 2003).
Moreover, the results revealed that proliferation within a specific 8-hour time frame
around El 1.0 (the early phase of proliferation) was a critical period for the
establishment of the male pathway and the formation of the testis (Schmahl and
Capel, 2003).
Following sexual differentiation, in mice, the gonad can be distinguished
histologically by E13.5. Cells within the testes are arranged into two distinct
compartments: testicular cords and the interstitial region. Testicular cords
(precursors of the seminiferous tubules) are composed ofprimordial germ cells and
3
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epithelialized Sertoli cells (Tilmann and Capel, 1999). The interstitial region, which
surrounds the testicular cords, contains the steroidogenic Leydig cells and the
peritubular myoid cells (a smooth muscle cell lineage forming the connective tissue
of the gonads). In contrast, cells within the ovaries have an undefined "ground-
glass" appearance and show little structural differentiation until the later stages of
gestation (Parker et al., 2001).
In the mouse, Sertoli cells are the supporting cell lineage of the testis as they
maintain the growth and maturation of germ cells. They are also essential for the
early stages of testis development. Analysis of cells from the testes of chimeric XX
<r-> XY embryos revealed that Sertoli cells were the only cell type to show a strong
bias for the Y chromosome. Approximately 90% of Sertoli cells were XY, whereas
other testicular cell types were XX or XY with equal frequency (Palmer and
Burgoyne, 1991). This genetic evidence suggested that expression of genes on the Y
chromosome (including Sry) might only be required in the Sertoli-cell lineage.
However, it appears the requirement for Sry is not absolute as approximately 10% of
Sertoli cells in the adult chimeras were XX (had no Y chromosome or Sry gene),
which suggests that a downstream paracrine factor could be involved in the
recruitment of non-AVy-expresssing cells to the Sertoli pathway.
Migration of mesenchymal cells from the mesonephros into the adjacent XY gonad
is also important for testicular development and cord formation in mice.
Recombinant gonadal organ culture experiments have shown that the recruitment of
cells from the mesonephros is male-specific (Martineau et al., 1997) and in vitro
culture experiments using gonads that normally form ovotestes have shown that
migration is absent from ovarian regions and is confined to regions where testis cords
develop (Albrecht et al., 2000). In addition, cord formation was found to be
impaired when migration was blocked at El 1.5 by culturing the gonad without
attached mesonephroi (Buehr et al., 1993) and by placing a barrier between the two
tissues in culture (Tilmann and Capel, 1999). Furthermore, culturing of an XY
gonad on the surface of an XX gonad caused the migration of cells from the
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mesonephros to be induced in the XX gonad between El 1.5 - E13.5, which resulted
in the formation of cord-like structures and expression of male markers in some
samples (Tilmann and Capel, 1999).
Vascularization also contributes to the morphogenesis of the XY mouse gonad. At
the early bipotential stages of gonad development, vasculature growth from the
mesonephros into the gonad is identical in XX and XY gonads (Brennan et ah, 2002;
Bullejos et ah, 2002). However, following Sry expression, additional endothelial
cells are only recruited to the XY gonad. These migrating cells then assemble to
generate the coelomic vessel, an arterial system denoted by the arterial maker ephrin-
B2 and elements of the Notch signalling pathway (Brennan et al., 2002). This
arterial system in the early mouse testis establishes an alternative pattern of blood
flow that is diverted from the mesonephros through the coelomic vessel. It has been
suggested that the arterial system increases blood flow through the testis in order to
promote the efficient export of testosterone from the early testis, as the delivery of
testosterone is essential for establishment ofmale characteristics in sex determination
(Brennan et ah, 2002).
Testosterone is produced by Leydig cells in the testis. The main function of Leydig
cells is steroidogenesis. There are two distinct types of Leydig cells in mice: foetal
and adult lineages (Habert et al., 2001). Foetal Leydig cells are present in the testis
from E12.5 until their numbers decrease shortly after birth. The role of these foetal
Leydig cells is the masculinization of the male urogenital system. More specifically,
foetal Leydig cells produce testosterone to virilize the internal and external genitalia.
Adult Leydig cells appear during puberty and testosterone produced on this occasion
is required for the onset of spermatogenesis and maintenance of male reproductive
function (Habert et al., 2001). However, it should be noted that foetal Leydig cells
are more active than adult Leydig cells in testosterone production.
Peritubular myoid cells are believed to be amongst the cells that originate from the
mesonephros (Martineau et al., 1997; Tilmann and Capel, 1999), which subsequently
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migrate into the developing mouse testis. These cells are found within the interstitial
region, surrounding and enclosing the Sertoli and germ cells, creating discrete testis
cords. Once peritubular myoid and Sertoli cells associate, they secrete a matrix that
forms the basal lamina, which separates the testis cords from the interstitial
compartment (Tung et al., 1984). Disruption or delay of testis cord formation may
cause gonadal dysgenesis or infertility. A significant deficiency ofperitubular myoid
cells, along with disorganised and incomplete formation of testis cords, was observed
in Daxl null mice. This indicates the important role that Daxl plays in testis
differentiation by regulating the development of peritubular myoid cells and the
formation of intact testis cords (Meeks et al., 2003a).
The internal genitalia (derived from the genitourinary tract) are initially the same in
both male and female mouse embryos, where they have two identical sets of paired
ducts: the Miillerian (paramesonephric) ducts and the Wolffian (mesonephric) ducts
(Parker et al., 2001). Upon Y chromosome activation of the male developmental
pathway, the gonads develop into testes (Figure 1.2), whereby Sertoli cells within the
testicular cords produce a glycoprotein hormone, Miillerian inhibiting substance
(MIS) (Tran et al., 1977). This hormone mediates the regression of the Miillerian
ducts (Jost, 1953). In parallel, Leydig cells differentiate within the interstitial region
and synthesize testicular androgens, which result in stabilisation and differentiation
of the Wolffian ducts and formation of the external genitalia. In the absence of
testicular hormones, the Wolffian ducts regress and the Miillerian ducts form the
oviducts, Fallopian tubes, uterus and upper vagina giving rise to a female phenotype
(Figure 1.2) (Jost et al., 1973).
Similar to the internal genitalia, the external genitalia also possess structures that are
initially found in both sexes. These include the genital tubercle, the urethral groove
and the labial (or labio-scrotal) folds. In the female mouse, at approximately El4.5,
the genital tubercle differentiates into the clitoris and glans clitoridis (Kaufman,
1999). While, a stage later, the urethra forms from the urethral groove at El5.5. In
addition, the labial folds do not fuse across the ventral midline but form the labia
6
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Figure 1.2 Structure of Urogenital System
Schematic diagram of the urogenital system, where (A) represents
bipotential/indifferent gonads, (B) illustrates the development of the gonad into testes
and (C) the development into ovaries. (Figure adapted from Gilbert, 2000).
Chapter 1 Introduction
majora, whereas the labia minora results from the lack of fusion of the urethral folds.
In the male mouse, the glans penis differentiates from the distal part of the genital
tubercle at approximately E14.5, the urethral groove forms the penile urethra and the
labial folds fuse across the midline in the region of the cloacal membrane to form the
scrotum (Kaufman, 1999).
1.3 Genes Involved in Formation and Survival ofthe Gonad
Over the last decade, numerous studies have been conducted in order to gain a better
understanding of the molecular mechanisms underlying the formation of the gonadal
primordium. However, to date, very little is known. So far, only four genes have
been discovered to be critical in this process. These are: the Wilms' Tumour
suppressor gene (Wtl), the steroidogenic factor gene (Sfl), the Lim-type homeobox
containing gene (Lhx9) and the evenskipped homologue gene (Emxl). It is apparent
that all of these genes are essential for the development and survival of the
bipotential gonad, as knockout mutations of each of these genes result in mice
lacking gonadal tissues.
1.3.1 Wilms' Tumour Suppressor Gene (Wtl)
Wilms' tumour, or nephroblastoma, is a paediatric kidney cancer that originates from
pluripotent embryonic renal precursors (Bennington, 1975). Positional cloning
strategies led to the identification of the WT1 tumour suppressor gene at chromosome
1 lpl3 (Call et al., 1990; Gessler et ah, 1990). The WT1 gene is highly complex and
encodes 24 different protein isoforms through a combination of alternative splicing,
RNA editing and differential initiation of translation (Little et al., 1999). All the
WT1 proteins contain four zinc fingers of the Kruppel type at the C-terminus. In
+KTS isoforms, zinc fingers 3 and 4 are separated by three amino acids which affect
their ability to bind DNA (Larsson et al., 1995). These proteins co-localise with
8
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nuclear speckles and splicing factors (Larsson et al., 1995). In contrast, -KTS
isoforms show a predominant diffuse nuclear localisation typical of transcription
factors (Larsson et al., 1995). This suggests that the different WT1 isoforms may
have different biochemical functions (Little et al., 1999).
In humans, individuals affected by Frasier syndrome carry a point mutation on one
copy of WT1, preventing the production of the +KTS isoform from that allele. As a
consequence, the ratio between the +KTS and -KTS isoform is altered (Klamt et al.,
1998). In our laboratory, animal models for Frasier syndrome have been generated.
XY mice homozygous for the Frasier mutations are completely sex reversed which
suggests that Wtl is required for sex determination (Hammes et al., 2001).
Interestingly, it has been discovered that the +KTS and -KTS isoforms ofWT1 have
distinct functions in gonad formation and sex determination. -KTS isoforms are
necessary for the survival of the gonadal primordium and mice ablated for the -KTS
isoform show increased apoptosis (Hammes et al., 2001). Absence or reduced levels
of +KTS isoforms, as found in human Frasier patients, show a decrease in Sry
expression levels and, consequently, Sox9 and MIS fail to be activated (Hammes et
al., 2001). In addition transgenic mice genetically depleted of Wtl do not develop
kidneys, gonads, spleen and adrenals (Kreidberg et al., 1993) indicating that Wtl is
essential for the formation of these organs.
In the developing mouse, expression of Wtl first appears in the urogenital ridge at
E9.0 and continues to be expressed after formation of the gonads, particularly in the
male sex cords (structures that contain the precursors of Sertoli cells) (Shimamura et
al., 1997). After birth, Wtl is expressed in the testis, specifically in Sertoli cells, but
not in Leydig or germ cells (Shimamura et al., 1997). In addition, Wolffian and
Miillerian ducts do not express Wtl either. Wtl-null mice die at an early stage of
embryonic development, E13.5, due to malformations of the heart and diaphragm
(Moore et al., 1999). The gonadal anlagen in Wtl knockout mice undergoes
apoptosis, hence Wtl -null embryos lack gonads. This demonstrates that early
expression of Wtl is necessary for development of the undifferentiated gonad,
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although migration of the primordial germ cells remains unaffected (Kreidberg et al.,
1993). Recent studies have detected Wtl expression in embryonic germ cells
beginning at El 1.5, following the migration of primordial germ cells into the gonad
(Natoli et al., 2004). Furthermore, germ cells isolated from Wtl-mi\\ embryos show
impaired growth in culture (Natoli et al., 2004). These data have led to the discovery
of a previously unknown role for Wtl in gonadal germ cell proliferation or survival.
1.3.2 Steroidogenic Factor Gene (Sfl)
The orphan nuclear receptor steroidogenic factor 1 (SF1) plays an important role in
the gonadal and adrenal development pathways, and is known to regulate the
expression of enzymes involved in steroid biosynthesis (Reviewed in Parker and
Schimmer 1997). In mice, Sfl is expressed between E9.0 and E12.0 in the gonads of
both sexes (Ikeda et al., 1994). However, its expression is then down regulated in
developing ovaries (Ikeda et al., 1994). Similar to Wtl knockout mice, the gonadal
anlagen in Sfl knockout mice also seem to undergo apoptosis in both sexes, although
the initial stages of genital ridge formation are unaffected (Luo et al., 1994). Thus,
the gonads of Sfl''' embryos do not develop beyond the early indifferent stage and
XY Sfl mutant embryos lack testes and therefore develop a female urogenital system
(Luo et al., 1994).
In humans, a heterozygous 2-bp G35E (GGC—>GAA) mutation in exon 3, which
encodes part of the DNA-binding domain of SF1, has been shown to cause complete
XY sex reversal (including normal female external genitalia and retention of the
uterus) and adrenal failure (Achermann et al., 1999). Interestingly, Sfl+/' mice do not
display the XY intersex phenotype described in the heterozygous SF1 human patients
(Bland et al., 2000). Evidence that SF1 regulates the regression of Mullerian
structures, either by directly acting on the MIS promoter or through an abnormality
of Sertoli cell development or function, has also been found (Achermann et al.,
1999). Interestingly, site-directed mutagenesis studies in mice revealed that this
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heterozygous 2-bp G35E (GGC—>GAA) mutation found in humans only disrupts the
binding site of SF1; it does not effect protein translation, stability or nuclear
localisation (Giuili et ah, 1997).
Recently, in mice, the specific in vivo roles of SF1 in discrete gonadal cell lineages
was explored using the Cre-loxP system to inactivate SF1 in a cell-selective manner
at a relatively early stage of gonadal development (Jeyasuria et al., 2004). The
results strongly indicate that SF1 in Leydig cells is essential for expression of the
cholesterol side-chain cleavage enzyme (Cyplla), which catalyses the first reaction
in testosterone production, and the steroidogenic acute regulatory protein (StAR), a
second essential component of steroidogenesis. Thus, providing the first evidence
that SF1 is essential for the expression of these target genes in vivo (Jeyasuria et al.,
2004). Furthermore, the results also indicate important roles of SF1 in estrogen
production by granulosa cells in vivo (Jeyasuria et al., 2004).
Taken together, these data suggest that SF1 has at least three important functions in
sexual development. Firstly, in stabilisation and development of the genital ridge,
secondly, in formation of the testis, and finally, in regulation of MIS and also in
regulation of steroid synthesis in Leydig and granulosa cells (Koopman, 1999).
1.3.3 Lim-type Homeobox Containing Gene 9 (Lhx9)
Lim-type Homeobox Containing Gene 9 (Lhx9), a member of the LIM homeobox
domain gene family of transcription factors, has been mapped to mouse chromosome
1 (Failli et al., 2000). Analysis in the gonadal region found Lhx9 transcripts to be
expressed in the medial surface of the urogenital ridge from 9.5 dpc in both sexes
(Birk et al., 2000). At E13.5, Lhx9 is differentially expressed. In males, the
expression pattern of Lhx9 is high in the mesothelial layer and the outer part of the
testis (the developing tunica), lower in the interstitial mesenchyme, and almost
absent in the sex cords (Birk et al., 2000). In females, Lhx9 expression is mainly
11
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restricted to the cortical region (Birk et al., 2000). Although Lhx9 is normally
expressed in the embryonic central nervous system, limbs and pancreas, Lhx9
knockout mice did not show any abnormalities in these structures (Birk et ah, 2000).
However, targeted disruption of Lhx9 resulted in the failure of a discrete gonad to be
formed (Birk et al., 2000). More specifically, Lhx9~/~ and wild-type urogenital ridges
were indistinguishable at El 1.5. However, by E12.0, budding was apparent in the
wild-type genital ridge, yet no such proliferation was seen in the Lhx9 mutants.
Furthermore, at E13.5, when distinct testes and ovaries can be observed in wild-type
embryos, no gonads were visible in Lhx9'/~ embryos (Birk et al., 2000). This
developmental defect is thought to be caused by the failure of somatic cells in the
genital ridge to proliferate, as alkaline phosphatase staining revealed the presence of
primordial germ cells within E12.0 Lhx9~/~ genital ridges, thus indicating that germ
cell migration occurred at the expected time (Birk et al., 2000). In view of the fact
that Lhx9 mutants display a gonadal deficiency, it can therefore be concluded that
Lhx9 is vital for gonad formation.
1.3.4 Evenskipped Homologue Gene 2 (Emx2)
The homeobox gene Emx2 is a mouse cognate of a Drosophila head gap gene, empty
spiracles (ems), and is fundamental for the development of the dorsal telencephalon
(Yoshida et al., 1997). Simultaneously, Emx2 is expressed in the epithelial
components of the developing urogenital system and Emx2 transcripts are
specifically observed in the developing gonad. Interestingly, kidneys, ureters,
gonads and genital tracts are completely missing in Emx2 mutant mice (Miyamoto et
al., 1997). The ablation of the gonadal tissue is considered to be due to proliferative
defects within the coelomic epithelium, as poor thickening of this was seen in El 1.5
Emx2 deficient embryos (Miyamoto et al., 1997). Consequently, Emx2 may
participate in proliferation, differentiation and/or survival of gonadal cells. However,




1.4 Gonad Formation: Developmental Cascade
Evidently, it is important to discover new genes which are involved in the formation
of the gonad, but it is also of equal importance to understand the functional role(s)
and relationship(s) they have with each other. Considering the above genes are all
expressed in the developing gonad at approximately the same time, one can speculate
that they are likely to share a common pathway.
As the effects on gonadogenesis in Wtl knockout mice are remarkably similar to
those observed in Sfl knockout mice (the gonads appear normal at early stages but
regress through apoptosis as they reach a certain period of development), the possible
interactions between Wtl and Sfl have been examined. Analysis of the genital ridges
of Wtl knockout mice indicated that Sfl expression is completely absent (Wilhelm
and Englert, 2002). This finding suggests that the expression of the Sfl gene in the
early gonad is WT1-dependent. Furthermore, Sfl expression, which could first be
detected at E9, was dependent on WT1 at this stage. This implies that WT1 is
required for the initiation of Sfl expression. Interestingly, characterisation binding
studies show only the -KTS form ofWT1 is able to bind to and transactivate the Sfl
promoter (Wilhelm and Englert, 2002). This observation is consistent with
differential roles for the -KTS and +KTS variants of WT1, whereby the -KTS
isoform is required for the survival of the gonadal primordium and the +KTS isoform
seems primarily involved in the male sex determination pathway (Hammes et al.,
2001).
Investigations into the possible interactions of Lhx9 with Wtl and Sfl have also been
conducted, by examining their expression in Lhx9-null embryos (Birk et al., 2000).
No change in the expression pattern of Wtl was found. However, a reduced
expression of Sfl in El 1.5 Lhx9 deficient urogenital ridges was observed. This
suggests that WT1 is necessary but not sufficient to activate the expression of Sfl.
Furthermore, taken together with the continuous expression of Lhx9 in Sfl knockout
embryos, these findings imply that Lhx9 may also be upstream ofSfl. Consequently,
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it has been found that Wtl and Lhx9 activate the expression of Sfl in the
developmental cascade leading to early gonadogenesis (Wilhelm and Englert, 2002).
In conclusion, it should be noted that deciphering part of a developmental cascade,
and interpreting experimental data based on the impact of a gene knockout on the
expression of other genes, is difficult. Direct and indirect effects of unknown factors
may influence the results. An alternative approach to test for genetic interactions
would be to generate double homozygous mutants by crossing heterozygous
knockouts of the genes of interest. These mutants could potentially confirm previous
results and provide insight into the phenotypic consequences of the absence of both
genes.
1.5 Genes Involved In Sex Determination
1.5.1 Sex Determining Region of the Y Chromosome (Sty)
Genetic and developmental studies have shown that, depending on the presence or
absence of the Y-linked sex-determining gene, SRY (Sex determining Region of the
Y chromosome), the bipotential gonad will develop either as a testis or ovary (Figure
1.3). SRY plays a crucial role in male sex determination. It encodes a high-mobility
group (HMG) box protein that can function as a DNA binding protein (Su and Lau,
1993). It is believed to act within cells of the supporting cell lineage of the
indifferent gonad to stimulate a series of events resulting in differentiation of Sertoli
rather than follicle cells (Hacker et ah, 1995). Further studies have shown that SRY
initiates a "remarkable" increase in vascularization of the gonad and on somatic cell
proliferation at the coelomic epithelium of XY gonads, resulting in a thickening of
this later (Schmahl et ah, 2000).
In the mouse, Sry is expressed in a proportion of cells in the gonadal ridge, which





























Figure 1.3 Early Development of the Gonad
Schematic diagram of the early developmental stages of the gonad, illustrating some
of the essential genes involved and the cell types present. (Figure adapted from
Swain and Lovell-Badge 1999).
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(Lovell-Badge et al., 2002). Its expression in the genital ridge is wave-like from the
central and/or anterior regions, which subsequently extends to both poles and ends in
the caudal pole (Bullejos and Koopman, 2001). As previously mentioned, analysis
of chimeric mice derived from XX and XY cells demonstrated that nearly all
testicular Sertoli cells were XY while other cell lineages did not favour either
chromosome (Palmer and Burgoyne, 1991). Therefore, the action of SRY is believed
to initiate differentiation of the Sertoli cell lineage in the testis. Once SRY triggers
Sertoli cells they in turn guide the differentiation of the other testicular cell types,
resulting in structural organisation and formation of the testis cords (Koopman et al.,
1991). Thus, the decision of sex determination is fundamentally one of cell fate: a
cell, which would otherwise become a granulosa cell, becomes a Sertoli cell due to
its activation by SRY.
In mice, transcription of Sry in the male (XY) urogenital ridge is switched on at
El0.5, reaching a peak at El 1.5, prior to overt differentiation, before being
completely switched off by E13.0 (Hacker et al., 1995). The expression of Sry in
pre-Sertoli cells (Albrecht and Eicher, 2001) initiates the differentiation of Sertoli
cells, whereby at El2.5 Sertoli cells sequester primordial germ cells within testis
cords. By E13.5, as a result of interactions with Sertoli cells, germ cells arrest in the
G1 phase of the mitotic cell cycle and do not enter meiosis until well after birth
(McLaren, 1988). In the absence of germ cells in the male gonad, the somatic cell
lineages appear to differentiate normally (McLaren, 1991), although a number of
abnormalities can be detected in empty testis tubules of adult mice. Despite the fact
that germ cells are not required for the organisation of the testis cords, they may
facilitate this process by responding to the masculinising somatic environment and
become committed to spermatogenesis (Adams and McLaren, 2002). The expression
of Sry also induces the migration of peritubular myoid cells from the mesonephros,
which facilitates testis cord formation (Tung et al., 1984).
In the absence of Sry expression, ovarian fate occurs (Gubbay et al., 1992; Hawkins
et al., 1992). In contrast to the XY gonad, germ cells are important for the formation
16
Chapter 1 Introduction
and maintenance of the structure of the ovary. In the absence of germ cells, follicle
cells do not assemble and deteriorate rapidly (McLaren, 1988). It has been shown
that when El4.5 XX somatic cells are recombined with XY somatic cells, testis cord
structures form normally. Whereas, when XX germ cells are recombined with XY
somatic cells, cord structures are disrupted (Yao et ah, 2003). In the XX gonad, germ
cells enter meiosis by E13.5 and arrest in prophase I by birth (McLaren, 1988). It
has been suggested that once germ cells commit to meiosis (McLaren and Southee,
1997), they reinforce ovarian fate by antagonising the testis pathway (Yao et ah,
2003).
Since the discovery of SRY, several other genes have been isolated which play a part
in the process of gonadal development and sex determination (Figures 1.4 and 1.5).
Most of them have been isolated from human patients affected by complete or partial
sex reversal in addition to abnormalities in other organs. In fact, some of these genes
are essential for normal kidney (WT1 and SF1), adrenal (DAX1 and SF1) and
cartilage (SOX9) formation, as well as being required for sex determination.
1.5.2 Sry-box Gene 9 (Sox9)
Sox (Sry-box) genes are involved in many developmental processes. For example,
chrondrogenesis, hematopoiesis, neurogenesis, lens development and sex
determination (Reviewed in Wilson and Koopman 2002). The Sox gene family
encodes proteins with at least 50% amino acid identity to the 79 amino acid HMG-
type DNA-binding motif present in Sry (Bowles et ah, 2000). The sequence-specific
DNA binding and transactivation properties of SOX proteins indicate they function
as transcription factors with characteristics of both traditional transcription factors
and architectural chromatin factors (Reviewed in Wilson and Koopman 2002).
The Sox9 gene is distinctly related to Sry (59% nucleotide identity within the HMG






Figure 1.4 Genes Involved in Gonad Formation and Sex Determination
Schematic model of genes that are involved in gonad formation and sex
determination, particularly illustrating the different functions of the Wtl ± KTS

























Figure 1.5 Gene Expression Profiles of Sex Determining Genes
Mouse gene expression profiles of sex determining genes in male and female gonads,
from E9.5 - El4.5 (Figure adapted from Morrish and Sinclair 2002).
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shown to play a key role in testis development (Reviewed in Clarkson and Harley
2002). It is known that in the human syndrome campomelic dysplasia, heterozygous
loss-of-function mutations in SOX9 cause skeletal dysmorpology and repeatedly
leads to defects in testicular differentiation or complete XY sex reversal, where
ovaries are found instead of testes (Foster, 1996). In contrast, sex determination in
heterozygous Sox9 knockout mice occurs normally, indicating that this pathway is
less sensitive to gene dosage in mice than in humans (Bi et ah, 2001).
In mice, Sox9 expression within the developing gonad is sexually dimorphic.
Although the level of expression is initially equal in male and female foetal gonads
(following Sry activation), Sox9 increases in XY gonads and decreases in XX gonads
(Kent et ah, 1996). At E12.5-E13.5, Sox9 expression is localised to the sex cords in
the testis, which are composed of Sertoli and germ cells at this stage (Kent et ah,
1996; Morais da Silva et ah, 1996). In addition, the expression of Sox9 was also
detected within the sex cords of El 7.5 male gonads by in-situ hybridisation (Kent et
ah, 1996), which indicates that Sox9 expression is maintained in the testicular cords
as they differentiate into the seminiferous tubules. The early activation of Sox9 after
the expression of Sry, its association with sex reversal in man, and its ability to
functionally substitute for Sry in transgenic mice (Bishop et ah, 2000; Vidal et ah,
2001) suggest that Sox9 is a direct downstream target of Sry in the sex determination
pathway. In addition, high levels of Sry expression are found to persist in Sox9
knockout mice, indicating that the activation of Sox9 leads to the down regulation of
Sry (Chaboissier et ah, 2004).
Sox9 can function as a transcriptional activator and there is compelling evidence that
it regulates Mis. Co-transfection studies have shown that Sox9 can bind and
transactivate the Mis promoter in vitro (De Santa Barbara et ah, 1998). In addition,
mutations in the Sox9-binding site upstream of the Mis promoter do not initiate Mis
transcription in vivo (Arango et ah, 1999). Recently, an in vitro study has revealed
that Sox8, a close homologue of Sox9, can also activate the Mis promoter, although
to a lesser degree (Schepers et ah, 2003). The expression of Sox8 commences at
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El 2, following the activation of Sox9, whereby it also shows a Sertoli cell-specific
pattern in the developing testis. However, homozygous Sox8 knockout mice do not
show a gonadal phenotype (Sock et ah, 2001). Conversely, Sox8/Sox9 double
knockout analyses suggest that Sox8 reinforces the function of Sox9 in testis
formation (Chaboissier et ah, 2004).
1.5.3 Miillerian Inhibiting Substance {MIS)
During mammalian male sexual differentiation, one of the first factors secreted by
foetal Sertoli cells is Miillerian inhibiting substance (MIS), also known as anti-
Mtillerian hormone (AMH) (Tran et ah, 1977). MIS is a homodimeric glycoprotein
linked by disulphide bonds, belonging to the transforming growth factor-(3 (TGF(3)
superfamily (Picard et ah, 1978). It initiates the regression of the Miillerian ducts
during sexual development of the male gonad by affecting mesenchymal cells
surrounding the Mullerian ducts (Dyche, 1979). Its type II receptor, MIS type II
receptor (MISRII), also known as anti-Miillerian hormone receptor (di Clemente et
al., 1994), has a very restricted expression pattern and overlaps with the MIS
expression pattern in foetal Sertoli and postnatal granulosa cells. It is found in the
mesenchymal cells of the Mullerian ducts (Baarends et al., 1994), foetal ovaries and
testes, and subsequently in granulosa, Sertoli and Leydig cells (Racine et al., 1998).
MIS signalling is mediated by the single transmembrane-spanning serine/threonine
kinase receptors type I and II. The MIS type II receptor binds MIS (Mishina et al.,
1999) and then recruits type I receptor forming tetraheteromers. When receptor I is
phosphorylated by the MIS type II receptor, downstream signalling occurs.
Recently, the widely expressed type I bone morphogenetic protein (BMP) receptor
Bmprla (also known as Alk3) has been identified as a type I receptor for Mis-
induced regression of Mullerian ducts (Jamin et al., 2002). Targeted deletion of
Bmprla in the mesenchymal cells of the Mullerian duct resulted in retention of
oviducts and uteri in males (Jamin et al., 2002). Thus, Mis has an impact on cell
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function by signalling via mesenchymal cells surrounding the Miillerian ducts, which
causes it to regress in the presence of the male gonad. Since this receptor is also
expressed in the female gonad, it can be concluded that the regulation of Mullerian
duct regression is due to the expression ofMis by Sertoli cells in the testis.
In the mouse testis, Mis expression is first detected at El 1.5 and it continues to be
expressed throughout foetal development. Several days after birth, the expression
level continues and only declines at puberty. In contrast, Mis expression is first
detectable in granulosa cells of growing follicles in the female several days after
birth and persists throughout life (Hirobe et al., 1992). The over-expression ofMis in
male transgenic mice showed gonadal abnormalities, such as feminized genitalia and
fewer Leydig cell numbers, and exhibit reduced serum levels of testosterone (Lyet et
al., 1995). Hence, testosterone-dependent organs such as seminal vesicles,
epididymis and external genitalia are under-developed or not virilised. The over-
expression ofMis in female transgenic mice resulted in infertility and most have a
blind-ending vagina due to the absence of a uterus and oviducts (Behringer et al.,
1990). Although the ovaries are present at birth, the majority of animals have
ovaries that do not contain germ cells and cord-like structures develop within 2
weeks after birth (Behringer et al., 1990). In adult females, the ovaries have
degenerated. Therefore, in mice, the presence ofMis at the foetal stage has a marked
impact on ovarian and female germ cell development.
In mice, MA-deficient males possess testes that are fully descended and produce
functional sperm. However, they also developed female reproductive organs which
interferes with the transfer of sperm into females, resulting in a large majority of
these males being infertile (Behringer et al., 1994). Consequently Mis does not
appear to be essential for the differentiation of the testis in the male, but it may affect
subsequent testicular function. For example, in the regulation of postnatal Leydig
cell development, as Mis knockout male mice develop Leydig cell hyperplasia
(Behringer et al., 1994). Mis null females exhibit normal fertility but with abnormal
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follicle recruitment (Durlinger et al., 1999). Further studies indicated that Mis may
be able to inhibit the initiation of follicle growth in ovaries.
The MIS promoter contains an SF1 binding site which is crucial for high expression
levels of the MIS gene in Sertoli cells in vitro and in transgenic MZS-reporter mice
(Giuili et al., 1997). However, this SF1 binding site in the MIS promoter is not
required for the initiation ofMis transcription, but is necessary for the upregulation
ofMis during embryogenesis (Arango et al., 1999). More specifically, WT1 -KTS
isoforms associate and synergise with SF1 to promote MIS expression (Nachtigal et
al., 1998). In addition, it has been proposed that overexpression of Daxl may
antagonise the synergy between SF1 and WT1 to impair testis development
(Nachtigal et al., 1998). Further mutational analysis studies of the MIS promoter
have found that multiple SF1 binding sites, along with multiple GATA 4 binding
sites, are required for normal tissue-specific and developmental expression of MIS
(Watanabe et al., 2000).
1.5.4 Dosage-Sensitive Sex-Reversal Adrenal Hypoplasia Congenita Critical
Region on the X Chromosome (Daxl)
The Daxl gene encodes an orphan member of the nuclear receptor superfamily that
does not contain the typical zinc finger DNA-binding motif, but contains a ligand-
binding domain with sequence homology to that of other family members (Zanaria et
al., 1994). Mutations of DAX1 in humans causes an X-linked form of adrenal
hypoplasia congenital (AHC) in males (Achermann et al., 2001). AHC patients fail
to undergo puberty as they also have hypogonadotropic hypogonadism. These
findings led to investigations ofDaxl in mice, whereby the expression of Daxl was
found to be present in the adrenal cortex, gonads, hypothalamus and anterior
pituitary (Guo et al., 1995). During urogential development in the mouse, the
expression pattern ofDaxl is sexually dimorphic. Daxl is expressed in somatic cells
of the genital ridge at E10.5-E11.0 and peaks at E12.0 (Swain et al., 1996). The
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levels of Daxl transcripts in males decrease as testis cords develop, whereas the
levels ofDaxl in females remain unchanged, and the gene continues to be expressed
during ovarian development.
In humans, duplication of the DAX1 gene results in male to female sex reversal
(Bardoni et al., 1994). However, in mice, multiple copies of the Daxl gene have
only been found to cause sex reversal on the background of a weak Sry allele (Swain
et al., 1998). Therefore, Daxl and Sry act antagonistically where increasing
expression of the former leads to female development and increasing activity of the
latter to male development. Although Daxl was once considered to be a candidate
ovarian determining gene, this hypothesis now seems unlikely as Daxl null mutant
XX mice have normal ovarian development and function (Yu et al., 1998). Evidence
now suggests that the effects of Daxl are highly dosage sensitive and dependent
upon genetic background (Meeks et al., 2003c), whereby transgenic overexpresssion
of Daxl causes varying degrees of gonadal dysgenesis and male-to-female sex
reversal at the highest dose (Swain et al., 1998). Daxl has also been found to
interact with Sfl, another orphan nuclear receptor, which plays a key role in the
development and function of the same tissues. In vivo studies have implicated that
SF1 regulates the expression ofDaxl as S/7-deficient mice show reduced levels of
Daxl expression (Hoyle et al., 2002). In addition, a SF1 consensus-binding site
found in Daxl is required to initiate its expression in the developing gonad.
However, the achievement of high levels ofDaxl at this stage requires multiple SF1
consensus binding sites (Hoyle et al., 2002). This is consistent with results from MIS
promoter studies, whereby SF1 has been shown to be involved and act through
several binding sites (Watanabe et al., 2000).
Furthermore, results obtained in Daxl knockout mice (Ahch, the mouse Daxl
homologue) suggest that Daxl may also play a role in the initiation and maintenance
of spermatogenesis (Yu et al., 1998). Spermatogenesis is the process by which
spermatogonia (primitive germ cells) undergo mitosis and meiosis to provide a
constant supply of male gametes. Mutant male mice were both infertile and
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hypogonadal despite normal serum levels of testosterone, gonadotrophins and
adrenal steroids (Yu et al., 1998). In wild-type adult male mice, Daxl transcripts are
detected in both Sertoli and Leydig cells (Ikeda et al., 1996; Swain et al., 1996).
However, the relative contributions of Sertoli and Leydig cell dysfunction could not
be determined from the Daxl knockout mouse. To directly investigate the role of
Daxl in Sertoli cells, DAX1 was expressed by the MIS promoter (MIS-DAX1) in the
genetic background of the Daxl knockout model (Jeffs et al., 2001). Sertoli cell-
specific expression of the DAX1 transgene was shown to be sufficient to partially
rescue the primary testicular defect of the male Daxl knockout mouse (Jeffs et al.,
2001). Moreover, fertility was restored to similar levels found in wild-type
littermates. However, histopathological examination of the testes only revealed a
slight improvement in testicular morphology compared to Daxl knockout mice.
More specifically, a larger number of seminiferous tubules with round and elongated
spermatids were observed in the rescued animals (Jeffs et al., 2001). This finding
suggests that Daxl may play an important role in other testicular cell types, namely
the Leydig cells.
An analysis of Leydig cells from the Daxl knockout mice revealed the expression of
aromatase (Cypl9) was up-regulated (Wang et al., 2001). This enzyme converts
testosterone to estradiol. Estradiol acts as a mitogen to somatic cells of the testis, and
over-expression of aromatase causes degeneration of the germinal epithelium and
Leydig cell hyperplasia (Li et al., 2001). This led to the hypothesis that the
phenotype observed in Daxl knockout testis may partly be due to steroidogenic
dysfunction of the Leydig cells. A 2.1-kilobase fragment of the murine luteinizing
hormone receptor 5' promoter (LHR-DAX1) was used to generate transgenic mice
that selectively express Daxl in Leydig cells (Meeks et al., 2003b). Similar to the
Sertoli cell-specific DAX1 rescue, fertility was improved, whereby sperm production
was increased. Although testicular size was not increased, testicular pathology was
slightly improved in these Leydig cell-specific rescue animals in comparison to the
Daxl knockout animals (Meeks et al., 2003b).
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Taking the Sertoli cell-specific DAX1 rescue along with the Leydig cell-specific
DAX1 rescue, the testis phenotype of Daxl knockout mice exhibits the combined
effects of Daxl deficiency in both Sertoli and Leydig cells. Thus, the function of
Daxl is believed to be critical in both Sertoli and Leydig cells.
1.5.5 Wingless-Type MMTV Integration Site Family, Member 4 (Wnt4)
Wnt4 is a member of the Wnt family of secreted molecules that was originally
identified as mammalian homologues of the Drosophila wingless gene (Nusse et ah,
1991; Rijsewijk et al., 1987). Members of this family are locally acting secreted
growth factors, which can trigger a cascade of intracellular signals resulting in
transcriptional activation of a variety of target genes (Miller, 2002). Thus, they are
involved in different developmental processes such as cell differentiation, cell
migration, cell polarity and cell proliferation. Wnts bind to members of the Frizzled
family of cell-surface receptors (Borello et ah, 1999) and are known to take part in at
least three separate signalling pathways to effect gene expression (Pandur et ah,
2002). The most well known being the Wnt/p-catenin pathway which is highly
conserved between species. In vertebrates, Wnt-11 and Wnt-5A have been shown to
activate the Wnt/JNK pathway (Yamanaka et al., 2002) and the Wnt/Ca2+ pathway
has been described in Xenopus (Kuhl et al., 2000) and zebrafish (Slusarski et al.,
1997).
So far, Wnt4 is the only signalling molecule of the Wnt family known to be involved
in sex determination. The expression of Wnt4 is down-regulated in the developing
male gonad after El 1.5, but it persists in the developing female gonad (Vainio et al.,
1999). It has been shown that targeted deletion of Wnt4 leads to the masculinization
of XX mice, whereby basic development of the Wolffian ducts and degeneration of
the Mullerian ducts is found (Vainio et al., 1999). Therefore, Wnt4 is believed to
suppress male development in the developing ovary.
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Interestingly, it has been observed that both Wnt4 and Daxl are switched off in the
developing testis (at El 1.5 and E12.5, respectively), but continue to be expressed in
the developing ovary and an excess of both genes can feminize XY embryos (Swain
et al., 1998). In addition, it has been shown that, overexpression of Wnt4 up-
regulates Daxl which leads to a XY female phenotype (Jordan et ah, 2001). These
results suggest that Daxl and Wnt4 are both involved in the prevention of testis
formation. As Wnt4 knockout mice show a more severe phenotype compared to the
Daxl knockout mice, this is consistent with the hypothesis that Wnt4 acts upstream
of Daxl. However, it is possible that Wnt4 causes sex reversal independently of
Daxl. Further transgenic analyses need to be conducted in order to address this
issue.
In humans, an XY female with ambiguous genitalia carrying a large duplication of
chromosome lp35 including the WNT4 locus was identified (Jordan et ah, 2001).
This led the authors to hypothesise that this patient's inter-sex phenotype result from
a gain ofWNT4 function. The authors investigated this hypothesis by generating a
gain-of-function mouse model using a clone carrying the human WNT4 gene
controlled by its endogenous promoter (Jordan et al., 2003). This transgenic mouse
model showed that WNT4 overexpression interferes with the normal development of
testicular vasculature and testosterone synthesis (Jordan et al., 2003), but did not
result in an XY sex reversed phenotype as first noted in the human patient carrying a
duplication of the WNT4 locus (Jordan et al., 2001). This may be due to the
phenotype in this particular WNT4 transgenic mouse line reflecting a milder form of
the symptoms displayed in human patients or other genes which are duplicated
within the same chromosome region are necessary for a full XY sex reversal.
Alternatively, it may be due to differences between species whereby the transgenic
mouse line reacts differently or is less susceptible to WNT4.
It was once thought that Wnt4 has additional roles in female development, for
example, in the suppression of Leydig cell formation. However, it has recently been
shown that the role ofWNT4 in gonad development (Vainio et al., 1999) is to pattern
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the sex-specific vasculature and to regulate steroidogeic cell recruitment (Jeays-Ward
et al., 2003). Moreover, WNT4 represses endothelial and steroidogenic cell
migration from the mesonephros into the developing XX gonad, which prevents the
formation of a male-specific coelomic blood vessel and the production of
masculinising sex hormones (Jeays-Ward et al., 2003). Interestingly, it has been
demonstrated that WNT4 does not effect Leydig cell differentiation as Sfl:Wnt4
(BAC construct containing Wnt4 cDNA inserted into the 5'untranslated region of the
Sfl gene by homologous recombination) transgenic embryos showed that WNT4
disrupts the vascular pattern formation of the testis, but the differentiation of Leydig
cells in the XY gonad is not affected (Jeays-Ward et al., 2003). Thus, WNT4 is able
to repress the molecular pathway that controls the process of migration of at least
two different cell types from the mesonephros into the gonad. Further work will be
required to establish these molecular pathways in detail, which may lead to a better
understanding of the cell movements within the developing gonad.
1.5.6 Fibroblast Growth Factor 9 (Fgf9)
Fgf9 is one of at least 22 members of the Fgf family (Ornitz and Itoh, 2001).
Members of this family regulate many developmental processes, including
embryogenesis of the lung, limb and anterior pituitary. Fg/9 is widely expressed. In-
situ hybridisation of mouse embryos detected Fgf9 expression in skeletal myoblasts,
limb apical ectoderm, ventricular myocardium, gut luminal epithelium and the inner
ear (Colvin et al., 1999). Fgf9~/~ mice die at birth, which is most likely to be caused
by lung hypoplasia (Colvin et al., 2001). The observation that females were
dramatically overrepresented amongst Fgf9~'~ embryos led to the discovery of novel
functions for Fg/9 in sex determination and testicular development.
Mice lacking Fgf9 were found to be male-to-female sex reversed (Colvin et al.,
2001). Fg/9 is also speculated to act downstream of Sry due to reduced mesenchyme
in Fgf9~/~ XY gonads and the fact that testicular Fgf9 expression begins shortly after
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the onset of Sry expression (Colvin et al., 2001). Fgf9'/~ XY gonads also displayed
impaired Sertoli cell development, suggesting that Fgf9 could directly induce Sertoli
cell specification, proliferation and/or maintenance of differentiation. In addition,
reduced proliferation below the coelomic epithelium at E12.5 was found, indicating
that Fgf9 is required for normal proliferation at this stage. Finally, exogenous FGF9
has been shown to induce mesonephric cell migration into El 1.5 XX gonads, which
suggests that FGF9 could act as a chemotactic factor for mesonephric cells in the
early testis (Colvin et ah, 2001).
1.5.7 Mouse Homologue of Polycomb (M33)
M33, a mouse homologue of Polycomb, was isolated by means of the structural
similarity of its chromodomain (Pearce et al., 1992) to Polycomb genes in
Drosophila. The fifth exon of M33 contains a region of homology shared by
Drosophila and Xenopus (Pearce et al., 1992; Reijnen et al., 1995). Katoh-Fukui et
al. disrupted M33 in mice by inserting a poly(A) targeting vector into its fifth exon
(Katoh-Fukui et al., 1998). More than half of the resultant homozygous mutant mice
died before weaning, and intriguingly survivors demonstrated male-to female sex
reversal (Katoh-Fukui et al., 1998). Defects in the formation of genital ridges were
observed in both XX and XY homozygous mutant embryos (Katoh-Fukui et al.,
1998). Furthermore, these defects occurred at approximately the time of Sry
expression. This suggests that the deficiency ofM33 in mice may cause sex reversal
by interfering with events upstream ofSry.
1.5.8 Friend of GATA2 (Fog-2)
Friend of GATA-2 {Fog-2) is an 1,151 amino acid nuclear protein that contains eight
zinc finger motifs that are structurally related to those of FOG (Svensson et al.,
1999). Fog-2 is first expressed in the mouse embryonic heart and septum
29
Chapter 1 Introduction
transversum at E8.5 and is subsequently expressed in the developing neuroepithelium
and urogenital ridge (Svensson et ah, 1999). In the adult, Fog-2 is expressed
predominately in the heart, brain and testis (Svensson et ah, 1999).
Mice homozygous for a null allele of Fog-2 (Fog-2'A) die at mid-gestation from
cardiac defects (Svensson et ah, 2000). Examination of these mutant XY gonads at
El3.5 revealed that testicular cords were absent and semi-quantitative RT-PCR
showed a significant decrease in the Sry RNA transcript level in El 1.5 Fog-2~/~ XY
gonads when compared with Fog-2+/' and Fog-2+/+ control XY gonads (Tevosian et
ah, 2002). Fog-2 interacts directly with the N-terminal zinc finger of GATA-4 both
in vitro and in vivo (Svensson et ah, 1999). The analysis of the gonads of Gata-4"
embryos is not possible as they die at approximately E7.0-E9.5 (Kuo et ah, 1997;
Molkentin et ah, 1997). However, a Gata-4 knock-in allele (Gata-4kl) approach,
which disrupts the interaction between GATA-4 and FOG-2 (Tevosian et ah, 2002),
allows insight into the effects of the GATA-4/FOG-2 interaction in mammalian
gonad development. Analysis of Gata-4kl/kl XY gonads also revealed the absence of
testicular cords (Tevosian et ah, 2002), similar to Fog-2~'~ XY gonads. Examination
of Fog-2'1' XY and Gata-4k,/kl XY gonads showed that the expression of Sertoli cell
markers (Sox9, Mis and Dhh) were absent (Tevosian et ah, 2002). This indicates that
Sertoli cell differentiation and downstream genes of Sry are impaired in the absence
of FOG-2 or fully functional GATA-4. Taken together, Fog-2 and Gata-4 play a
crucial role in the sex development cascade.
1.6 Identification ofGenes by Microarray Screens
1.6.1. Production ofMicroarrays
In the past, comparing expression levels between different tissue samples or cell
types was restricted to testing one or a few genes at a time. With the advancement of
microarray technology, it is now possible to investigate many genes simultaneously
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and to determine which genes are being expressed in a particular cell or tissue type at
a specific time and under certain conditions. A microarray consists of multiple
features (spots) of DNA that can be used to establish the level ofmRNA expression
within different tissue samples or cell types. The DNA from each spot represents a
gene of interest and is a probe for the mRNA encoded by that gene. Each spot has a
unique DNA sequence and each spot will hybridise only to its complementary DNA
strand.
At present, microarrays can be produced by two different methods. DNA probes
may be synthesized individually, using PCR for cDNAs or chemical synthesis for
oligonulceotides. Then, these DNA probes are spotted onto the microarrays, into
very small grids, by a robot. Alternatively, DNA oligonucleotides can be
synthesized directly onto the microarrays using UV-masks and photoactivated
chemistry (Figure 1.6). This is the method currently used by Affymetrix. Probes are
synthesized in parallel, whereby an A, C, T or G nucleotide is simultaneously added
to multiple growing chains of linker molecules attached to a silane matrix (providing
a surface that can be spatially activated by light). Each growing chain is a 'site'.
Deprotected sites will have the next base (A, C, T or G) bound to them using UV
light, then the next base is bound to those sites and repeated with a different base. To
control which sites will be deprotected, a photolithographic mask which allows UV
light to activate certain sites is used. This technology by Affymetrix enables large
arrays of oligonucleotides to be produced in parallel, however each probe is a
maximum of 25 nucleotides in length due to synthesis efficiencies (Affymetrix).
1.6.2 Screening for Sex Determining Genes
Sex determination is a complicated process. Although a large number of sex-
determining genes are now known, many more genes remain unidentified. Over the
past few years, new genes involved in sex determination in mice have been isolated
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Figure 1.6 Manufacturing of Microarrays Using Photolithography and
Combinatorial Chemistry (Affymetrix)
Schematic diagram illustrating the syntheses ofDNA oligonucleotides directly onto
microarrays using UV-masks and photoactivated chemistry. (Figure adapted from
Affymetrix).
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microarrays for normalisation of male and female gonadal samples. To date only a
few of these screens have been carried out, which have led to the identification of
several new genes. For example, a suppression-subtractive hybridisation approach
was used to construct normalised cDNA libraries enriched for male-specific or
female-specific transcripts in mouse E12.5 urogential ridges and E13.5 gonads
(Grimmond et ah, 2000). Subsequently, these libraries were efficiently screened for
candidate sex determination and gonadogenesis genes, whereby Vanin-1 (Vnnl) and
Protease nexin-1 (Pn-1) were both shown to be play a role in testis development
(Grimmond et ah, 2000).
Another sex differential screen using a similar PCR-based cDNA subtraction
approach has been reported. In this screen, E12.5 XY gonadal cDNA was subtracted
with El2.5 XX gonadal cDNA, which yielded 19 genes that were expressed at
significantly higher levels in XY gonads (Menke and Page, 2002). Amongst these
was Pn-1, which again showed higher expression in male gonads than female
gonads. In a reciprocal subtraction of E12.5 XX gonadal cDNA with E12.5 XY
gonadal cDNA, two genes (Fst and Adamtsl9) were identified to be expressed at
higher levels in XX gonads (Menke and Page, 2002). The differential expression of
all these genes was verified by whole-mount in-situ hybridisation.
More recently, another subtractive hybridisation screen using E12.0 - E12.5 mouse
testis and ovaries has been conducted (McClive et ah, 2003). In this screen, 54 genes
were identified to show higher expression in the testis than in the ovary. Both Vnnl
and Pn-1 were again identified to be more highly expressed in male gonads than
female gonads. From the 19 genes found to be more highly expressed in XY gonads
previously identified by Menke and Page (Menke and Page, 2002), 4 of these genes
were also identified in the screen by McClive et al. (McClive et ah, 2003). These
genes were: Cerebellin 1 precursor protein (Cblnl), Procollagen, type IX, alpha 3
(Col9a3), Prostaglandin D2 synthase (Ptdgs) and Pn-1. In addition, McClive et ah
(McClive et ah, 2003) identified 8 genes that were novel or of unknown function.
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Plus, analysis of another 18 testis and 9 ovary genes from the same screen is ongoing
(McClive et al., 2003).
The above mentioned cDNA screenings have proven to be successful in identifying
expression differences which arise during gonadal sex differentiation, leading to the
discovery of novel sex determination candidates. However, many other genes
involved in the process of gonadal development and sex determination remain to be
identified.
1.7 FunctionalAnalysis Approaches
Studying the molecular genetics ofmammalian development is most commonly done
by the production of knockout mice. While this is an excellent method of
functionally analysing genes, this technique is not viable for investigating genes that
are necessary at multiple stages of development due to embryonic lethality or
abnormalities at the initial stage the gene is required. As a result, this prevents the
examination of downstream events. These difficulties can be overcome by advanced
transgenic techniques, such as the cre-lox system (Gu et al., 1994; Kuhn et al., 1995).
However, this is dependent upon having tissue-specific promoters that may not be
available. In addition, generation and analysis of knockout mice is time-intensive
and expensive. Taking all this into consideration, along with the fact that our aim is
to analyse the function of as many potential sex determination candidates as possible
from our microarray results, an in-vitro approach of gene-specific knockdown in
gonadal organ cultures will be attempted. This would be done using the recently










Figure 1.7 Schematic Diagram of the RNA Interference Mechanism (Figure
adapted from Dykxhoorn, Novina et al. 2003).
a) Schematic representation of a siRNA which is characterised by 5'
phosphorylated ends, a 19 nucleotide duplexed region and a 2 nucleotide
unpaired and unphosphorylated 3' ends that are characteristic of RNase III
cleavage products.
b) The siRNA pathway. Long dsRNA is cleaved by the Rnase III family member,
dicer, into siRNAs in an ATP-dependent reaction. These siRNAs are
incorporated into the RNA-inducing silencing complex (RISC) and unwound into
separate strands. The anti-sense strand then guides RISC to its homologous
target mRNA and then endonucleolytic cleavage of the target mRNA occurs.
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1.7.1 Mechanism of RNAi
RNAi is a sequence-specific, post-transcriptional gene silencing process in plants and
animals. It is triggered by double-stranded RNA (dsRNA) that is homologous in
sequence to the silenced gene (Sharp, 2001), whereby the degradation is specific to
the identified region of the dsRNA (Zamore et ah, 2000). This dsRNA is cleaved by
the "dicer" enzyme, a highly conserved family member of ribonuclease III (Bernstein
et al., 2001), to produce shorter fragments of 21- and 22-nucleotide RNAs.
Biochemical characterisation studies have shown that siRNAs are 21-22 nucleotide
dsRNA duplexes with symmetric 2-3 nucleotide 3' overhangs and 5' phosphate and
3' hydroxyl groups (Elbashir et al., 2001; Elbashir et al., 2001). These 21- and 22-
nucleotide siRNA duplexes are incorporated into a multi-protein RNA-inducing
silencing complex (RISC). Only siRNAs which are 5' phosphorylated can enter into
RISC (Nykanen et al., 2001) and those lacking a 5' phosphate are rapidly
phosphorylated by an endogenous kinase (Schwarz et al., 2002). The duplex siRNA
is unwound and separated into single strands. The anti-sense strand then guides
RISC to its homologous target mRNA, where it binds to the target mRNA for
endonucleolytic cleavage (Figure 1.7), destroying the target mRNA and thus
specifically suppressing the expression of that gene (Gura, 2000).
1.7.2 Application of siRNAs
SiRNA represents a novel method in molecular biology for analysing the function of
a specific gene in a biological system. The effect of siRNA was established in
Caenorhabditis elegans, whereby the use of dsRNA was discovered to be
significantly more effective at producing interference than either strand alone (Fire et
al., 1998). Purified anti-sense and sense RNAs were found to only have a marginal
interference activity and required a very high dose of injected RNA to produce any
visible effect. In contrast, a mixture of anti-sense and sense RNAs of the same gene
segment produced a highly effective interference activity with the endogenous gene
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(Fire et al., 1998). Since this discovery, duplex siRNA molecules have been used in
all RNAi experiments and the technique has been applied in a variety of organisms.
Recently, in the mouse, duplex siRNA was used in three-dimensional organ culture
of kidney rudiments to investigate previously inaccessible aspects of Wtl in renal
development. Using siRNA to repress Wtl expression at different stages of renal
development, Wtl was found to be required not only at the beginning but also later
for nephron differentiation (Davies et al., 2004). In addition, RNAi for the Paired
box gene 2 (Pax2) and Wnt4 siRNAs display phenotypes that are in accordance with
in vitro observations made on the interactions of these genes. Pax2 is known to bind
and transactivate the Wtl promoter in vitro (Dehbi et al., 1996; McConnell et al.,
1997). Using Pax2 siRNAs, Wtl expression is repressed and both bud growth and
nephron differentiation is blocked (Davies et al., 2004). However, Wnt4 siRNAs
blocks nephron differentiation without having an affect on Wtl expression (Davies et
al., 2004). This is in line with Wnt4v~ knockout mice, where the basic mesenchymal
expression of Wtl is unchanged (Sim et al., 2002). Thus, the use of siRNAs to
knockdown gene expression was successful in this organ culture system.
The use of siRNA in gene expression knockdown is being adapted for various culture
systems. However, to date, siRNA has never been applied in gonadal organ cultures.
Analysis of a large number of sex-determining genes is time-consuming, therefore an
in vitro approach of gene specific knockdown would be advantageous. Thus, the
development of a system that could be used on a wide-scale was required and such a
system could be based on siRNA. We believe that the establishment of siRNA in
gonadal organ cultures would be an alternative approach for allowing many sex
determination genes to be functionally analysed.
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1.8 Aims and Summary ofProject
This thesis describes a project that aims to further identify new genes involved in the
development of the gonad, which may lead to a better understanding of the male and
female developmental pathways. Therefore, a sex determination screen using
Affymetrix GeneChip arrays will be performed as they provide the largest, most
complete set of mouse transcripts available at the time. Wild-type E12.5 male and
female gonads will be used for our screen. More specifically, each embryo will be
quantitatively staged to ensure more accuracy of the developmental time point and
only gonads staged between 28 to 30 tail somites will be used. The trigger for sex
determination is controlled by the expression of Sry, which peaks at El 1.5. Using
E12.5 gonads, which reflects a time point shortly after the initiation of sex
determination, will allow the isolation of genes at a very early stage of the sex
determination process rather than genes expressed in the already differentiated
tissues of the ovary or testis. The mesonephros will be removed from each gonad to
increase the sensitivity of our screen and focus on genes directly involved in sex
determination.
Following the Affymetrix sex determination screen, microarray data will need to be
verified to ensure that the results show sex differentially expressed genes. This will
first be done by whole-mount in-situ hybridisation of male and female gonads at
El2.5. Initially, a known sex differentially expressed gene, also identified from the
screen, will be used. If this is confirmed to be sex differentially expressed, a number
of novel candidates showing the largest differences between male and female
expression will then be selected for further analysis. Extending this analysis,
transcripts that are shown to be sex differentially expressed will be selected for a
more detailed expression profile analysis. This will involve further in-situ
hybridisation of male and female gonads at El 1.5, E13.5 and E14.5. In addition, in-
situ hybridisation of E14.5 gonadal sections will be performed in an attempt to
identify the specific cell type within which each gene is expressed. Real-time PCR
of these candidates will also be carried out to verify the fold changes from the
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microarray analysis and to determine a specific gonadal development gene
expression profile, ranging from 17 to 36 tail somites.
It would also be interesting to analyse the function of these potential candidates. Due
to the expected high number of candidates that may arise, a fast yet efficient
approach was needed. It was therefore decided to attempt the novel approach of
applying siRNAs to a gonadal organ culture system. Once this system is established,
the function ofmany potential sex determination candidates can be analysed.
In this thesis, chapter 3 describes the Affymetrix sex determination screen, along
with the results obtained and analysis of the microarray data. Verification of this
microarray data set is described in chapter 4, whilst chapter 5 shows a detailed
analysis of three novel sex determination candidates identified from the screen.
Finally, chapter 6 describes the novel approach of applying siRNAs to a gonadal
organ culture system. It shows the establishment of this system by illustrating
several known sex determination genes were successfully targeted and knocked-
down by applying this technique. Importantly, siRNA against Sry effectively
blocked male gonad differentiation resulting in a lack of expression ofmale specific
markers. Taken together these results suggest that the siRNA approach in gonad
cultures can be used to efficiently analyse the function of candidate genes isolated in
our sex determination screen. This may lead to a better understanding of the sex
development pathways.
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2.1 Manipulation ofNucleic Acids
2.1.1 General Reagents Used in Molecular Biology Procedures
All chemicals were analytical grade and were supplied by Sigma, Promega, Gibco
BRL, Flowgen, Fisher Scientific, Invitrogen, Roche and Boehringer Mannheim.
General solutions were prepared, autoclaved and stored at room temperature.
Tris.HCl:
Tris base (tris[hydroxymethyl]aminomethane) was dissolved in sterile water. HC1
was used to adjust the pH to the required value.
EDTA:
EDTA (ethyldiaminetetra-acetic acid di-sodium salt) was dissolved in sterile distilled
water. The solution was adjusted to pH8.0 by adding solid NaOH pellets.
TE Buffer:
lOmM Tris.HCl (pH7.5); ImM EDTA.




Distilled water was added to a final volume of 1 litre. Stock was diluted to IX with
distilled water.
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2.1.2 DNA Electrophoresis
DNA molecules were separated according to their size by agarose gel electrophoresis.
Agarose Gel Loading Buffer:
Loading buffer was prepared as a 10X stock and stored at room temperature.
Final concentration
Made to required volume with distilled water.
Gels were prepared by heating and dissolving the required amount of agarose (Q-
BioGene) in IX TBE. Molten agarose was cooled and ethidium bromide added to a
final concentration of 50/xg/100ml agarose. The percentage of agarose used was
dependent on the size range of the DNA molecules to be separated. PCR products
were generally run on 1% - 2% agarose gels. DNA size markers were run alongside
experimental samples to estimate the size and amount of DNA in the samples. The
size marker used routinely was bacteriophage lamda DNA digested with HindllI ('A,')
(Gibco). Samples were run in IX loading buffer. Following electrophoresis DNA
fragments were visualised on an UV trans-illuminator. IfDNA fragments were to be
purified from the gel then low melting point agarose (Flowgen) was used and the
DNA was recovered using a gel extraction kit (Qiagen), according to the
manufacturer's instructions.
2.1.3 DNA Quantification
DNA concentrations were determined either by agarose gel electrophoresis or by
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To determine the concentration by electrophoresis, several different volumes of the
DNA (e.g. 1, 3 and 5/rl) were run alongside standard amounts ofDNA (usually DNA
size markers). An estimate of the concentration was made by visual comparison of
the intensity of the sample's fluorescence to that of the known amounts of DNA
under UV illumination.
To determine the concentration with a spectrophotometer, the DNA sample was
diluted 1:100 with dH20. The spectrophotometer was calibrated using a water only
blank sample. The samples were placed in clean cuvettes and the absorbance at
260nm (A260) was measured. The concentration of the original sample was
calculated as follows:
Concentration (mg/ml) = A26o x 100 (dilution factor) x 50 (conversion factor).
2.1.4 Restriction Digests
Restriction enzymes were either purchased from Amersham, Promega or Boehringer
Mannheim. Digestions of DNA with restriction endonucleases were carried out in
the appropriate buffer using the optimal conditions as recommended by the particular
manufacturer. Digests were performed using IX buffer, DNA (lOng - 1/rg/p.l) and
0.5 - 5 units of enzyme per fxg ofDNA. The total volume of enzyme never exceeded
10% of the reaction volume to avoid glycerol inhibition of digestion. Incubations
were at 37°C, unless otherwise instructed, for periods from 1 hour to overnight.
2.1.5 PCR
DNA molecules were amplified by polymerase chain reaction (PCR). Primers were
purchased from Invitrogen as lyophilised desalted compounds. Stocks were made up
to 500ng/pil using sterile dH20. Working stocks were diluted to lOng/jitl (1:50
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dilution). Primers were used in PCRs at a final concentration of lng/ptl (1:10
dilution). REDTaq1M ReadyMix™ PCR Reaction Mix (Sigma) containing
AmpliTag, PCR buffer, dNTPs, Mg2+ and gel loading buffer was routinely used at
10/xl per 20/ri reaction. PCRs were done in a MJ Research DNA Engine Tetrad.
100ng-200ng of genomic DNA/cDNA was used for PCR reactions. Generally all
PCR programmes were identical (35 cycles), except the annealing temperature was









45 seconds } x 34 cycles
1 minute }
9 minutes
2.1.6 Generation of DNA Templates for Riboprobes
DNA templates for riboprobes were generated by PCR amplification using primers
with T3 and T7 promoter sequences incorporated into their design (see Appendix 1).
All primers were purchased from Invitrogen as lyophilised desalted compounds and
made up as described in section 2.1.5. JumpStart Taq (Sigma) was used in an
attempt to reduce non-specific priming and the formation of primer dimers.
JumpStart Taq (Sigma) is a Taq DNA polymerase with a neutralizing antibody
rendering it inactive at room temperature. Its activity is restored once the reaction
temperature reaches 70°C. PCR reactions were set up as follows:
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2X JumpStart™ REDTaqIM ReadyMixllvl PCR Reaction Mix (Sigma)
Primer 5' (10ng//ri)
Primer 3' (10ng//xl)










94°C 45 seconds }
n°C (variable annealing temperature) 45 seconds } x 34 cycles
72°C 1 minute }
72°C 9 minutes
The correct PCR products were excised from the gel and the DNA was recovered
using a gel extraction kit (Qiagen), according to the manufacturer's instructions.
DNA was stored at -20°C until labelling with digoxygenin (section 2.5.1).
2.2 RNA Manipulation
2.2.1 Preparation of RNA
Cells were treated with 0.25% trypsin/EDTA (Gibco) to detach them from the dish
and collected into a loose pellet by centrifugation at a low speed (3000rpm) for 5
minutes. The supernatant was removed before cells were flash-frozen in liquid
nitrogen and stored at -80°C. Dissected/cultured gonads were also immediately
flash-frozen in liquid nitrogen to minimise RNA degradation and then stored at -
80°C. Total RNA was isolated from flash-frozen samples using an Absolutely RNA
RT-PCR Mini-prep kit (Stratagene). Manufacturer's instructions were followed and
eluted RNA samples were stored at -80°C.
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2.2.2 cDNA Synthesis and RT-PCR
2-5fig of total RNA from each sample was diluted with sterile dH20 to bring the
volume to 18/xl and then 2/xl of 1.5mM random hexamer (Amersham) was added.
Samples were denatured at 95°C for 5 minutes and then placed on ice. 8/xl of 5X
reaction buffer (Gibco), 2/xl of lOOmM DTT (Gibco), 8/xl of 2.5mM dNTP mix
(Promega), 2/xl of RNase inhibitor (Roche) and 3jttl ofM-MLV reverse transcriptase
(Gibco) was added to each sample. Samples were incubated at 37°C for 1 hour, then
heated at 95°C for 5 minutes and the resulting cDNA was stored at -20°C until
required. RT-PCR was carried out as described in section 2.1.5.
2.3 Mouse Experiments
All animals were maintained in a specific pathogen free (SPF) environment and
experiments were carried out under Home Office licence. Wild-type animals were
either bred in-house or obtained from Charles River Laboratories. Breeding animals
were maintained on a C57/B1-6 background.
2.3.1 Mouse Strains and Timed Matings
C57/B1-6 mice were used in all wild-type timed matings. Only Sox8++ mice (from
Dr Michael Wegner) were used in Sox8 experiments (Sock et al., 2001). Embryos
for all experiments were generated from timed matings, with the morning of vaginal
plug detection being counted as embryonic day 0.5 (E0.5).
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2.3.2 Genotyping of Embryos
Genotyping by PCR amplification was performed to determine the sex of each
embryo. Genomic DNA derived from embryo heads or embryonic yolk sacs (for
intact whole-mount in-situ hybridisation embryos) was digested in 300/rl of mouse
tail buffer/proteinase K at 55°C for 2-3 hours and then stored at -20°C overnight.
During setup of PCR reaction mix, DNA samples were centrifuged at 4°C and 0.2/xl







Proteinase K (stock lOmg/ml) (Sigma) was added at time of use to a final
concentration of 0.2mg/ml.
The following pairs of primers (purchased from Invitrogen as lyophilised desalted
compounds) were used in the same reaction:
Zfy 5' (forward primer): GAC TAG ACA TGT CTT AAC ATC TGT CC
Zfy 3' (reverse primer): CTT ATT GCA TGG ACT GCA GCT TAT G
Pax6 H499 (forward primer): CTT TCT CCA GAG CCT CAA TCT G
Pax6 H500 (reverse primer): GCA ACA GGA AGG AGG GGG AGA
The Y chromosome-linked Zfy primers were used to identify male samples and the
Pax6 primers were used as an internal control. Thus, male samples show two DNA
bands (Zfy and Pax6, approximately 200bp and 150bp respectively), whilst female
samples show one DNA band (Pax6, approximately 150bp).
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PCR Reaction Mix:


























2.3.3 Quantitative Staging of Embryos
Embryos were quantitatively staged by tail somite counting, beginning at the first
somite posterior to the hind limb towards the tip of the tail. Using this method,
E10.5 embryos corresponds to approximately 8 tail somites, El 1.5 embryos
corresponds to approximately 18 tail somites, and E12.5 embryos corresponds to
approximately 30 tail somites (Hacker et ah, 1995; Schmahl et ah, 2000).
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2.4 Affymetrix GeneChip Microarrays
2.4.1 RNA Isolation
Wild-type E12.5 gonads were dissected in PBS, transferred to 1.5ml microfuge tubes,
immediately snap-frozen in liquid nitrogen and stored at -80°C. After the genotype
of each pair of gonads was determined by PCR amplification (as described in section
2.3.2), gonads of the same sex were pooled together. Only gonads quantitatively
staged between 28 to 30 tail somites (as described in section 2.3.3) were used. The
Absolutely RNA RT-PCR Mini-prep kit (Stratagene) was used for RNA isolation
and manufacturer's instructions were followed. A total of 52 male gonads and 52
female gonads were pooled in screen 1, which yielded 6.00/ig and 4.60jU.g of RNA
respectively. For screen 2, a total of 20 male gonads and 20 female gonads were
pooled, which yielded 2.64/ig and 1.43/xg ofRNA respectively. RNA was quantified
by measuring the absorbance at 260nm (A260) using a spectrophotometer. The
concentration of each sample was calculated as follows:
Concentration (/rg//rl) = A260 x dilution factor x 0.04 (conversion factor).
2.4.2 Screen 1
For screen 1, double-stranded cDNA was synthesized from total RNA using cDNA
Synthesis System (Roche). All components were contained in kit. Following
manufacturer's instructions, 2/xl of oligo [(dT)24 T7 promotor]65 primer was added to
each RNA sample and incubated at 70°C for 10 minutes and then placed on ice. 8jul
5X RT-buffer, 4/xl 0.1M DTT, 2/zl AMV, 1/xl RNase inhibitor and 4/xl lOmM dNTP
mix were added to each sample, gently mixed and incubated at 42°C for 1 hour.
Tubes were then placed on ice to terminate this first strand reaction. For second
strand synthesis, 30/xl 5X second strand buffer, 1.5/xl lOmM dNTP mix, 6.5/zl second
strand enzyme blend, 72/rl redistilled water was added to the first strand reaction.
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Samples were gently mixed and incubated at 16°C for 2 hours. 20/rl T4 DNA
polymerase was added and incubated at 16°C for 5 minutes. The reaction was
stopped by adding 17/xl 0.2 M EDTA (pH 8.0). To digest the residual RNA, 1,5/xl
RNase I was added and samples were incubated at 37°C for 30 minutes. Then, 5/xl
Proteinase K was also added and samples were incubated for another 30 minutes at
37°C. Phenol was used to clean-up the double-stranded cDNA, followed by ethanol
precipitation. Each pellet was dissolved in 6/xl RNase-ffee water. The synthesis of
double-stranded cDNA was checked by running a small aliquot on a 1% agarose gel.
Following the synthesis of double-stranded cDNA, the in-vitro transcription labelling
reaction was set up as detailed below:
NTP labelling mix for 1 reaction:
2fil 10X ATP (75mM; Ambion)
2/xl 10X GTP (75mM; Ambion)
1.5/xl 10X CTP (75mM; Ambion)
1.5/xl 10X UTP (75mM; Ambion)
3.75/xl Bio-11-CTP (lOmM; Affymetrix)
3.75/xl Bio-16-UTP (lOmM; Affymetrix)
For each in-vitro transcription labelling reaction:
6/xl double-stranded cDNA
14.5/xl NTP labelling mix (as described above)
2.5fil 10X T7 transcription buffer (Ambion)
2/xl 10X T7 enzyme mix (Ambion)
Samples were incubated at 37°C for 5 hours. 75/xl DEPC-treated water was added to
each cRNA product and the RNeasy Mini Kit (Qiagen), following manufacturer's
instructions, was used to clean-up the labelled cRNA. A small aliquot was taken to
measure the absorbance at 260nm (A260), determining the amount of labelled cRNA
obtained. The concentration of each sample was calculated as follows:
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Concentration (/xg//xl) = A26o x dilution factor x 0.04 (conversion factor).
The male pool of gonads resulted in 8.76/xg of labelled cRNA and the female pool of
gonads resulted in 6.96/xg of labelled cRNA. 5jUg of labelled cRNA from each pool
was fragmented and hybridised onto separate microarrays (section 2.4.4).
2.4.3 Screen 2
For screen 2, the small sample labelling protocol version II produced by Affymetrix
was used. Following their recommendations, 1/xl T7-01igo(dT) promoter primer
(5/xM; Affymetrix) was added to each RNA sample and incubated at 70°C for 6
minutes and then cooled to 4°C for 2 minutes. Meanwhile, the RT_Premix_l was




5X first strand buffer (Invitrogen) 4/xl
0.1M DTT (Invitrogen) 2/xl
1 OmM dNTP mix (Invitrogen) 1.5/xl
RNase inhibitor (Roche) 1/xl
Superscript II (Invitrogen) 2/xl
Total volume 12/xl
3/xl of the RT_Premix_l was added to each sample, mixed thoroughly and incubated
at 42°C for 1 hour. Samples were then heated at 70°C for 10 minutes to inactivate
Superscript II. Tubes were placed on ice to cool while the SS_Premix_l was
prepared.
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5X second strand buffer (Invitrogen)
1OmM dNTP mix (Invitrogen)
DNA ligase (Invitrogen)










32.5/xl of the SS_Premix_l was added to each first strand reaction. Components
were mixed thoroughly and incubated at 16°C for 2 hours. 1/xl T4 DNA polymerase
(Invitrogen) was added and incubated at 16°C for 10 minutes. This first cycle
double-stranded cDNA was cleaned-up by ethanol precipitation and pellets were
dried in a speed vacuum.
At room temperature, the following reagents from the MEGAscript T7 kit (Ambion)
were added to the dried double-stranded cDNA pellet:
For 1 reaction
DEPC-treated water 4/1.1
Pre-mixed NTPs, 18.75mM each 4/xl
1OX reaction buffer 1 /xl
10X enzyme mix 1/xl
Total volume 10/xl
Components were mixed thoroughly and incubated at 37°C for 5-6 hours. This first
cycle in-vitro transcription reaction resulted in amplification of the cRNA. 90/xl of
RNase-free water was added to each cRNA product and the RNeasy Mini Kit
(Qiagen), following the RNeasy Mini Protocol from manufacturer's handbook, was
used to clean-up the cRNA.
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The entire cRNA elute was used in the second cycle amplification reaction.
Beginning with the second cycle first strand cDNA synthesis, 1 /il random primers
(Invitrogen) was added to each cRNA sample, mixed thoroughly, incubated at 70°C
for 10 minutes and then cooled on ice for 2 minutes. Meanwhile, the RT_Premix_2
was prepared.
RT Premix 2:
5/xl of the RT_Premix_2 was added to each sample, mixed thoroughly and incubated
at 42°C for 1 hour. To remove the RNA template, l/xl RNase H (Invitrogen) was
added and samples were incubated at 37°C for 20 minutes. To inactivate the RNase
H, samples were heated at 95°C for 5 minutes and then chilled on ice for 2 minutes.
To synthesize the second strand of the second cycle cDNA, 2/xl T7-01igo(dT)
promoter primer (5/xM; Affymetrix) was added to each chilled sample, mixed
thoroughly and incubated at 70°C for 6 minutes. Tubes were placed on ice to cool
while the SS_Premix_2 was prepared.
For 2 reactions
5X first strand buffer (Invitrogen)
0.1M DTT (Invitrogen)















5X second strand buffer (Invitrogen) 15/xl
1 OmM dNTP mix (Invitrogen) 1.5/xl
DNA polymerase I (Invitrogen) 2/xl
Total volume 62/xl
62jtil of the SS_Premix_2 was added to each sample, mixed thoroughly and
incubated at 16°C for 2 hours. Then 2/xl T4 DNA polymerase (Invitrogen) was
added, mixed thoroughly and incubated at 16°C for 10 minutes. This second cycle
double-stranded cDNA was cleaned-up by ethanol precipitation and pellets were
dried in a speed vacuum. cDNA pellets were stored at -20°C overnight before
proceeding to the second cycle of in-vitro transcription and labelling reaction.
At room temperature, the following reagents from the ENZO BioArray High Yield
RNA Transcript Labelling Kit (Affymetrix) were added to the dried double-stranded
cDNA pellet from the previous step:
For 1 reaction
DEPC-treated water 22/xl
10X HY reaction buffer 4/xl
10X Biotin labelled ribonucleotides 4/i\
10X DTT 4fil
10X RNase inhibitor mix 4ill
20X T7 RNA polymerase 2ill
Total volume 40/xl
Components were thoroughly mixed and the pellet was completely dissolved before
samples were incubated at 37°C for 4-5 hours. 60/xl ofRNase-free water was added
to each cRNA product and the RNeasy Mini Kit (Qiagen), following the RNeasy
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Mini Protocol from manufacturer's handbook, was used to clean-up the labelled
cRNA. A small aliquot was taken to measure the absorbance at 260nm (A260),
determining the amount of labelled cRNA obtained. The concentration of each
sample was calculated as follows:
Concentration (/xg//xl) = A260 x dilution factor x 0.04 (conversion factor).
The male pool of gonads resulted in 17.52/xg of labelled cRNA and the female pool
of gonads resulted in 16.48/xg of labelled cRNA. 15/xg of labelled cRNA from each
pool was fragmented and hybridised onto separate microarrays (section 2.4.4).
2.4.4 Fragmentation and Hybridisation
2.4.4.1 Solutions for Fragmentation and Hybridisation
5X Fragmentation Buffer:




Store at room temperature
12X MES Stock Buffer:
70.4g MES free acid monohydrate (Sigma)
193.3g MES Sodium Salt (Sigma)
800ml Molecular Biology Grade water (BioWhittaker)
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2X Hybridisation Buffer:
8.3ml 12X MES Stock Buffer
17.7ml 5M NaCl
4.0ml 0.5M EDTA
0.1ml 10% Tween 20 (Sigma)
19.9 ml dH20
2.4.4.2 Fragmentation and Hybridisation Procedure
16pl of labelled cRNA (5pg in screen 1, 15/xg in screen 2) was fragmented in 4/xl 5X
fragmentation buffer by incubating at 95°C for 35 minutes and then placed on ice to
cool.
Component Screen 1 Screen 2















2X Hybridisation Buffer lOOpl 150pl
dH20 To final volume of 250pl To final volume of 300pl
Final Volume 250pl 300pl
Table 2.1 Hybridisation Cocktail for Single Probe Array
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The above components were mixed for each fragmented cRNA target for
hybridisation to multiple probe arrays (as recommended by Affymetrix).
Probe arrays were equilibrated to room temperature immediately before use.
Affymetrix Mouse U74Avl and U74Bvl GeneChips were used in screen 1. In
screen 2, the complete set of Affymetrix Mouse U74v2 GeneChips (A, B and C) was
used. Once equilibrated, arrays were filled with 250pl IX hybridisation buffer and
incubated at 45°C for 10 minutes with rotation. Meanwhile, each hybridisation
cocktail was heated to 99°C for 5 minutes and then incubated at 45°C for 5 minutes.
Hybridisation cocktails were centrifuged for 5 minutes to remove any insoluble
material from the hybridisation mixture. The buffer solution was removed from the
probe array cartridge and replaced with the relevant hybridisation cocktail (avoiding
any insoluble matter at the bottom of the tube). Probe arrays were placed in a 45°C
rotating oven (Affymetrix) and hybridisation occurred for 16 hours.
2.4.5 Washing, Staining and Scanning
2.4.5.1 Solutions for Washing, Staining and Scanning
Non-Stringent Wash Buffer:
300ml 20X SSPE (3M NaCl, 0.2M NaH2P04, 0.02M EDTA; BioWhittaker)
lml 10% Tween 20 (Sigma)
698ml dH20
Filter sterilise (0.2/xm)
Add lml 5 % Antifoam (Sigma)
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Stringent Wash Buffer:
83.3ml 12X MES Stock Buffer
5.2ml 5M NaCl




41.7ml 12X MES Stock Buffer
92.5ml 5M NaCl
2.5ml 10% Tween 20 (Sigma)
112.8ml dH20
Filter sterilise (0.2/xm)
Add 0.5ml 5 % Antifoam (Sigma)
SAPE Stain Solution:
600|al 2X Stain Buffer
540|ul dH20
48pl 50mg/ml acetylated BSA (Gibco)
12)0.1 lmg/ml SAPE (Molecular Probes)
Mix well and divide into two aliquots of 600|ol each to be used for stains 1 and 3
respectively.
Antibody Solution:
300jul 2X Stain Buffer
266.4 dH20
24pl 50mg/ml acetylated BSA (Gibco)
6|ul lOmg/ml normal goat IgG (Sigma)
3.6fol 0.5mg/ml biotinylated anti-streptavidin goat antibody (Vector Laboratories)
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10mg/ml Goat IgG Stock (Sigma):
Resuspend 50mg in 5ml PBS
Store at 4°C
2.4.5.2 Washing, Staining and Scanning Protocol
EukGE-WS2
Post Hyb Wash #1 10 cycles of 2 mixes/cycle with non-
stringent wash buffer at 25°C
Post Hyb Wash #2 4 cycles of 15 mixes/cycle with stringent
wash buffer at 50°C
Stain Stain probe array for 10 minutes in SAPE
stain solution at 25°C
Post Stain Wash 10 cycles of4 mixes/cycle with non-
stringent wash buffer at 25°C
Second Stain Stain probe array for 10 minutes in
antibody solution at 25°C
Third Stain Stain probe array for 10 minutes in SAPE
stain solution at 25°C
Final Wash 15 cycles of 4 mixes/cycle with non-
stringent wash buffer at 30°C. The
holding temperature is 25°C.
Table 2.2 Fluidics EukGE-WS2 protocol for washing and staining standard
probe arrays
Hybridisation cocktails were removed from each probe array cartridge and stored at -
80°C. Probe arrays were filled with non-stringent wash buffer and inserted into the
fluidics station (Affymetrix). Following Affymetrix's technical manual, the fluidics
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station (Affymetrix) was setup to wash and stain each microarray using the EukGE-
WS2 protocol (Table 2.2).
After washing and staining, the probe arrays were ejected from the fluidics station
(Affymetrix) and placed into the HP GeneArray scanner (Affymetrix). Probe arrays
were scanned and data was acquired. Data for all chips were analysed using
Affymetrix Microarray Suite (version 4.0.1 in screen 1 and version 5.0 in screen 2).
2.5 RNA In-situ Hybridisation
2.5.1 Labelling Riboprobes with Digoxygenin
Riboprobes were labelled with digoxygenin for non-radioactive in-situ hybridisation.
The polymerases, DIG labelling mix, transcription buffer and RNase inhibitor were
purchased (Roche). Plasmids containing the riboprobe were linearised with an
appropriate restriction enzyme. DNA templates containing the riboprobe generated
from T3 and T7 PCR amplification (as described in section 2.1.6) did not require
linearisation. The labelling reaction was setup as below and incubated at 37°C for 2
hours.
dH20 13pil-x/xl
1 OX Transcription Buffer 2ptl
1OX NTP mix-DIG labelled UTP 2jul
Linearised DNA x/xl
RNase Inhibitor 1/rl
Polymerase (T3 or T7) 2^1
20fil
59
Chapter 2 Materials and Methods
Template DNA was digested by adding 2/xl DNase 1 (RNase free) (Roche) for 15
minutes at 37°C. The labelled RNA was precipitated with 2.5/xl 3M NaOAc and
75/il 100% ethanol at -80°C for 30 minutes. Tubes were then centrifuged at 4°C for
20 minutes at maximum speed. The pellet was washed with 50/xl cold 70% ethanol
and resuspended in 30/xl DEPC-treated dHhO. 1 /xl RNase inhibitor was added. The
RNA was checked by electrophoresis.
2.5.2 Whole-mount In-situ Hybridisation
Wild-type embryos were processed for whole-mount in-situ hybridisation. Embryos
were dissected in PBS and the head (or embryonic yolk sac for intact embryos) was
used for genotyping. All steps were done at room temperature unless stated
otherwise. Solutions were made up using DEPC-treated water and PBS for steps up
to and including the hybridisation step. These solutions were DEPC-treated by
adding l/il/ml DEPC (Sigma) to sterile water or PBS, gently shaking at room
temperature for several hours (usually overnight) prior to re-autoclaving.
2.5.2.1 Solutions for Whole-mount In-situ Hybridisation






25ml 1M Tris.HCl (pH8)
426.5ml DEPC H20
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PBT:
PBT was prepared fresh each time by adding 0.5ml 10% Triton X-100 to 50ml




Dissolve above in 400ml dH20
Adjust to pH7 with conc. HC1
Adjust to 500ml with dH20
Treat with 0.01% DEPC
Autoclave
Heparin (Sigma):
lOOmg/ml in 4X DEPC-SSC
Store at -20°C
Hybe Buffer:
50ml De-ionised Formamide (Sigma)
25ml 20X DEPC-SSC
50/xl Heparin
lOOjul Tween 20 (Sigma)
20ml DEPC H20
Adjust to pH6 with 1M citric acid




Add 0.1% Tween 20 (Sigma) before use
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125ml 1M Tris.HCl (pH7.5)
Adjust to 500ml with dH20
SSC/FA/Tween 20: (prepared fresh each time, not autoclaved)
5ml 20X SSC
25ml Formamide (Sigma)
50/rl Tween 20 (Sigma)
Adjust to 50ml with dH20
MAB:
11,6g Maleic acid (Sigma)
8.8g NaCl
Add 800ml dH20
Adjust with NaOH to pH7.5
Adjust to 1L with dH20
MABT:
MAB + 0.1% Tween 20 (Sigma)
NTMT: (prepared fresh each time, not autoclaved)
lml 5M NaCl
2.5ml IMMgCh
50pil Tween 20 (Sigma)
5ml 1M Tris.HCl (pH9.5)
500/xl 200mM Levamisole (final conc.: 2mM)
Add 41ml dH20
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10% Blocking Solution:
Dissolve lOg blocking reagent (Roche) in 100ml MAB
Autoclave and store at -20°C
Add 0.1% Tween 20 (Sigma) before use
2.5.2.2 Procedure for Whole-mount In-situ Hybridisation
Embryos were prepared by first fixing in 4% PFA at 4°C overnight. PFA was
removed and embryos were washed with PBT twice for 10 minutes each. Embryos
were dehydrated through a methanol series of increasing concentrations (25%, 50%,
75% methanol/PBT and twice with 100% methanol) for 10 minutes each, then stored
in 100% methanol at -20°C.
Embryos were rehydrated through a decreasing methanol concentration series (75%,
50%, 25% methanol/PBT and twice with PBT) for 10 minutes each, then bleached
with 6% hydrogen peroxide in PBT for 30 minutes. Embryos were washed three
times in PBT for 5 minutes each and digested in 20jUg/ml proteinase K in PBT for
appropriate time (2 minutes for E10.5, 4 minutes for El 1.5, 6 minutes for E12.5, 8
minutes for E13.5 and 10 minutes for E14.5). Embryos were washed in freshly
prepared PBT/glycine twice for 5 minutes each. Then further washed for 5 minutes
each with PBT twice, RIPA buffer three times and PBT three times. Embryos were
re-fixed in freshly prepared 4% PFA/0.2% glutaraldehyde in PBT for 20 minutes on
ice and then washed three times with PBT for 5 minutes each. Embryos were placed
in 2ml screw cap vials and washed in hybe buffer/PBT (1:1) for 10 minutes, then
with hybe buffer for 10 minutes and then incubated in hybe buffer for 3 hours at
65°C. Probes were diluted in hybe buffer (1:200 - 1:1000 dilution) and denatured at
80°C for 3 minutes. Probes were transferred to corresponding embryos and
hybridised at 65°C overnight.
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The following day, the probe was removed and embryos were washed twice with
hybe buffer at 65°C for 30 minutes each, then once in 1:1 hybe
buffer/SSC/FA/Tween 20 at 65°C for 5 minutes. Embryos were then subjected to a
series of SSC/FA/Tween 20 washing steps at 65°C: 5 minutes twice, 10 minutes
three times, 30 minutes once and 1 hour five times. Embryos were cooled down to
room temperature and washed with 1:1 SSC/FA/Tween20/TBST for 10 minutes, then
washed twice with TBST and twice with MABT for 10 minutes each. Embryos were
transferred into glass vials and pre-blocked with 10% blocking solution/MABT for 1
hour, then incubated with anti-DIG AP fab fragment (1:5000 dilution; Roche) in 1%
blocking solution at 4°C overnight while gently shaking.
The next day, the antibody was removed and embryos were washed three times in
TBST for 5 minutes each and a further five times in TBST for 2 hours each.
Embryos were left gently shaking in TBST at 4°C overnight.
Finally, embryos were prepared for staining by washing three times in NTMT for 20
minutes each. Embryos were stained in BM Purple AP substrate (Roche) with 1%
Tween 20 and 2mM Levamisole in the dark. Embryos were checked every 30
minutes until the stain developed. Embryos were fixed using 4% PFA.
2.5.3 RNA Insitu Hybridisation on Wax Sections
Wild-type E14.5 embryos were used for in-situ hybridisation on wax sections.
Embryos were dissected in PBS and the head of the embryos was used for
genotyping. Gonads were fixed in 4% PFA at 4°C overnight. PFA was removed and
gonads were washed three times in PBT for 5 minutes each on ice. Gonads were
dehydrated through a methanol series of increasing concentrations (30%, 50% and
three times 80% methanol/PBT) for 10 minutes each and then stored in 80%
methanol at -20°C until ready for sectioning.
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2.5.3.1 Preparation of Sections
Gonads were hand-processed for paraffin wax-embedding, firstly by 100% methanol,
three times for 5 minutes each on ice, then twice in xylene for 10 minutes each at
room temperature before three times in pre-warmed wax at 58°C for 10 minutes each.
Gonads were embedded in wax immediately after processing. 10/xm transverse
sections were cut on a microtome (Leica 2030) by Dr Robert Watson and sections
were floated out into a 42°C waterbath and collected onto superfrost glass slides
(BDH). Sections were air-dried for at least one hour and stored at 4°C until ready for
hybridisation.
2.5.3.2 Solutions for RNA In-situ Hybridisation on Wax Sections
Pre-hybridisation Solution:
25ml De-ionised Formamide (Sigma)
12.5ml 20X SSC (3M NaCl, 0.3M Na3Citrate, DEPC-treated)
lg Blocking Powder (Boehringer Mannheim)
0.5ml 10% Trition X-100 (Sigma)
2.5ml 10% CHAPS (Sigma)
lml Yeast RNA (50mg/ml; Sigma)
0.5ml 0.5M EDTA
250/rl Heparin (lOmg/ml; Sigma)
Adjust final volume to 50ml with DEPC H2O
Hybridisation Solution:
Heat 2/xl RNA probe in 100/xl pre-hybridisation solution to 80°C for 3 minutes and
add to slides.
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0.5ml 10% Trition X-100 (Sigma)
2.5ml 10% CHAPS (Sigma)
Adjust final volume to 50ml with dH20
TNT:
2.5ml 1,5M Tris (pH7.5)
1.5ml 5M NaCl
0.5ml 10% Trition X-100 (Sigma)
Adjust final volume to 50ml with dH20
Blocking Solution:
7.5ml Sheep Serum (heat inactivated)
lg BSA (Sigma)
2.5ml 1M Tris (pH7.5)
1.5ml 5M NaCl
0.5ml 10% Trition X-100 (Sigma)
Adjust final volume to 50ml with dH20
Antibody Solution:
Add 1:2000 anti-DIG AP fab fragment (Roche) to fresh blocking solution (5gl
antibody per 10ml blocking solution).
NMT:
5ml 1M Tris (pH7.5)
lml 5M NaCl
2.5ml 1M MgCl2
Adjust final volume to 50ml with dH20
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Staining Solution:
3.3/zl/ml NBT (Roche) and 3.5/il/ml BCIP (Roche) in NMT
2.5.3.3 Procedure for RNA In-situ Hybridisation on Wax Sections
Slides were placed in coplin jars and sections were de-waxed with two 10-minute
washes in xylene, then washed in two 5-minute washes of 100% methanol and
rehydrated through a decreasing methanol concentration series (70%, 50%, 30%
methanol/PBT and three times with PBT) for 5 minutes each. Sections were fixed in
4% PFA for 10 minutes, washed three times with PBT for 5 minutes each, then
digested in 10/ig/ml Proteinase K in PBT for 5 minutes and further washed three
times with PBT for 5 minutes each. Slides were transferred to a humidified chamber
and incubated with 1ml pre-hybridisation solution/slide for 4 hours at 65°C. The
pre-hybridisation solution was removed and replaced with 200/xl hybridisation
solution/slide (plus a coverslip to prevent evaporation). Slides were incubated at
65°C overnight.
The following day, coverslips were removed and slides were transferred to a coplin
jar for a series of post-hybridisation washes at 65°C. Beginning with two 10-minute
washes in 100% post-hybridisation solution, one 10-minute wash in 75% post-
hybridisation solution/2X SSC, one 10-minute wash in 50% post-hybridisation
solution/2X SSC and one 10-minute wash in 25% post-hybridisation solution/2X
SSC. Then two 30-minute washes in 2X SSC, 0.1% CHAPS, two 30-minute washes
in 0.2X SSC, 0.1% CHAPS and, finally, three 5-minute washes in TNT at room
temperature. Slides were transferred to a humidified chamber and incubated with
lml blocking solution/slide for 1 hour at 4°C. The blocking solution was removed
and slides were further incubated with blocking solution for two times, 1 hour each at
4°C. lml antibody solution was placed on each slide and incubated at 4°C overnight.
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The next day, the antibody was removed and slides were transferred to a coplin jar
for a series of post-antibody washes at room temperature. This consisted of four 10-
minute washes in TNT, 0.1% BSA and four 10-minute washes in NMT, 0.1% Triton
X-100. Slides were then placed in staining solution and checked every 30 minutes
until the stain developed. Sections were fixed in 4%PFA at 4°C overnight.
The next day, slides were rinsed three times in PBS for 10 minutes each and counter-
stained with nuclear fast red (Vector Laboratories) for 30 seconds. Staining was
stopped by rinsing slides under tap water and then washing with 95% methanol for 5
seconds, followed by 100% ethanol for 5 seconds. Slides were cleared by washing in




TM4 cells were purchased from ECACC and cultured in Ham's F12 and DMEM (1:1)
medium (Gibco) supplemented with 2mM glutamine (Gibco), 5% horse serum
(Gibco) and 2.5% FCS (Gibco). Cells were maintained in 75cm2 canted neck tissue
culture flasks (Iwaki) and incubated at 37°C in 5% CO2. 0.25% trypsin/EDTA
(Gibco) was used to detach cells from the bottom of the flask when cultures were 70-
80% confluent and required to be split. For experiments, cells were plated in 35mm
tissue culture dishes (Iwaki) and cultured as normal.
2.6.2 Gonad Culture
The gonad plus mesonephros (urogenital ridge) were dissected from each embryo
and the head was used for genotyping. Isolated gonads and mesonephroi were
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placed on 1.5% agar blocks (Difco Bacto Agar in DMEM) in 35mm tissue culture
dishes (Iwaki). 1ml culture medium (DMEM supplemented with 10% FCS and
100% penicillin and streptomycin; Gibco) was added to the bottom of each dish.
Dishes were incubated at 37°C in 5% C02. Cultures were replenished with fresh
culture medium after 4-6 hours and every 12 hours thereafter until the desired stage.
2.7 siRNA
2.7.1 Production of siRNAs
siRNAs were synthesised using the Silencer siRNA construction kit (Ambion). All
reagents were supplied in kit (unless otherwise stated).
Following manufacturer's recommendations, siRNA oligonucleotide templates were
designed for Sry and Sox9 (sequences were checked against the mouse genome
database to eliminate any sequences with significant homology to other genes). All
siRNA oligonucleotide templates were purchased from Invitrogen as HPLC purified
compounds.
Sense and anti-sense siRNA oligonucleotide templates were prepared for
transcription by hybridisation to the T7 promoter primer (Ambion) at 70°C for 5
minutes, then at room temperature for 5 minutes. For each siRNA, two transcription
reactions were assembled at room temperature to synthesize the sense and anti-sense
RNA strands of the siRNA separately. For each transcription reaction, the following
components were mixed in the order shown:
Component (Ambion) Amount
Sense or anti-sense siRNA template 2/jl\
Nuclease-free water 4/zl
2X NTP mix 10/rl
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10X T7 Reaction buffer 2/xl
T7 Enzyme mix 2/xl
Components were mixed gently and incubated at 37°C for 2 hours. Sense and anti-
sense transcription reactions were combined into a single tube and further incubated
at 37°C overnight.
The following day, the dsRNA was digested with RNase and DNase by adding the






Contents were mixed gently and incubated at 37°C for 2 hours. 400/11 siRNA
binding buffer (Ambion) was added to the nuclease digestion reaction and incubated
at room temperature for 5 minutes. The siRNA was purified using filter cartridge
columns (Ambion) and eluted in 100/xl nuclease-free water (Ambion). siRNAs were
stored at -80°C until they were prepared for transfection.
2.7.2 siRNA Protocol
Cells/gonad cultures were rinsed in PBS and then incubated with Opti-MEM I
(Gibco) for 1 hour. During this time, the transfection mix was prepared as follows:
For every lOO/il of transfection mix: 3/d siRNA (60pmol) was mixed with 50/il
Opti-MEM I (Gibco). In a separate tube, 3/xl Oligofectamine (Invitrogen) was mixed
with 12/xl Opti-MEM I (Gibco). Both tubes were incubated at room temperature for
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10 minutes, then the two mixes were combined and incubated at room temperature
for a further 20 minutes. 32/zl Opti-MEM I (Gibco) was added to the combined mix
to bring the total volume to 100/tl. This mixture was then directly overlaid onto
cells/gonad culture and incubated at 37°C in 5% CO2 for 4 hours.
After the 4-hour incubation, 1ml fresh culture medium was added to each dish.
Ham's F12 and DMEM (1:1) medium (Gibco) supplemented with 2mM glutamine
(Gibco), 5% horse serum (Gibco) and 2.5% FCS (Gibco) was used for cells. DMEM
(Gibco) supplemented with 10% FCS (Gibco) and 100% penicillin and streptomycin
(Gibco) was used for gonad cultures. Cells/gonad cultures were then grown as
described in section 2.6.
2.8 X-Gal Staining
Following culture, Sox8+/+ gonads were rinsed in PBS and fixed in fixative for 30
minutes at 4°C. Gonads were then washed three times in P-Gal wash solution at
room temperature for 20 minutes each. Subsequently, gonads were stained in freshly
prepared X-Gal staining solution overnight at 37°C in the dark and post-fixed in











: 0.1M sodium dihydrogen
Phosphate Buffer:
0.1M disodium hydrogen orthophosphate (Na2HPC>4)
orthophosphate (NaH2P04).
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B-Gal Wash Solution:
Final concentration






1) 25mg X-Gal was dissolved in 0.5ml dimethyl formamide.





Two solutions were mixed together and filtered before use.
2.9 Real-time PCR
Samples were run on a Roche Light-cycler instrument and analysed using the Roche
Light-cycler software package (version 3.5.3).
2.9.1 Sequence-Specific Hybridisation
For sequence-specific real-time PCR, the light-cycler fast start DNA master
hybridisation probes kit (Roche) was used. Sequence-specific hybridisation probes
were designed and purchased from TIB MOLBIOL, Berlin.
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Each reaction was generally set-up as follows:
1 OX DNA fast start mix 2/xl
MgCl2 (25mM) 2.4/xl
Sense primer (10ng//d) l/rl
Anti-sense primer (10ng/jttl) l/rl
Fluorescein probe (2ng//xl) l/il






} x 45 cycles
}
95°C 10 minutes No acquisition
95°C 3 seconds No acquisition
55°C 10 seconds Single acquisition
72°C 16 seconds No acquisition
40°C 30 seconds No acquisition
2.9.2 SYBR Green System
For SYBR green real-time PCR, the light-cycler fast start DNA master SYBR green I
kit (Roche) was used. Primers were purchased from Invitrogen as lyophilised
desalted compounds.
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Each reaction was generally set-up as follows:
10X SYBR Green fast start mix 2/xl
MgCl2 (25mM) 2/xl
Sense primer (10ng/jul) 1/xl




SYBR Green Light-cvcler Programme:
95°C 10 minutes No acquisition
95°C 3 seconds No acquisition }
55°C 5 seconds No acquisition }
72°C 18 seconds No acquisition } x 45 cycles
82°C 30 seconds Single acquisition }
95°C 0 seconds No acquisition
65°C 45 seconds No acquisition
95°C 0 seconds Continuous acquisition at a slope of 0.1°C/sec.
40°C 30 seconds No acquisition
2.10. Microscopy andAssociated Equipment
Dissections of embryos were done with the aid of a Leica MZ12s microscope.
Photographs ofwhole-mount embyros, gonads and gonad cultures were taken using a
Zeiss AxioCam HRc digital coloured camera attached to a Zeiss Stemi SV11 Apo
microscope. Images were captured using Zeiss Axiovision software.
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Images of wax sections were captured using a Photometries Coolsnap HQ digital
monochrome camera (Ropern Scientific, Tucson, USA) attached to a Zeiss Axioplan
II microscope equipped with a filterwheel in the transmission lightpath containing
Andover rgb colour additive filters (L.O.T. Oriel Ltd, UK). Sequential images were
captured using the red, green, and blue filters and these images were then merged
together to provide the coloured image. Image capture, control of the filterwheel and
merging of images were controlled by in-house scripts written for IP Lab Spectrum
(Scanalytics corp, Fairfax VA, USA). Dr Paul Perry wrote all scripts for capturing
digital images with IP Lab software.
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3.1 Introduction
The work presented in this chapter compares the gene expression profile of male and
female developing mouse gonads using Affymetrix GeneChip arrays. Affymetrix
GeneChip arrays were used as they provided the largest, most complete set ofmouse
transcripts available at the time. In this study, microarrays were used as a starting
point to screen for possible candidates. These candidates would later be verified by
other methods, such as in-situ hybridisation and real-time PCR. The outcome of this
study may lead to the identification of novel candidates involved in gonadal
development and may provide further insight into the male and female sex
determination pathways.
3.2 Affymetrix GeneChip Arrays
The Affymetrix murine genome U74 set of microarrays consists of three GeneChip
probe arrays (A, B and C). Each array contains oligonucleotide probes specific for
approximately 6,000 known mouse genes and approximately 6,000 EST sequences
from the UniGene database (Build 74). Different regions of certain genes are
represented in different probe sets on the microarray to ensure a more accurate data
set. In a preliminary attempt (screen 1), the Affymetrix murine genome U74 version
1 A and B chips were used. Unfortunately, these arrays contained a percentage of
sequences assigned in the wrong direction due to submission errors from GenBank
and UniGene. Therefore, Affymetrix produced a mask file containing the ambiguous
sequences so that they could be excluded from the data set. This problem was
rectified in the database and the Affymetrix murine genome U74 version 2 was later
produced. Consequently, the A, B and C chips from this new and corrected version
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Figure 3.2 Fragmented cRNA Samples for Screen 1
16pl of labelled male and female cRNA samples were fragmented, lpl of each
fragmented cRNA sample was loaded onto an agarose gel prior to hybridisation onto
microarrays. Results show both cRNA samples were fragmented and of significant
quality.
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3.3 Screen 1
3.3.1 Experimental Design
To identify new genes involved in gonadal development and sex determination, wild-
type male and female gonads were quantitatively staged (as described in section
2.3.3) and dissected from mouse embryos at El2.5 (28 to 30 tail somites). Induction
of sex determination is driven by the expression of Sty, which peaks at El 1.5. A
screen at E12.5 (Figure 3.1), shortly after the initiation of sex determination, should
therefore lead to the isolation of genes at a very early stage of the sex determination
process rather than genes expressed in the already differentiated ovarian/testicular
tissues. In contrast to screens performed in other laboratories, we decided to remove
the mesonephros from each gonad. This we hoped would increase the sensitivity of
the screen and focus on genes directly involved in the sex determination process.
Equal amounts of RNA were hybridised to each GeneChip to reduce the variability
between samples and to allow the data sets to be compared. Figure 3.2 shows an
aliquot of the male and female fragmented cRNA samples run on an agarose gel to
ensure the cRNA was of good quality before hybridisation to microarrays.
3.3.2 Normalisation ofArrays
The Affymetrix GeneChip arrays were scanned and analysed with Affymetrix MAS
4.0.1 software to identify transcripts that were classified as being 'absent', 'present'
or 'marginal'. In addition to the unique probes represented on the arrays, each array
contains control probes (such as P-actin and GAPDH) that account for the quality of
the biotinylated RNA samples and hybridisation protocol. A report file detailing the
statistics of each array can be generated. The key features of this report are the
percentage of probe sets which are 'present' and the 3'-5' GAPDH ratio. As a
guideline, Affymetrix propose users to expect approximately a minimum of 30% of
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the probe sets to be reported as 'present' and a 3'-5' GAPDH ratio no greater than 3
shows full-length transcripts were hybridised to arrays.
In our studies, 31.5% of the probe sets was scored as 'present' (after the mask file
was applied) using the male sample on the MGJU74A chip and the 3'-5' GAPDH
ratio was 1.77 (Appendix 4a). The corresponding MG_U74A chip hybridised with
the female sample was scored as 28.5% probe sets 'present' (after the mask file was
applied) and the 3'-5' GAPDH ratio was 2.45 (Appendix 4b). Considering only 5pg
of RNA (instead of the recommended 15pg) was used for each sample, the statistics
obtained fell approximately within the manufacturer's guidelines. Hybridisation to
the control probes was also checked and found to be 'present' in both arrays. Based
upon these findings, the two GeneChips were of comparable quality. Next the
expression data from the two arrays was normalised to account for the individual
hybridisation intensities. Thus, meaningful comparisons can be made between the
male and female arrays.
Due to the positive percentages and ratios obtained from the A chips, suggesting that
the male and female RNA samples were of reasonable quality, progression onto the
B chips occurred. The male and female hybridisation cocktails from the A chips
were re-used for the B chips. The MG_U74B chip hybridised with the male sample
was scored as 12.1% probe sets 'present' (after the mask file was applied) and the 3'-
5' GAPDH ratio was 2.22 (Appendix 4c). The corresponding MGJU74B chip
hybridised with the female sample was scored as 14.7% probe sets 'present' (after
the mask file was applied) and the 3'-5' GAPDH ratio was 3.53 (Appendix 4d). The
percentage of probe sets scored as 'present' was extremely low in both arrays as
there were over 40% incorrect genes and ESTs represented on the B arrays, which
dramatically reduced the number of correct genes and ESTs in both data sets.
Applying the mask files removed these incorrect sequences and they were classified
as percentage 'absent' probe sets, thus accounting for the low percentage of 'present'
probe sets obtained. The 3'-5' GAPDH ratio has increased in both male and female
B arrays compared to their A array equivalent. This was caused by the re-use of the
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hybridisation cocktails as RNA quantity and quality will be reduced. Therefore, a
higher 3'-5' GAPDH ratio was to be expected. To ensure good hybridisation of the
samples to the arrays, the hybridisation to the control probes was checked. Both
arrays reported these to be 'present'. Subsequently, the expression data from these
two B arrays was normalised in the same way as for the A arrays, thus allowing
meaningful comparisons to be made between both sets ofmale and female arrays.
3.3.3 Data Analysis
The differences in gene expression profiles between male and female gonads were
first analysed by scatter plot analysis. This graphical representation gives an
indication of the overall similarities or differences between the two RNA samples,
where each point on the graph represents a single annotated gene or EST on the
microarray. The position of each point on the scatter plot is determined by the
difference in signal intensity of this transcript from one RNA sample to the other.
Figure 3.3 shows the scatter plot analysis (GeneSpring 6.1, Silicon Genetics) of the
female gonadal pool ofRNA versus the male gonadal pool ofRNA (chips U74A and
U74B with mask file applied). The signal intensities of the female array (X axis) are
compared to the signal intensities of the male array (Y axis). The distance with
which a point lies from the line of no change (line of intercept passing through the
point of origin) represents the differential expression of a gene between the male and
female samples. For example, a point lying close to the line of no change represents
a gene that is expressed at similar levels in both pools ofRNA, whereas a point lying
away from the line signifies a gene to be differentially expressed between the two
pools of RNA. Depending upon the point lying closer towards the X or Y axis, the
sex specific expression of the gene can be easily distinguished as female specific
points will be found closer to the X axis and male specific points will be found closer
to the Y axis. The location of a point within the scatter plot, in relation to the origin,
indicates its level of expression in relation to the other genes.
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Sex female (raw)
X-axis: Frances_Male and Female v4 All (Default Interpretation): Sex female
Y-axis: Frances_Male and Female v4 All (Default Interpretation): Sex male
Colored by: Frances_Male and Female v4 All, Default Interpretation (Sexmale)
Gene List: all genes (37886)
Figure 3.3 Scatter Plot Analysis of the Gene Expression Profile of Wild-type
E12.5 Gonads
Each point represents the normalised expression level of an individual transcript
within male and female RNA samples. Genes that are more highly expressed in male
lie closer to the Y axis and genes that are more highly expressed in female lie closer
to the X axis.
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The two black lines parallel to the line of no change (one above and one below) refer
to the significant expression level of each gene or EST. These lines represent a fold
change of plus or minus 2 (top or bottom line respectively). Therefore, points which
lie above the top line have a fold change of greater than 2 and are more highly
expressed in male gonads. Whereas, points which lie below the bottom line have a
fold change more than -2 and are more highly expressed in female gonads. Points
that lie between these two lines have a fold change less than 2 and -2 which, in this
case, deems them to be differentially expressed to an insignificant extent.
The points on the scatter plot are also colour-coded by a gradient system ranging
from red to green. This colour-coded system reflects the expression levels of each
gene or EST as a ratio to the median (a standard normalised value). Black points
represent transcript expression levels that have not deviated from the median or have
only deviated slightly from it. These black points are classed as having unchanged or
marginally changed expression levels. Red and green points represent transcript
expression levels that have deviated from the median. The brighter the red or green,
the greater the deviation. It should be noted that the red and green colours do not
represent sex specificity. It should also be noted that negative signal intensities are
not accurately represented in the scatter plot as the GeneSpring 6.0 software does not
allow negative values to be plotted against the median. Therefore, all negative signal
intensities are considered to have a value of zero and are either plotted on the X axis
or Y axis depending on their sex specificity. In summary, the colour of each point is
related to signal intensity and the position of each point refers to the sex specificity.
To begin to analyse the data set, an arbitrary value of fold changes of greater than 2
or -2 was chosen to represent genes that are differentially expressed between male
gonads and female gonads. Plus, to focus on the more reliable sex differentiated
genes or ESTs within the data set, genes and ESTs marked as 'present' in at least one
sample (male or female) were selected. Using these criteria in GeneSpring 6.1
(Silicon Genetics), 1096 genes and ESTs were found to be differentially expressed.
Of the 1096 genes and ESTs differentially regulated in the data set, 521 of these were
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Sex female (raw)
X-axis: Frances_Male and Female v4 All (Default Interpretation): Sex female
Y-axis: Frances_Male and Female v4 All (Default Interpretation): Sex male
Colored by: Frances_Male and Female v4 All, Default Interpretation (Sex male)
Gene List Frances v4 present in 1 and more than 2 fold (1096)
Figure 3.4 Scatter Plot Analysis of Genes Expressed Greater than 2 or -2 and
Present in at Least One Sample ofWild-type E12.5 Gonads
Each point represents the normalised expression level of an individual transcript
within male and female RNA samples. Genes that are more highly expressed in male
lie closer to the Y axis and genes that are more highly expressed in female lie closer
to the X axis.
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up-regulated (more highly expressed in male) and 575 were down-regulated (more
highly expressed in female). This is represented in a scatter plot in figure 3.4
(GeneSpring 6.1, Silicon Genetics). It should be noted that using GeneSpring 6.1
software (Silicon Genetics), a larger number of differentially regulated genes were
obtained compared to analysis using Affymetrix MAS 4.0.1 software. This is due to
the different normalisation standards within each software programme. The data set
was initially analysed using Affymetrix MAS 4.0.1, then later analysed with
GeneSpring 6.1 (Silicon Genetics).
3.3.4 Initial Verification ofMicroarray Data Set
To first verify the microarray data set was representing sex specific genes, transcripts
with the highest fold changes were closely examined for known sex differentiating
genes. Using Affymetrix MAS 4.0.1, one of the highest male specific fold changes
was the patched homologue (Ptc). This gene was up-regulated by 11.4-fold and was
deemed to be increased in male gonads (high-lighted in red in Appendix 5). This
was found to be consistent with previous data, whereby Ptc was observed to be
localised to Leydig cells and peritubular cells (Clark et al., 2000). Ptc is also known
to be the receptor for the Desert hedgehog (Dhh) gene, which is a signalling
molecule expressed by Sertoli cells. Interestingly, homozygous Dhh-null female
mice have no obvious phenotype whereas homozygous Dhh-null male mice are
sterile and the expression of Ptc is lost in Dhh mutants (Bitgood et al., 1996).
Therefore, Ptc had already been implicated in the testicular development pathway.
Interestingly, Dhh/Ptc signalling has been shown to play an important role in testis
formation as it triggers Leydig cell differentiation (Yao et al., 2002). Thus, Ptc was
the chosen candidate to assess the validity of our sex specific data set.
This was carried out by RNA in-situ hybridisation on eviscerated male and female
E12.5 embryos using a Ptc probe (kindly donated by Walter Birchmeier's
Laboratory, Berlin). Figure 3.5 shows a pair ofmale E12.5 gonads and a pair of
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Figure 3.5 In-situ Hybridisation of Wild-type E12.5 Gonads Using Ptc
Homologue Probe
a) Male El2.5 gonads showing strong staining within the interstitial region.
b) Female E12.5 gonads showing no specific staining.
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female E12.5 gonads. Both were hybridised with the Ptc probe under the same
conditions. A distinct staining pattern within the interstitial region of the male
gonads can be observed, whereas no specific staining is seen in the female gonads.
This confirmed that Ptc is indeed male specific and our initial screen has pulled out
sex differentially expressed genes and ESTs.
It should be noted that testatin (high-lighted in blue in Appendix 5) also showed a
large fold change value of 7.3 and deemed to be increased in male gonads. Testatin
is a cystatin-related gene and has been shown to be expressed during early testis
development in mice (Tohonen et al., 1998). Furthermore, testatin has been found to
be expressed during testis cord formation in pre-Sertoli cells (the site of Sry action)
immediately following the peak of Sry expression (Tohonen et al., 1998). The
human orthologue of this gene has now been isolated (Eriksson et al., 2002). Similar
to mouse testatin, human testatin is also specifically expressed in the testis which
suggests that testatin has a role in male reproduction. Interestingly, testatin was also
later identified in the subtraction hybridisation screen by Menke and Page (Menke
and Page, 2002), but before that in a signal peptide differential display by Tohonen et
al. (Tohonen et al., 1998). The identification of testatin, along with Ptc, in our initial
screen further corroborates the isolation of sex differentially expressed genes and
ESTs in the data set.
3.3.5 Sex Differentially Expressed Genes
Using Affymetrix MAS 4.0.1, the data set was further analysed for other sex
differentially expressed genes, whereby comparisons were made against other genes
found to be sex differentially expressed. Table 3.1 shows a list of genes that were
examined and their expression levels within the data set. These data are also
graphically represented in a scatter plot (Figure 3.6) along with heat maps of their
expression between male and female (Figure 3.7) (GeneSpring 6.1, Silicon
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Sex female (raw)
X-axis: Frances_Male and Female v4 Ail (Default Interpretation): Sex female
Y-axis: Frances_Male and Female v4 All (Default Interpretation): Sexmale
Colored by Frances_Male and Female v4 All, Default Interpretation (Sex male)
Gene List Frances v5 A and B known genes (34)
Figure 3.6 Scatter Plot Analysis of Sex Differentially Expressed Genes that were
Examined in our Data Set
Each point represents the normalised expression level of an individual transcript
within male and female RNA samples. Genes that are more highly expressed in male
lie closer to the Y axis and genes that are more highly expressed in female lie closer
to the X axis.
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Figure 3.7 Heat Map of Sex Differentially Expressed Genes that were Examined
in our Data Set
Female signal intensities (left column) and male signal intensities (right column) of
genes listed on right. All signal intensities are calculated against the median. Green
indicates a decrease, red indicates an increase and black indicates no deviation from
the median.
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independent from those on the heat maps. Heat maps are a colour-coded
representation based on signal intensity, whereby a change in signal between male
and female are shown by a change in red and green. Signal intensities for heat maps
are calculated against the median and any deviation from the median results in colour
change of green or red depending upon the sex specificity of the gene. For example,
genes that are coloured green in female and red in male indicate a change up and
therefore are more highly expressed in males than females. Conversely, genes that
are coloured red in female and green in male indicate a change down and therefore
are more highly expressed in females than males. Genes that are black in both male
and female represent little or no change in signal intensities between the two sexes.
Genes that are either green or red in both male and female indicate a deviation from
the median, but no difference between the expression levels which means such genes
are increased or decreased in both sexes. Many genes from this list were taken from
a PCR-based cDNA subtraction screen, whereby El2.5 XY gonadal cDNA was
compared with E12.5 XX gonadal cDNA (Menke and Page, 2002). A proportion of
these genes were in agreement with our data set and the others gave a no change
value. This may be due to technical differences between the two systems, such as
genes on our arrays are only represented by 25 nucleotides and the RNA samples
may not hybridise well to these short sequences. Thus, low signals may be detected
in both male and female samples resulting in no change in expression level being
measured in our system.
Not all genes from this list were expected to be differentially expressed at E12.5. For
example, Wtl was expected to be 'present' as it first appears in the urogenital ridge
at E9.0 and continues to be expressed after formation of the gonads (Shimamura et
al., 1997). More noticeably, the expression of Wtl is not sexually differentiated at
E12.5 (Morrish and Sinclair, 2002). Our results were in agreement with this as Wtl
was found to be 'present' and not changed. This also helped to verify our data set to
be stage specific at E12.5 and that the genes and ESTs represent expression levels
during the sex differentiation process.
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Well-known sex differentially expressed genes at El2.5 include Sry and Sox9 in the
male gonad and Wnt4 in the female gonad. Unfortunately, Sox9 was amongst the
incorrectly submitted sequences and so it's expression within our data set could not
be checked. Sry was expected to be 'present' in male but not greatly increased as it's
expression peaks at El 1.5 and is completely switched off by E13.0 (Hacker, Capel et
al. 1995). Our data set revealed both Sry probe sets to be unchanged but one probe
set was registered to be 'present' and the other was registered as 'absent'. This
difference may be due to hybridisation of the RNA samples to the individual probe
sets on the microarray. The expression of Wnt4 is down-regulated in the developing
male gonad after El 1.5, but it persists in the developing female gonad (Vainio et al.,
1999). Therefore, Wnt4 was expected to be 'absent' in the male gonad and 'present'
in the female gonad. Consequently, the difference call should be a decrease. Our
data set was in agreement with this and showed a fold change value of 18.4.
Another gene predicted to be more highly expressed in male gonads than female
gonads is Podocyte Expressed 1 (Pod-1). This is also in agreement with our findings,
where our data showed a 'present call' in the male sample and an 'absent call' in the
female sample. More specifically, the expression ofPod-1 was found to be increased
in male gonads by a fold change of 3.0. The expression pattern of Pod-1 has been
shown to be complex as it is dependent not only on the sex of the embryos but also
on their stage of development (Tamura et al., 2001). For example, at El 1.5, the
expression of Pod-1 was found to be at the same level in male and female gonads,
but it became stronger in the male than the female at E13.5 (Tamura et al., 2001).
This high level of Pod-1 expression was found to persist throughout the foetal stages
of development, but it slowly declined during the neonatal stages until 20 days after
birth (Tamura et al., 2001), which coincides with progression of the first wave of
meiosis and spermatid formation in the testis. In contrast, the expression level of
Pod-1 in the ovary was increased after birth and became stronger than the testis by
three weeks after birth (Tamura et al., 2001). Pod-1 was found to be specifically
expressed in the coelomic epithelial cells, peritubular myoid and epithelial-like cells
(Tamura et al., 2001). Interestingly, the expression pattern ofPod-1 in the foetal
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testis is closely related and for the most part complementary to that ofSfl (Tamura et
ah, 2001), which suggests that these two genes may interact with each other in the
sex determination cascade.
As previously mentioned, two testis-specific genes discovered by a cDNA
microarray screen for genes displaying sexually dimorphic expression during murine
gonad development are Protease nexin-1 (Pn-1) and Vanin-1 (Vnnl) (Grimmond et
ah, 2000). The male-specific expression of Pn-1 is reported to begin as early as
El 1.25 and found to be expressed in Sertoli cells at E12.5 (Grimmond et ah, 2000).
The expression of Vnnl has been found in pre-Sertoli cells at El 1.5 and its
expression pattern continues to be testis specific during embryonic development,
whereas no expression is detected in female gonads (Grimmond et ah, 2000). These
genes were checked against our screen. Pn-1 was found to be 'present' in the male
and increased with a fold change of 4.0. Vnnl was found to be 'present' in the male
and increased with a fold change of 3.6. Hence, our results corresponded with those
from Grimmond et al (Grimmond et al., 2000).
In our data set, the double-sex related gene (DMRT1) was found to be 'present' in
male gonads but 'absent' in female gonads. However, the difference (fold change)
between them was only 1.9, which is considered to be below the significant threshold
and the difference call was deemed to be unchanged. This may be due to the fact
that, in the mouse, Dmrtl is still expressed in the genital ridges of both sexes at
E12.5 and only becomes sexually dimorphic at E14.5, where its expression remains
strong in the male sex cords but decreases to a low level in the female ovary (De
Grandi et al., 2000). This specific expression pattern has led to the hypothesis that
Dmrtl plays a role in sex determination in either sex, or with a later role in testis
differentiation, or possibly both. Indeed, knockout analysis in mice demonstrated the
important role ofDmrtl in testicular differentiation, whereby homozygous Dmrtl'
mutants have severely hypoplastic testes with disorganised seminiferous tubules and
missing germ cells (Raymond et al., 2000).
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Another gene found to be 'present' in male gonads but 'absent' in female gonads,
with a low detectable fold change of 1.0, is Gata-4 (a member of the GATA family
of transcription factors). The expression of Gata-4 has been detected in El 1.5
gonads of both XX and XY mouse embryos, specifically in the developing somatic
cell lineages (Sertoli in testis and granulosa in ovary) but not primordial germ cells
(Viger et al., 1998). In addition, Gata-4 expression has been shown to be continuous
in Sertoli cells throughout embryonic development but was notably down-regulated
in the ovary at El3.5 (Viger et al., 1998). Hence, Gata-4 may be involved in early
gonadal development and possibly sexual differentiation. The fact that Gata-4 is
expressed in both sexes and only becomes sexually dimorphic at a stage later than
the gonads used in our screen may account for the small fold change value that was
detected.
However, there were a few genes which are known to be differentially expressed in
male and female gonads at E12.5 which were not reported in our CHIP screening
results, the most notable being Mis. Our data set revealed Mis to be 'absent' in both
male and female samples with a difference call of 'no change'. Although a fold
change value of 1.8 was calculated, it is deemed insignificant due to the expression
of the gene not being 'present' in at least one sample. The undetectable differences
in some genes may be due to the oligonucleotide sequences used by Affymetrix
being taken from a less specific region of that particular gene. This would result in
poor hybridisation of the RNA samples to the probes on the CHIP and thus
producing an overall weak signal in the data set.
3.3.6 Potential Sex Determination Candidates
Although our screen did not identify all the sex differentiated genes that were
expected, the results still produced a sex specific data set. Therefore, genes and
ESTs with significant fold changes (greater than 2 and -2) were still considered to be
valid. In order to select the most probable male and female developmental genes and
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musculuscDNA,3end ClusterInclAW123164:UI-M-BH2.1-apd- d-06-0-Ul.s1MumusculuscDNA,3end ClusterInclAI851057:lll-M-BH0-ajv-g-07- O-Ul.slMumusculuscDNA,3end ClusterInclAI839436:UI-M-AN0-aco-f-08- O-Ul.slMumusculuscDNA,3end ClusterInclAA214997:mu83g08.r1Mus musculuscDNA,5end ClusterInclAA895031:vx6 f 7.r1M s musculuscDNA,5end ClusterInclAI327212:mg81e01.xM s musculuscDNA,3end ClusterInclAW048072:lll-M-BH1-alq-a- 02-0-Ul.s1MumusculuscDNA,3end ClusterInclAI643851:vu09h05.x1M s musculuscDNA,3end ClusterInclAI604578:vm27b08.y1M s musculuscDNA,5end ClusterInclAI850212:UI-M-BG1-aie-c-02- 0-UI.S1MusmusculuscDNA,3end ClusterInclAI605905:mu39b02.y1M s musculuscDNA,5end





















































jnces v4 male specific genes (Default Interpretation)
inces_Male and Female v4 All, Default Interpretation
»nces v4 male specific genes (51)
Figure 3.8 Male Potential Sex Determination Candidates that were Selected
from our Data Set
Female signal intensities (left column) and male signal intensities (right column) of
genes listed on right. All signal intensities are calculated against the median. Green






































>nces v4 female specific genes (Default Interpretation)
incesjuiale and Female vA AJi, Default Interpretation
genes (37886)
Figure 3.9 Female Potential Sex Determination Candidates that were Selected
from our Data Set
Female signal intensities (left column) and male signal intensities (right column) of
genes listed on right. All signal intensities are calculated against the median. Green
indicates a decrease, red indicates an increase and black indicates no deviation from
the median.
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ESTs, genes and ESTs with the highest fold changes and which were 'present' in one
RNA sample and 'absent' in the other were regarded as potential candidates which
may be involved in the sex determination process. Ranked from the highest fold
changes, 54 increased (male specific) and 35 decreased (female specific) genes and
ESTs were selected for further investigation and analysis. Table 3.2 shows a list of
the selected genes and ESTs along with the fold changes. Figures 3.8 and 3.9 show
heat maps of the selected male and female candidates (GeneSpring 6.1, Silicon
Genetics). In general, the potential male candidates are green in female and red in
male whereas the potential female candidates are green in male and red in female.
One or two candidates show black in both samples due to the signal intensities in
male and female being fairly close. For example, Affymetrix probe set ID 106949_at
is a potential female candidate as it is 'present' in female and 'absent' in male with a
significant fold change of 2.5. But the raw signal gave similar values in male and
female (2774 and 3037.4 respectively), therefore a difference in colour was not
observed on the heat map as there was no large difference in signal intensity.
It is estimated that in humans, chromosomal locations of approximately 50% of
mutations in male-to-female sex reversal patients are unidentified. Thus, the human
equivalent of the selected genes and ESTs were checked to assess whether they may
be related to complete or partial sex reversal in affected patients. Hence, their human
chromosomal locations were obtained using Ensembl EnsMart (Appendix 7). The
list of possible male and female sex determination candidates was passed onto our
collaborators (Prof. Giovanna Camerino, Univ. of Pavia) for further investigations
into the human sex developmental pathways.
3.3.7 Using a Statistical Algorithm
The screen 1 data set was initially analysed using Affymetrix MAS 4.0.1 as this was
the current version available at that time. Affymetrix MAS 4.0.1 generates
expression values by empirical algorithms. This version has now been updated to
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X-axis: Frances_Male and Female vS All (Default Interpretation): Sex female
Y-axis: Frances_Male and Female v5 All (Default Interpretation): Sex male
Colored by. Frances_Male and Female vS All, Default Interpretation (Sex male)
Gene List all genes (37886)
Figure 3.10 Scatter Plot Analysis of the Gene Expression Profile of Wild-type
E12.5 Gonads Using a Statistical Algorithm
Each point represents the normalised expression level of an individual transcript
within male and female RNA samples. Genes that are more highly expressed in male
lie closer to the Y axis and genes that are more highly expressed in female lie closer
to the X axis.
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Affymetrix MAS 5.0 and generates expression values by statistical algorithms
instead. Affymetrix claim this newer version to be more accurate as it provides the
additional value of statistical significance (p values) and confidence limits.
Affymetrix MAS 5.0 has also eliminated negative expression values (signals) and
only positive values are generated. Taking all this into consideration, the screen 1
data set was re-analysed with Affymetrix MAS 5.0 to ascertain whether a statistical
algorithm will alter the previously calculated values of genes and ESTs within the
data set.
Firstly, a scatter plot analysis (GeneSpring 6.1, Silicon Genetics) of the female
gonadal pool ofRNA versus the male gonadal pool of RNA was generated to obtain
an overall distribution of the genes and ESTs calculated by the statistical algorithm
(Figure 3.10). This was compared to the scatter plot calculated using an empirical
algorithm in Affymetrix MAS 4.0.1 (Figure 3.3). It is immediately obvious that the
global distribution between the two forms of algorithms produces a different
dispersal of genes and ESTs while the raw data is the same. The scatter plot
produced from Affymetrix MAS 5.0 (Figure 3.10) shows a larger clustering of genes
and ESTs. There are also no genes or ESTs positioned on the X axis or Y axis.
These noticeable differences are due to the statistical algorithm not producing any
negative values.
To further investigate the effect of the statistical algorithm, the same criteria used in
Affymetrix MAS 4.0.1 (fold change greater than 2 and present in at least one sample)
were applied to the re-analysis with Affymetrix MAS 5.0. This yielded 638 genes
and ESTs to be differentially expressed which is a substantial decrease compared to
the 1096 genes and ESTs found previously. Of the 638 genes and ESTs
differentially regulated, 296 of these were up-regulated (more highly expressed in
male) and 342 were down-regulated (more highly expressed in female). This is
represented in a scatter plot in figure 3.11 (GeneSpring 6.1, Silicon Genetics). A
comparison of the Affymetrix MAS 4.0.1 data set with the Affymetrix MAS 5.0 data
set, using the above mentioned criteria, resulted in a match of 289 genes and ESTs.
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X-axis: Frances_Male and Female v5 AJI (Default Interpretation): Sex female
Y-axis: Frances_Male and Female v5 All (Default Interpretation): Sex male
Colored by: Frances_Male and Female v5 All (Default Interpretation)
Gene List: Frances v5 Present in at least 1 and more than 2 fold (639)
Figure 3.11 Scatter Plot Analysis of Genes Expressed Greater than 2 or -2 and
Present in at Least One Sample of Wild-type E12.5 Gonads Using a Statistical
Algorithm
Each point represents the normalised expression level of an individual transcript
within male and female RNA samples. Genes that are more highly expressed in male
lie closer to the Y axis and genes that are more highly expressed in female lie closer
to the X axis.
X-axis: Frances_Male and Female v5 All (Default Interpretation): Sex female
Y-axis: Frances_Male and Female v5 All (Default Interpretation): Sex male
Colored by: Frances_Male and Female v5 All (Default Interpretation)
Gene List Frances Genes present in 1 and more than 2 fold in both v4 and v5 (289)
Figure 3.12 Scatter Plot Analysis Showing Genes Greater than 2 or -2 and
Present in at Least One Sample in Both Empirical and Statistical Algorithms
Each point represents the normalised expression level of an individual transcript
within male and female RNA samples. Genes that are more highly expressed in male
lie closer to the Y axis and genes that are more highly expressed in female lie closer
to the X axis.
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Figure 3.12 shows a scatter plot (GeneSpring 6.1, Silicon Genetics) of these genes
and ESTs and they are listed in Appendix 6. Although the expression levels of
various genes and ESTs were expected to be different based on the different
distribution from the scatter plots (Figures 3.3 and 3.10), this less than 50% overlap
was surprising.
A closer inspection of how certain genes were expressed in both data sets revealed
that the trend of genes and ESTs were the same. The difference was mainly in the
fold change. In general, Affymetrix MAS 5.0 produced lower fold change values
that has resulted in fewer differentiated genes and ESTs. For demonstration
purposes, the list of potential candidates selected for further analysis in Affymetrix
MAS 4.0.1 was converted to its statistical algorithm equivalent and heat maps were
generated in GeneSpring 6.1 (Silicon Genetics). The potential male candidates are
green in female and red in male as before. Concurrently, the potential female
candidates are green in male and red in female as expected. Therefore, the trend
within the selected potential candidates is the same.
In conclusion, the statistical algorithm has affected the ranking of genes and ESTs
but has not altered the sex specificity. Although many of the previously selected
potential candidates would have been selected again, if Affymetrix MAS 5.0 were
available at the beginning, it's possible that other genes and ESTs may have been
selected for further analysis as well. For example, Affymetrix probe set ID 92420_at
(Neurotrophin 3; Nt3) had 'present' and 'increased' calls but a fold change of 1.8 in
Affymetrix MAS 4.0.1 which is below our specified criteria and was therefore
excluded. However, Affymetrix MAS 5.0 calculated the same 'present' and
'increased' calls but with a fold change of 2.1 and thus would have been included as
a potential male candidate. NT3 is derived from the family of neurotrophins which
are growth factors involved in tissue morphogenesis. Recently, it has been reported
that NT3 expression is elevated in the embryonic rat testis during the time of
seminiferous cord formation and inhibition of NT3 caused a reduction in the
expression of Sox9 (Cupp et ah, 2003). The authors hypothesised that when male
109
Chapter 3 Affvmetrix Microarrav Analysis of Gonadal Development
sex determination is initiated, the developing Sertoli cells express NT3 as a
chemotactic agent for migrating mesonephros cells, which are essential to promote
embryonic testis cord formation and influence downstream male sex differentiation.
3.4 Screen 2
3.4.1 Experimental Design
Due to the flawed design of the Affymetrix murine genome U74 microarrays, a
complete data set was not obtained in screen 1. Therefore, a plan for the experiment
to be repeated using the corrected microarrays (Affymetrix murine genome U74
version 2) was intended. Plus, it would be more viable to corroborate the genes
identified in the first data set. However, due to time restrictions, it was impossible to
collect the same amount of total RNA used in screen 1 for screen 2. Consequently, it
was decided to try the new Affymetrix small sample labelling protocol version II.
This protocol is designed to allow small quantities of total RNA to be amplified and
labelled by two cycles of cDNA synthesis and in vitro transcription reactions for
target amplification prior to hybridisation to microarrays for expression profiling.
Unfortunately, there was not enough time to test the reproducibility of the protocol
and the consistency of the RNA amplification. Thus, the protocol was followed
strictly according to manufacturer's instructions (section 2.4.3).
As for screen 1, wild-type male and female gonads were quantitatively staged (as
described in section 2.3.3) and dissected from mouse embryos at E12.5 (28 to 30 tail
somites). Again, the adjacent mesonephros was removed from each gonad and equal
amounts of RNA were hybridised to each GeneChip. Figure 3.13 shows an aliquot
of the amplified male and female fragmented cRNA samples run on an agarose gel to
ensure the cRNA was of good quality before hybridisation to the microarrays. The
Affymetrix GeneChip arrays were scanned and analysed with Affymetrix MAS 5.0
software. Normalisation procedures used for screen 1 were applied to screen 2.
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Figure 3.13 Fragmented cRNA Samples for Screen 2
16pl of labelled male and female cRNA samples were fragmented, lpl of each
fragmented cRNA sample was loaded onto an agarose gel prior to hybridisation onto
microarrays. Results show both cRNA samples were fragmented and of significant
quality.
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However, it must be noted that screen 2 is not a replication of screen 1 as different
protocols were used so it is not feasible to compare the two data sets at a quantitative
gene expression level. But the two data sets may be compared at a biological level
where the differential expression of genes and ESTs in both screens should be
similar.
3.4.2 Results
Before the analysis of the second data set commenced, the statistics of the arrays
were checked by the generation of their report files. Appendices 4e and 4f show the
report files for male and female respectively. As in screen 1, the percentage ofprobe
sets scored as 'present' and the 3'-5' GAPDH ratio were examined. The
MG_U74Av2 chip hybridised with the male sample scored as 39.3% probe sets
'present' and the 3'-5' GAPDH ratio was 60.38 (Appendix 4e). The percentage of
probe sets 'present' was an expected value. However, the 3'-5' GAPDH ratio is far
too high. This reveals that the cRNA transcripts were too short and poor
hybridisation may have occurred. This is most likely caused by the second in vitro
transcription reaction not working well, thus not producing full-length transcripts.
The MG_U74Av2 chip hybridised with the female sample scored as 12.5% probe
sets 'present' and the 3'-5' GAPDH ratio was 1.29 (Appendix 4f). Although the 3'-
5' GAPDH ratio fell with the manufacturer's guidelines of less than 3, the absolute
calls for GAPDH and P-actin control probes were 'absent'. This indicates that the
quality of this RNA sample was not sufficient. Degradation may have occurred at
same point during the amplification procedure. In addition, the percentage of probe
sets 'present' is too low. Again, this is due to the poor quality of the RNA resulting
in poor hybridisation to the microarray. In summary, both RNA samples did not
amplify well and the arrays for screen 2 were unsuccessful. If time had permitted,
the reproducibility and consistency of the RNA amplification for El2.5 gonadal
tissue would have been tested and optimisation of the protocol would have been
carried out if required.
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3.5 Discussion
The use of microarrays has proven to be a helpful tool in fishing for novel sex
determining genes. Although all the potential candidates will have to be verified by
other methods, such as in-situ hybridisation, microarrays have provided a good
starting point. There are different approaches that can be applied when using
microarrays. We chose to take the simple and economical approach where only one
specific time point was used with pooled RNA samples and thus many arrays were
not necessary. This approach was sufficient for our needs. A different but more
costly and time-consuming approach would have been to repeat the screens
(Affymetrix recommends at least two replicates) for a more concrete data set, where
replicates would be cross-matched and so the number of false positives would be
reduced. Replicating screens will also allow genes to be statistically analysed, for
example hierarchical clustering could group genes which have the same biological
function. This would identify patterns within the data sets and distinguish
biologically relevant groups of genes. However, in a biological system with pooled
RNA samples, it is difficult to reproduce such a solid data set as the system has too
many variables. Alternatively, more time points could have been selected (for
example, El 1.5 and E13.5) to allow for a wider gene expression profile. From this,
the sex differentially expressed genes would be identified more easily. Of course, the
latter two approaches would be more feasible if smaller amounts of total RNA could
be used. Therefore, time would need to be spent on acquiring a well-optimised,
consistent and reproducible RNA amplification protocol if a more array-based
approach is to be taken.
Following the start of our Affymetrix sex determination screen, other laboratories
have performed two other sex determination screens using E12.5 gonads. However,
these were done by a suppression subtraction hybridisation method. The first one, as
mentioned above, was performed by Menke and Page (Menke and Page, 2002). In
their screen, they identified 19 genes that were expressed at significantly high levels
in male gonads. From these 19 genes, 6 of these were also found to be more highly
113
Chapter 3 Affvmetrix Microarrav Analysis of Gonadal Development
expressed at a significant level in our screen. These 6 genes were: Cerebellin 1
precursor protein (Cblnl), Procollagen type IX a3 (Col9a3), Prostaglandin D2
synthase (.Ptdgs), Renin (.Renl), Secreted phosphoprotein 1 (Sppl) and Protease
nexin-1 (.Pn-1). More recently, a second screen performed by McClive et al
(McClive et al., 2003) identified 54 genes with high expression in male gonads
versus low expression in female gonads. From these 54 genes, 8 of these were also
found to be more highly expressed in male gonads than female gonads in our screen.
These 8 genes were: Transcription factor 21 (Tcf21), Alcohol dehydrogenase 5
(.Adh5), Heterogeneous nuclear riboproteins methyltransferase-like 2 (Hunt112),
Vanin 1 (Vnnl) and Cerebellin 1 precursor protein {Cblnl), Procollagen type IX a3
{Col9a3), Prostaglandin D2 synthase {Ptdgs) and Protease nexin-1 {Pn-1) again.
Thus, in our Affymetrix microarray approach, we have identified common genes
with the above mentioned suppression subtraction hybridisation approaches.
Although in each screen the number of common genes is not large, it should be noted
that there were only 4 genes that are common when comparing the two suppression
subtraction hybridisation screens against each other. Hence, most approaches will
reveal common genes but also genes that are only found in that particular study.
Interestingly, both screens did not identify Sox9 either and only the screen by Menke
and Page identified Mis. Thus, results of each screen will depend upon the methods
used and the time points analysed. Combined approaches are required to generate a
more complete gene expression profile of the developing gonad.
The preliminary attempt to identify novel sex determining candidates was relatively
successful in screen 1. As the exact screen was not replicated, it was difficult to rule
out the false positives within the data set. Therefore, a wide scale verification
method was chosen for the next step. Hence, 89 putative candidates in total were
selected to be further analysed. It is expected that some of the selected candidates
represent false positives and hence will not be differentially expressed in male or
female gonads. Thus RNA in-situ hybridisation of E12.5 gonads will be performed
to identify the true sex differentiating genes and ESTs (Chapter 4). Moreover,
quantitative real-time PCR will be used to determine the temporal gene expression
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pattern of each candidate throughout gonadal differentiation (Chapter 5). To
summarise, the aim of using Affymetrix GeneChips to identify novel sex
determining candidates has been accomplished. In addition, the approach we took
can be used for other biological systems.
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Chapter 4 Verification of Microarray Data
4.1 Introduction
When performing microarray screens, it is important to confirm the results obtained.
This can be either done by repeating the screens several times to obtain a statistically
significant set of data, or to use alternative methods to confirm differential
expression patterns. This chapter examines the sex specific expression of potential
candidates by performing PCR amplification and whole-mount in-situ hybridisation.
4.2 Analysis of Potential Sex Determination Candidates by PCR
Amplification
To investigate the potential sex determination candidates (as selected in chapter 3,
Table 3.2), a total of nine candidate genes from the A chip were chosen for a
qualitative RT-PCR analysis using RNA isolated from E12.5 male and female
gonads. These included the five highest ranking candidates (Affymetrix probe set
ID: 104637_at (fold change of 12.3), 92932_at (fold change of 6.7), 101446_at (fold
change of 4.3), 96336_at (fold change of 4.3) and 96926_at (fold change of 4.2). A
further four candidates were selected to assess whether lower fold change values
would also show a differential male and female expression pattern by PCR
amplification. These candidates were Affymetrix probe set ID: 104135_at (fold
change of 3.1), 98109_at (fold change of 2.7), 97446_at (fold change of 2.4) and
100403_at (fold change of 2.3). In addition, GAPDH primers were used as a positive
control to ensure that male and female pools of cDNA were of equal quantity.
Figure 4.1 shows the results of the PCR amplification. As all the candidates chosen
for this assay were previously identified to be enriched in male gonads, it was
expected that each candidate would be more highly expressed in the male sample
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Figure 4.1 Expression Analysis of Potential Candidates by PCR Amplification
Expression analysis of 9 potential candidates by PCR amplification (35 cycles) using male and female
gonadal samples. GAPDH was used as a positive control to ensure that both samples were of equal
concentration. Water was used as a negative control. Samples are labeled by Affymetrix probe set ID
and GenBank descriptions corresponding to microarray data represented in Table 3.2.
Chapter 4 Verification ofMicroarrav Data
was striking as strong expression in the male sample can be seen, whereas no
expression in the female sample was detected. Affymetrix probe set ID 96926_at
(fold change of 4.2) also showed a clear difference between the two samples, where a
dramatic decrease in the female sample was observed compared to the strong
expression in the male sample. A high level of expression in the male sample and a
low level of expression in the female sample could also be seen in Affymetrix probe
set ID 101446_at (fold change of 4.3) and Affymetrix probe set ID 104135_at (fold
change of 3.1). It should also be noted that the GAPDH positive control shows no
difference between male and female samples, confirming that both cDNA samples
are of equal concentration and differences in expression levels between male and
female were not due to a difference in DNA concentration. These results gave us the
confidence to proceed with RNA in-situ hybridisation for these candidates and for an
additional 80 previously selected candidates.
4.3 Further Analysis of Potential Sex Determination Candidates by
Whole-mount In-situ Hybridisation
RNA in-situ hybridisation probes were designed for all of the selected candidates.
Anti-sense probes were produced by PCR amplification (as described in section 2.5.1
and as listed in Appendix 1). Subsequently, whole-mount in-situ hybridisation was
performed on eviscerated E12.5 male and female embryos for each probe. Results
were separated into the following four categories: increased expression in testis,
increased expression in ovary, equal expression in both sexes and undetectable
expression in either sex. It should be noted that from the 89 selected potential sex-
determining candidates in screen 1 (chapter 3), 54 candidates were identified to be
more highly expressed in male gonads and 35 candidates were identified to be more
highly expressed in female gonads (Table 3.2). Subsequently, of the 89 probes that
were assayed by whole-mount in-situ hybridisation, 3 were found to be confirmed
with increased expression in testis , none were found to be increased in the ovary , 41
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were found to be expressed in both testis and ovary and 45 were found to have
undetectable expression in either testis or ovary .
The 3 candidates with confirmed high expression in testis were Affymetrix probe set
ID 92932_at (fold change of 6.7), Affymetrix probe set ID 101446_at (fold change of
4.3) and Affymetrix probe set ID 96926_at (fold change of 4.2). These 3 candidates
were novel and of unknown function. Their GenBank descriptions were cerebellin 1
precursor protein (Cblnl) for Affymetrix probe set ID 92932_at (fold change of 6.7),
tumour protein D52-like 1 (Tpd52ll) for Affymetrix probe set ID 101446_at (fold
change of 4.3) and secreted modular calcium-binding protein 2 (Smoc2) for
Affymetrix probe set ID 96926_at (fold change of 4.2). It should be noted that the
GenBank descriptions for these candidates will be used hereafter.
Figures 4.2, 4.3 and 4.4 show the whole-mount in-situ hybridisation on E12.5 gonads
of Cblnl, Tpd52ll and Smoc2 respectively. It can be seen that the expression of each
candidate is only within the testis as staining can only be detected in male gonads,
while female gonads remain unstained. Thus, all 3 potential candidates initially
identified from screen 1 have been verified to be sex differentially expressed at
E12.5.
4.4 Discussion
It is important to verify microarray data by other methods to rule out false positives
within the data set. Using PCR amplification as an initial indicator for several
potential candidates showed that differential expression levels could be obtained
between male and female gonadal samples. This led to the wide scale, whole-mount
in-situ hybridisation approach of assaying 89 potential candidates. Unfortunately,
this method only yielded confirmation of 3 candidate genes to be male specifically
expressed at El 2.5. Moreover, none of the female potential candidates were positive
by in-situ hybridisation. This may be due to the RNA in-situ hybridisation probes
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Figure 4.2 Cblnl In-situ Hybridisation of E12.5 Gonads
Whole-mount in-situ hybridisation of El 2.5 gonads using anti-sense Cblnl probe. Top panel
shows Cblnl staining in male gonads, whereas no staining is observed in female gonads (lower
panel). Sense probes were negative for both male and female gonads (data not shown).
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Figure 4.3 Tpd52ll In-situ Hybridisation of E12.5 Gonads
Whole-mount in-situ hybridisation ofEl 2.5 gonads using anti-sense Tpd52ll probe. Top panel
shows Tpd52ll staining in male gonads, whereas no staining is observed in female gonads (lower
panel). Sense probes were negative for both male and female gonads (data not shown).
Figure 4.4 Smoc2 In-situ Hybridisation of E12.5 Gonads
Whole-mount in-situ hybridisation of E12.5 gonads using anti-sense Smoc2 probe. Top panel
shows Smoc2 staining in male gonads, whereas no staining is observed in female gonads (lower
panel). Sense probes were negative for both male and female gonads (data not shown).
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not being specific enough or optimisation of individual probes may be required.
Alternatively, the transcripts are lowly expressed and are therefore not detected by
in-situ hybridisation. However, it should be noted that screen 1 identified follistatin
(Fst) as a female specific gene with a fold change value of 9 (high-lighted in green,
Appendix 5). This gene was also later identified in the subtraction hybridisation
screen by Menke and Page (Menke and Page, 2002) as more highly expressed in
female gonads than male gonads. Therefore, the most likely explanation is that there
were technical difficulties with the in-situ hybridisations. These technical difficulties
can range from insufficient proteinase K treatment to poor hybridisation of RNA
probes. Future optimisation of in-situ hybridisation conditions should resolve these
problems.
In summary, although the whole-mount in-situ hybridisation results helped to
confirm male specific expression in the 3 candidates that were more highly expressed
in the male gonads, the differential expression between male and female gonads of
the remaining 86 candidates cannot be ruled out. Hence, there may be more male
and female specific genes within the selected potential candidates that were assayed.
Due to the clear differential expression of the 3 male specific candidates, further
analysis of these 3 putative genes will be carried out in an attempt to determine their
expression pattern and gene expression profile. This will be done by further whole-
mount in-situ hybridisation at El 1.5, E13.5 and E14.5 (chapter 5). In addition, real¬
time PCR of these candidates will be conducted to gain a more quantitative measure
of differential expression between male and female gonads.
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Chapter 5 Expression Analysis of Cblnl, Tpd5211 and Smoc2
5.1 Introduction
To gain further insights into the sexually dimorphic expression patterns and gene
expression profiles of Cblnl, Tpd52ll and Smoc2, more detailed analyses were
required. This chapter will investigate the other embryonic tissues within which
these genes may be expressed by PCR amplification. It also extends the initial
verification of these candidate genes (described in chapter 4) and shows further
whole-mount in-situ hybridisation of male and female gonads at El 1.5, E13.5 and
El4.5. In addition, RNA in-situ hybridisation of El4.5 gonadal sections will be
performed in an attempt to identify the specific cell type within which each gene is
expressed. Moreover, quantitative real-time PCR of these candidates will be carried
out to verify the fold changes from the microarray analysis and to determine their
temporal expression patterns, ranging from 17 to 36 tail somites.
5.2 Expression Pattern of Cblnl, Tpd52ll and Smoc2 by PCR
Amplification
We have shown that Cblnl, Tpd52ll and Smoc2 have a sexually dimorphic
expression pattern at E12.5. However, their expression patterns within other tissues
were unknown and were therefore investigated. PCR amplification of cDNA from
E12.5 heart, lungs, kidneys, liver, forelimbs, hindlimbs and the head was carried out.
Results are shown in figure 5.1. For Cblnl, strong expression in the forelimbs,
hindlimbs and the head, moderate expression in the liver, yet no expression in the
heart, lungs or kidneys is detected. Tpd52ll showed strong expression in the
forelimbs, hindlimbs and the head, along with moderate expression in the heart,
lungs and liver. However, expression could not be detected in the kidneys. Finally,
for Smoc2, expression seems to be ubiquitous as it is detected in all of the embryonic













































Figure 5.1 Expression Pattern of Cblnl, Tpd52ll and Smoc2 by PCR Amplification
RNA was isolated from the above El2.5 organs and eDNA was synthesised accordingly.
Expression analysis of each sample was determined by PCR amplification (35 cycles)
and assayed by gel electrophoresis. GAPDH was used as a positive control to observe any
differences in cDNA concentration. Water was used as a negative control for each gene.
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5.3 Expression Pattern ofCblnl, Tpd52ll and Smoc2 in Gonads
5.3.1 Whole-mount In-situ Hybridisation of Gonads
Extending the initial sex differential verification of Cblnl, Tpd52ll and Smoc2 with
E12.5 gonads, whole-mount in-situ hybridisation was also carried out for El 1.5,
E13.5 and E14.5 gonads. Cblnl results (Figure 5.2) indicate stronger expression in
male gonads than female gonads at each stage assayed. However, the staining
pattern seems to be diffuse throughout the gonad, particularly in the E13.5 and E14.5
male gonads. Although staining is not detected in El 1.5 and E13.5 female gonads,
there may be a low level of expression in E14.5 female gonads.
Figure 5.3 shows the Tpd52ll results. Marginal staining can be observed in El 1.5
male gonads, whereas the El 1.5 female gonad shows no staining. At E13.5, Tpd52ll
expression can be detected in male gonads, whereas female gonads are not staining.
In fact, Tpd52ll expression seems to be expressed within the testicular cords. This
expression pattern is also shown in El4.5 male gonads. However, there is marginal
staining in female gonads also at this stage.
Smoc2 results (Figure 5.4) also show staining in El 1.5 male gonads, when compared
to El 1.5 female gonads where no staining is detected. Staining is also observed in
El3.5 and E14.5 gonads. Although the expression is stronger in male gonads, there
is slight expression in the female gonads. It should also be noted that the
mesonephroi of male and female E13.5 and E14.5 urogenital ridges are stained,
whereby expression may be stronger in the female mesonephroi at these stages.
5.3.2 RNA In-situ Hybridisation on Gonadal Sections
RNA in-situ hybridisation was conducted on El4.5 transverse gonadal sections (as





Figure 5.2 Cblnl In-situ Hybridisation of E11.5, E13.5 and E14.5 Gonads
Whole-mount in-situ hybridisation ofEl 1.5, E13.5 and E14.5 gonads using anti-sense Cblnl probe.
Staining detected in male gonads, no staining observed in female gonads. Sense probe was negative for





Figure 5.3 Tptl52ll In-situ Hybridisation of E11.5, E13.5 and E14.5 Gonads
Whole-mount in-situ hybridisation ofEl 1.5, El 3.5 and El 4.5 gonads using anti-sense Tpd52H probe.
Staining detected in male gonads and marginal staining found in E14.5 female gonads, no staining







Figure 5.4 Smoc2 In-situ Hybridisation of El 1.5, E13.5 and E14.5 Gonads
Whole-mount in-situ hybridisation ofEl 1.5, E13.5 and E14.5 gonads using anti-sense Smoc2 probe.
Staining detected in male gonads and marginal staining found in E13 .5 and E14.5 female gonads. Staining
also detected in the mesonephroi at E13.5 and E14.5. No staining observed in El 1.5 female gonads.
Sense probe was negative for both male and female gonads (data not shown).
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Cblnl, Tpd52ll and Smoc2 respectively. The Cblnl anti-sense probe revealed the
expression of Cblnl to be mainly localised within the central region of the male
gonad. However, this expression does not seem to be restricted to the sex cords.
Moreover, cortical regions seem to be moderately stained. It should be noted that the
sense control showed no staining within the male gonad and no expression was
detected in the female gonad when using both sense and anti-sense probes. The
Tpd52ll anti-sense probe showed strong staining within the sex cords of the male
gonad, but also slight staining in the region surrounding the sex cords. As for Cblnl,
no Tpd52ll expression is detected in the female gonad or with the sense probe in
male and female gonads. The Smoc2 anti-sense probe revealed Smoc2 expression
throughout the male gonad. In contrast, no expression could be detected in the
female gonad and the sense probe also showed no staining in the male and female
gonads. The Sertoli cell marker, Mis, was used as a positive control (Figure 5.8) and
clear expression can be detected within the sex cords of the testis.
5.4 Gene Expression Profiles ofCblnl, Tpd52ll and Smoc2 in Gonads
5.4.1 Experimental Design
In order to assess the sex-specific expression levels of Cblnl, Tpd52ll and Smoc2, a
quantitative analysis approach using real-time PCR was taken. Wild-type male and
female gonad pairs, ranging from early El 1.5 to late El2.5, were used to obtain their
temporal expression patterns. These gonad samples were accurately staged by tail
somite counting (as described in section 2.3.3) and ranged from 17 tail somites (early
El 1.5) to 36 tail somites (late E12.5). Each tail somite stage was treated as
individual samples to generate a specific time scale for assaying gene expression
profiles in relation to the developmental stages of the gonad. It was of particular
interest to identify whether the potential sex determination candidates (Cblnl,
Tpd52ll and Smoc2) were involved in the initial stages of sex development, as they






Figure 5.5 Cblnl In-situ Hybridisation of E14.5 Gonadal Sections
RNA in-situ hybridisation of E14.5 gonadal sections using Cblnl sense and anti-sense probes. Top 4 panels




Figure 5.6 Tpil52ll In-situ Hybridisation of E14.5 Gonadal Sections
RNA in-situ hybridisation of EI4.5 gonadal sections using Tpd52ll sense and anti-sense probes. Top 4 panels
show testis, bottom 4 panels show ovary. Staining only detected in testis using anti-sense probe.
Figure 5.7 Smoc2 In-situ Hybridisation of E 14.5 Gonadal Sections
RNA in-situ hybridisation of E 14.5 gonadal sections using Smoc2 sense and anti-sense probes. Top 4 panels
show testis, bottom 4 panels show ovary. Staining only detected in testis using anti-sense probe.
Male
y&k V#* *1
• % d StSm 3xi85iifc>'
"w ',> OST j»^r v]J.t




Figure 5.8 Mrs In-situ Hybridisation of E 14.5 Gonadal Sections
RNA in-situ hybridisation ofE14.5 gonadal sections using Mrs anti-sense probe (positive control). Top 4
panels show testis, bottom 4 panels show ovary. Staining only detected in sex cords of testis.
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hybridisation, Figures 5.2, 5.3 and 5.4). Therefore, real-time PCR analyses of Sry,
Sox9 and Mis were also performed to relate the expression of the newly identified
genes to that of known players in the sex determination pathway.
5.4.2 Real-time PCR Standardisation
In every real-time PCR run, a dilution series of cDNA is included to generate a
standard curve for quantification of the cDNA samples. To ensure accurate
quantification of each cDNA sample, cDNA amplification curves should fall within
the standard curves of the dilution series. Figure 5.9 presents an example of the real¬
time amplification curves obtained from a real-time PCR run using the Lightcycler
(Roche). Fluorescence (y axis) is plotted against the cycle number (x axis).
Fluorescence is measured once per sample at the end of the annealing step for
specific hybridisation probes and once per sample at the end of the elongation step
for SYBR green probes. In both cases, the software calculates a linear regression
line through the data points of the standard curves, which enables the respective
concentration of each sample to be calculated. The slope of the regression line is
also calculated by the software and represents the overall reaction efficiency.
Manufacturer's state to achieve standard curve efficiency between 1.5 and 2.2, the
slope has to be between -5.7 and -2.9 (Roche). The software also calculates an error
value that indicates the variation between each sample, such as pipetting errors. An
error value of up to 0.6 corresponds to a x value (concentration) deviation of up to
50% (Roche).
For all SYBR green reactions, a melting curve analysis should be added to the end of
the real-time PCR run. A melting curve analysis shows the specificity of the reaction
by demonstrating the specific amplicons (PCR products) generated in a graphical
representation (Figure 5.10). Hence, any unspecific products such as primer dimers
that are formed can be detected.
135
PName
1Tpd5211(ia4) 2Tpd5211(10-3) 3TpdS?ll(10-2) 4Ipd52l1(10»1) 5Tpd5211Male(RT9] 8Tc*ft2!1-Ferr^ile|RTl?| 7Tpd5211-Wolet
StandardC Lut lrrot
10(E£*04592E*042148 1OfKf*038180E?28 1DOCf*02653Gt♦Ol325 10008*015S1E*0135.44 2405E*013457 6ft***003857 <9928801>4100
i»|*1*1*1*1*1 51052364 CycleNum&et
LineaiRegie*won
*CiossngP nt* Slupec4848 Inie'cepi-4099 Erra-0480 »-O90
15234 LoQC«ireer4iation





















Figure5.10Real-timPCRMeltingCurves Anexampleofmeltingcurvesbt inedwhenusi gthSYBRgresyst m.pecif candno - p cificPCRpr du tscanbobserved.
Chapter 5 Expression Analysis of Cblnl. Tpd5211 and Smoc2
5.4.3 Real-time PCR Results - Quantification of Male and Female Expression
Levels
The SYBR green system was used to quantify the expression levels of the potential
sex determination candidates {Cblnl, Tpd52ll and SmocI). Target sequences
previously used for PCR (Figure 5.1) were also used for this real-time PCR analysis
and expression levels were normalised against Gapdh (SYBR green system). Figure
5.11 shows the differential expression levels of Cblnl. The y axis represents the
expression of Cblnl over the expression of Gapdh (normalised expression) against
individual El2.5 male and female gonadal cDNA (x axis). Microarray data and in-
situ hybridisation results have shown Cblnl to be increased in male gonads, therefore
the expression of Cblnl was expected to be more highly expressed in the male
sample and expressed lowly in the female sample. Indeed, the real-time PCR results
showed expression levels to be high in male and low in female. More specifically,
the difference in expression levels (fold change) between the two samples was found
to be 5.75. This difference value is in good agreement with the fold change value of
6.7 obtained from the microarray analysis (chapter 3).
Figure 5.12 shows the differential expression levels of Tpd52ll. The E12.5 male and
female gonadal cDNA used in the Cblnl real-time PCR analysis (as mentioned
above) was also used for this analysis. Microarray data and in-situ hybridisation
results have also shown Tpd52ll to be increased in male gonads, therefore the
expression of Tpd52ll was expected to be more highly expressed in the male sample
and less expressed in the female sample. Indeed, the real-time PCR results showed a
high level of expression in the male sample and a low level of expression in the
female sample. Furthermore, the difference in expression levels (fold change)
between the two samples was found to be 3.05. This fold change value is
comparable to the fold change value of 4.2 obtained from the micoarray analysis
(chapter 3).
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Figure 5.11 Differential Expression Levels of Cblnl
Total RNA was extracted from E12.5 male gonads and E12.5 female gonads. 5gtg of
each RNA sample was reverse transcribed to produce cDNA. Expression levels of
Cblnl were measured by real-time PCR. To control for the levels of cDNA, samples
were normalised with respect to the expression levels of GAPDH.



















Figure 5.12 Differential Expression Levels of Tpd52ll
Total RNA was extracted from E12.5 male gonads and E12.5 female gonads. 5pg of
each RNA sample was reverse transcribed to produce cDNA. Expression levels of
Tpd52ll were measured by real-time PCR. To control for the levels of cDNA,
samples were normalised with respect to the expression levels ofGAPDH.





























Figure 5.13 Differential Expression Levels of Smoc2
Total RNA was extracted from E12.5 male gonads and E12.5 female gonads. 5jag of
each RNA sample was reverse transcribed to produce cDNA. Expression levels of
Smoc2 were measured by real-time PCR. To control for the levels of cDNA,
samples were normalised with respect to the expression levels of GAPDH.
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Using the same El2.5 male and female gonadal cDNA samples as were used for the
Cblnl and Tpd52ll real-time PCR analyses (as mentioned above), Figure 5.13 shows
the differential expression levels of Smoc2. Similar to Cblnl and Tpd52ll, the real¬
time PCR results ofSmoc2 showed a high level of expression in male and a low level
of expression in female. Furthermore, the difference in expression levels (fold
change) between the two samples was found to be 5.20. This factor difference is
relatively close to the fold change value of 4.1 obtained from the microarray analysis
(chapter 3).
5.4.4 Real-time PCR Results - Temporal Expression Patterns
To begin the temporal expression pattern studies, genes with distinctive and known
expression profiles in gonadal development (such as Sry, Sox9 and Mis) would first
be used to ensure that the use of this system was viable and that gene expression
profiles could be obtained. Subsequently, temporal expression patterns of Cblnl,
Tpd52ll and Smoc2 could be related to these known male specific genes. Sequence-
specific hybridisation probes for Sry, Sox9 and Mis were used to quantify the
expression level of the respective gene in each sample. All samples were normalised
against a sequence-specific hybridisation probe for Gapdh. Gene expression profiles
of each gene were plotted on separate line graphs, whereby the normalised
expression levels (y axis) were plotted against the tail somite stage of each gonadal
sample (x axis).
In males, the expression of Sry has been shown to start at E10.5, which then sharply
increases to a peak at El 1.5 and becomes switched off before E12.5 (Hacker et ah,
1995; Jeske et ah, 1995). In females, the Sry gene is absent and, as expected, Sry
expression is not detected. Figure 5.14 represents the temporal expression profile of
Sry within the gonadal samples assayed. Indeed, the temporal expression pattern
obtained is as expected. More specifically, Sry is expressed at a significant level in
the male sample at 17 tail somites (early El 1.5) compared to the female sample.
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Figure 5.14 Temporal Expression Pattern of5>y
Total RNA was extracted from male and female gonad pairs, ranging from 17 to 36
tail somites. 1 Opg of each RNA sample was reverse transcribed to produce cDNA.
Expression levels of Sry were measured by real-time PCR. To control for the levels
of cDNA, samples were normalised with respect to the expression levels of GAPDH.
The temporal expression pattern of the male gonads is represented in blue and the
temporal expression pattern of the female gonads is represented in pink.
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Figure 5.15 Temporal Expression Pattern ofSox9
Total RNA was extracted from male and female gonad pairs, ranging from 17 to 36
tail somites. 10pg of each RNA sample was reverse transcribed to produce cDNA.
Expression levels of Sox9 were measured by real-time PCR. To control for the levels
of cDNA, samples were normalised with respect to the expression levels of GAPDH.
The temporal expression pattern of the male gonads is represented in blue and the
temporal expression pattern of the female gonads is represented in pink.
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Figure 5.16 Temporal Expresssion Pattern ofMis
Total RNA was extracted from male and female gonad pairs, ranging from 17 to 36
tail somites. lOpg of each RNA sample was reverse transcribed to produce cDNA.
Expression levels ofMis were measured by real-time PCR. To control for the levels
of cDNA, samples were normalised with respect to the expression levels ofGAPDH.
The temporal expression pattern of the male gonads is represented in blue and the
temporal expression pattern of the female gonads is represented in pink.
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This expression continues at the same level until 20 tail somites (El 1.5), where it
then sharply increases to a peak at 21 tail somites (El 1.5). It then gradually
decreases and is not expressed from 27 tail somites (early E12.5) to 36 tail somites
(late E12.5). The expression of Sty was not detected in the female samples (ranging
from 17 to 36 tail somites).
Small amounts of cytoplasmic Sox9 can be found in both male and female gonads at
E10.5. However, the expression ofSox9 is activated through the expression ofSry in
XY gonads and so a high level of nuclear Sox9 is not detected until El 1.5 in male
gonads (de Santa Barbara et al., 2000; Morais da Silva et al., 1996). Sox9 expression
continues to be highly expressed at E12.5 to E13.5 as its expression becomes
localised to the sex cords in the testis (Kent et al., 1996). As the expression of Sox9
is increased in males, it is decreased in females. Figure 5.15 represents the temporal
expression pattern of Sox9 in the gonadal samples assayed. The temporal expression
pattern obtained was found to be similar to the published data. Low levels of Sox9
are detected in males between 17 to 20 tail somites (El 1.5), levels then increased at
21 tail somites (El 1.5) and continue to rise towards E12.5. Between early E12.5 to
late E12.5 (26 to 36 tail somites) in the male samples, the expression of Sox9
oscillates, indicating a degree of variability in Sox9 expression at these time points.
However, Sox9 expression levels remain high in the male samples and low in the
female samples throughout this time scale at each time point. In fact, the expression
of Sox9 in the female samples remains at a low level at all stages.
Mis is first detected at El 1.5 in the male gonad (Hacker et al., 1995). From E12.5,
Mis is highly detected in males and cannot be detected in females (Munsterberg and
Lovell-Badge, 1991). Mis is then only down-regulated in males after birth and, in
contrast, can be detected in females 6 days after birth (Munsterberg and Lovell-
Badge, 1991). Figure 5.16 represents the temporal expression pattern ofMis in the
gonadal samples assayed. The temporal expression pattern obtained showed a
similar trend as determined in other studies. Whilst no expression ofMis could be
detected at El 1.5 (17 to 21 tail somites) in male or female samples, at 26 tail somites
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(early E12.5), the expression ofMis becomes sexually dimorphic, where it increases
dramatically in male samples and remains at undetectable levels in female samples.
Although the expression deviates from the expected smooth curve between early
E12.5 to late E12.5 (26 to 36 tail somites) in the male samples, the trend of the
expression can be seen to be increasing towards the later tail somite stages. No Mis
expression was detected in female samples throughout the time course of the
expression profile (early El 1.5 to late E12.5, 17 to 36 tail somites).
Taking all three gene expression profiles (Sry, Sox9 and Mis) together, the results
demonstrated that correct gene expression profiles could be obtained by real-time
PCR analysis. Therefore, the same gonadal male and female cDNA samples were
used for analysis of Cblnl, Tpd52ll and Smoc2 gene expression profiles. The SYBR
green system was used to quantify the expression level of the respective gene in each
sample. All samples were normalised against Gapdh primers also using the SYBR
green system.
Figure 5.17 shows the temporal expression pattern of Cblnl. The expression levels
of Cblnl seem to be low in both male and female samples to begin with (at El 1.5,
from 17 to 21 tail somites). Then from E12.5 (26 to 36 tail somites), the expression
of Cblnl becomes increased in male samples and decreased in female samples.
Although, in the male profile, there is a slight dip in expression level at 29 and 30 tail
somites, Cblnl is still more highly expressed in the male samples than in the female
samples at those specific stages. It can also be seen that the expression of Cblnl is
increasing in the male as the tail somite stage increases. In contrast, the expression
ofCblnl in the female remains low throughout El 2.5 (26 to 36 tail somites).
Figure 5.18 shows the temporal expression pattern of Tpd52ll. The expression
levels of Tpd52ll seem to be quite dynamic and variable in both male and female
samples. However, it should be noted that the Tpd52ll is still more highly expressed
in male than in female from 21 tail somites (El 1.5) onwards. There seem to be
particular large differences in expression levels between male and female samples at
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Figure 5.17 Temporal Expression Pattern of Cblnl
Total RNA was extracted from male and female gonad pairs, ranging from 17 to 36
tail somites. 10pg of each RNA sample was reverse transcribed to produce cDNA.
Expression levels of Cblnl were measured by real-time PCR. To control for the
levels of cDNA, samples were normalised with respect to the expression levels of
GAPDH. The temporal expression pattern of the male gonads is represented in blue
and the temporal expression pattern of the female gonads is represented in pink.
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Figure 5.18 Temporal Expression Pattern of Tpd52ll
Total RNA was extracted from male and female gonad pairs, ranging from 17 to 36
tail somites. 10pg of each RNA sample was reverse transcribed to produce cDNA.
Expression levels of Tpd52ll were measured by real-time PCR. To control for the
levels of cDNA, samples were normalised with respect to the expression levels of
GAPDH. The temporal expression pattern of the male gonads is represented in blue
and the temporal expression pattern of the female gonads is represented in pink.
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Figure 5.19 Temporal Expression Pattern of Smoc2
Total RNA was extracted from male and female gonad pairs, ranging from 17 to 36
tail somites. lOpg of each RNA sample was reverse transcribed to produce cDNA.
Expression levels of Smoc2 were measured by real-time PCR. To control for the
levels of cDNA, samples were normalised with respect to the expression levels of
GAPDH. The temporal expression pattern of the male gonads is represented in blue
and the temporal expression pattern of the female gonads is represented in pink.
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25 tail somites (early E12.5) and 35 tail somites (late E12.5). This degree of
variability is also observed at a lesser extent in female samples as the expression of
Tpd52ll remains at a constant low level throughout the time scale of 17 to 36 tail
somites.
Figure 5.19 shows the temporal expression pattern of Smoc2. The expression levels
of Smoc2 seem to be similarly expressed at low levels in both male and female
samples to begin with (at El 1.5, from 17 to 21 tail somites). Then at early E12.5 (26
tail somites), Smoc2 expression levels are increased in male while they remain at low
levels in female. In particular, there seems to be a peak of expression at El2.5 (28
tail somites) in the male sample which gradually decreases from that point onwards
towards late E12.5 (36 tail somites). At 36 tail somites, Smoc2 expression is still at a
significantly high level in male. Therefore, Smoc2 is still sexually dimorphic at this
time point. Moreover, the expression levels of Smoc2 in female remain low
throughout the time scale of 17 to 36 tail somites.
5.5 Discussion
PCR amplification and gel electrophoresis gave an indication of the expression
patterns of Cblnl, Tpd52ll and Smoc2 within various E12.5 embryonic organs.
Unfortunately, RNA in-situ hybridisation of whole embryos (E10.5, El 1.5 and
E12.5) was unsuccessful and did not confirm or provide further insight into their
expression patterns. Interpretation of the data was difficult due to technical
difficulties with detection as background staining occurred. This may be a result of
the probe design or optimisation of the whole-mount in-situ hybridisation protocol is
required. Both these factors are also true for the whole-mount in-situ hybridisation
of gonads. Although each probe is more highly expressed in male gonads than
female gonads, the expression patterns are diffuse and could be more specific. This
is particularly seen in Cblnl, as Menke and Page showed Cblnl to be expressed in a
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more specific pattern within the interstitial cells of an E13.5 testis (Menke and Page,
2002).
Although RNA in-situ hybridisation of E14.5 gonadal sections showed staining in
the testis and no staining in the ovary, the specific cell type within which each gene
is expressed could not be determined. This is again possibly due to technical
difficulties or the probe itself. Whilst all sense probes were negative (no staining),
anti-sense probes showed a diffuse staining in the testis and staining within an
individual cell type could not be distinguished. Different sets of probes should be
designed and optimisation of the protocol should be carried out to establish a more
specific expression pattern of each gene.
Quantitative real-time PCR analysis has further verified the sexually dimorphic
patterns, showing Cblnl, Tpd52ll and Smoc2 to be more highly expressed in male
gonads. Interestingly, the fold changes measured by real-time PCR analysis are
comparable to the fold changes obtained from the Affymetrix microarray screen 1,
thus confirming the quantitative expression levels between male and female gonads.
In addition, the real-time PCR analyses of Cblnl, Tpd52ll and Smoc2 have allowed
these individual temporal expression patterns at the initial stages of sex
differentiation (early El 1.5 to late E12.5) to be generated. These gene expression
profiles have given an indication of their expression level and expression pattern
throughout the specific time course assayed. It should be noted that the temporal
expression patterns of Cblnl, Tpd52ll and Smoc2 did not display large differences
between male and female samples throughout El 1.5 (17 to 21 tail somites).
Therefore, the marginal staining detected within El 1.5 male gonads by whole-mount
in-situ hybridisation of these genes may be due to weaker expression levels of these
genes at this time point.
Various degrees of variability between each consecutive sample, as observed within
the Tpd52ll temporal expression pattern in particular, may be caused by dissection
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artefacts and impurities within individual samples. Nevertheless, a clear trend can be
observed within each time-course of gene expression. Although variability may
occur due to the use of individual samples, one would have expected a smooth curve,
whereas the data displayed a more scattered pattern. It should be noted that the
temporal expression pattern of Sox9 and Mis also showed this scatter, yet it is known
that this is not the case in vivo. Thus, it is important to observe the trend of each
temporal expression pattern, rather than examining the expression levels at individual
time points.
Comparing the temporal expression patterns of Cblnl, Tpd52ll and Smoc2 to those
of Sry, Sox9 and Mis, similar trends can be identified. For example, the time-course
of Cblnl gene expression (Figure 5.17) resembles the temporal expression pattern of
Mis (Figure 5.16), from the respect that both genes become sexually dimorphic at
early El2.5 (26 tail somites) and continues to increase in the male. However, little or
no expression can be detected in females. As Cblnl is expressed at approximately
the same time and has a similar expression pattern to Mis, this suggests that there
may be a correlation between these two genes. Further investigations are needed to
certify and clarify this preliminary finding.
In addition, the advantage of examining the initial stages of sex differentiation allows
early targets of sex determination to be investigated. In this case, it was interesting
to explore whether Cblnl, Tpd52ll and Smoc2 are early targets within the male
development pathway. As expression levels of all three genes seem to increase when
the expression of Sry is almost switched off, it is unlikely that they are direct
downstream targets of Sry. However, they may be downstream targets of Sox9.
Promoter-binding studies need to be conducted to provide concrete evidence of such
regulation (further discussed in chapter 7).
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Chapter 6 Gene-specific Knockdown in Gonadal Organ Culture by
siRNA
6.1 Introduction
In this chapter, genes known to be involved in sex determination (such as Sry and
Sox9) will be targeted by duplex siRNAs. These siRNAs will first be tested on TM4
cells grown in monolayer culture and then tried on gonadal organ cultures. The
outcome of these experiments may establish the use of sex-specific siRNAs on gonad
cultures and may provide a faster method of investigating sex-determining genes.
This will enable many sex-determining candidates to be assayed and the downstream
effects of silenced genes can also be analysed, leading to a better understanding of
the sex developmental pathways.
6.2 Testing ofsiRNAs on TM4 Cells
6.2.1 TM4 Cell Line
The TM4 cell line is a mouse Sertoli cell line (purchased from ECACC). Firstly,
these TM4 cells were tested to assess whether they expressed the male specific
genes, Sry and Sox9. The RNA of a confluent plate of cells was extracted and cDNA
was synthesised (as described in section 2.2) for PCR amplification. An aliquot of
the RNA was saved to run alongside the cDNA sample to test for DNA
contamination. This is particularly important as the Sry gene is intron-less. Known
male samples were used as a positive control to ensure both sets of primers were
functioning. Figure 6.1 shows the results of the PCR on a DNA agarose gel. Lanes
1-4 represent Sry and lanes 5-8 represent Sox9. All controls showed the expected
results. In the TM4 cells cDNA samples, lane 5 was positive which indicates that the
TM4 cells express Sox9. However, lane 1 was negative indicating that the TM4 cells
did not express Sry. Therefore, only Sox9 siRNAs could be used on the TM4 cells.
154
Sry Sox9
Figure 6.1 Sry and Sox9 Expression Analysis of the TM4 Cell Line
RT-PCR analysis of the TM4 cell line using Sry and Sox9 primers. Total RNA was
collected from a confluent plate of cultured TM4 cells. 5pg of RNA was reverse
transcribed to produce cDNA. The same aliquot of DNA/RNA template was used
for both sets of primers. Results show the TM4 cell line to express Sox9, but not Sry
(lane numbers correspond to text).
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6.2.2 Experimental Design and Results
Four different siRNA oligonucleotide templates were designed and produced for
Sox9 (as described in section 2.7.1). These have different target sequences for Sox9
to test for the most effective siRNA. They are referred to as Sox9(10), Sox9(13),
Sox9(33) and Sox9(44) (individual target sequences can be found in Appendix 3).
Cells were cultured and plated at an equal density as described in section 2.6.1 and
the four siRNAs were individually applied to separate plates of cells. A negative
control of the transfectant (oligofectamine) alone was included to assess if it is toxic
to the cells and to ascertain that any reduction in expression levels was due to the
siRNA and not the transfectant causing apoptosis in the cells. In addition, a plate of
untreated cells (no siRNA or transfectant) was also included to account for the
standard level of expression in each experiment. After 24 hours post-transfection
with siRNA, cells were prepared for RNA extraction and cDNA synthesis (as
described in section 2.2). Using sequence-specific hybridisation probes for Sox9
(Appendix 2), levels of each siRNA knockdown were quantitatively measured by
real-time PCR (as described in section 2.9.1). Expression levels of each sample was
determined in the same run and normalised by measuring the amount of Gapdh,
(Appendix 2).
The above experiment was repeated before analysing the results. Variable
expression levels were observed between the two sets of data (data not shown). It
was unclear whether this variability was due to differences in cell density, cell death
or another factor within the individual experiments. Therefore, replicates of each
sample were performed in one experiment. Figure 6.2 shows a bar chart of the Sox9
siRNA knockdown observed. The replicates of each sample run alongside its
corresponding sample. All expression levels have been normalised against Gapdh to
account for any differences in cDNA concentration between each sample. All four
Sox9 siRNAs showed a reduction in Sox9 expression levels compared to the
untreated cells and transfectant (oligofectamine) alone cells. Knockdown in
expression levels between replicates were comparable, however all four Sox9
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Figure 6.2 Real-time PCR Analysis of Sox9 Expression in TM4 Cells Following
siRNA Treatment
Total RNA was collected from Sox9(10), Sox9(13), Sox9(33) and Sox9(44) siRNA
treated cells, along with transfectant (Oligofectamine; Oligo(-ve)) only and untreated
cells (cells(+ve)). 5 pig ofRNA was reverse transcribed to produce cDNA. Real-time
PCR analysis for Sox9 was performed. To control for the levels of cDNA, samples
were normalised with respect to the expression levels of GAPDH.
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siRNAs seemed to suppress Sox9 expression to a similar extent. Therefore, from the
four Sox9 siRNAs, no particular siRNA was found to be more effective at repressing
Sox9 expression in the TM4 cell system. Although the siRNAs did not completely
repress Sox9 expression levels, preliminary results indicated that the Sox9 siRNAs
can individually knockdown the expression of Sox9 by 15 - 45%. This encouraged
proceedings with the intended siRNA assays on gonadal organ cultures.
6.3 Repression ofSox9 Expression by siRNA in Gonad Cultures
6.3.1 Experimental Design
As all four Sox9 siRNAs seemed to have similar knockdown effects on the cell
system, but none seemed to repress the expression of Sox9 completely, all four Sox9
siRNAs were used in the same cocktail with the hope to cause a more efficient
knockdown effect on the gonad culture system. Wild-type E12.5 urogenital ridges
were dissected for cultures which would be quantitatively analysed by real-time PCR
(as described in section 2.9.1). As for the cell system, sequence-specific
hybridisation probes for Sox9 (Appendix 2) were used and each sample was
normalised by measuring the amount of Gapdh (Appendix 2). Sox8+ + E12.5
urogenital ridges were dissected for cultures which would be phenotypically
analysed by X-gal staining. E12.5 was the chosen time-point as the expression of
Sox9 is at a high level at this stage and the effect of siRNA is believed to be most
effective when the targeted gene is highly expressed, allowing the siRNA to produce
a more efficient knockdown effect. Gonad cultures were treated as described in
section 2.6.2. The gonad plus mesonephros (urogenital ridge) was used for all
gonadal organ cultures. Each pair of gonads and mesonephroi was separated, where
one gonad plus its mesonephros was treated with the Sox9 siRNA cocktail mix and
the corresponding gonad and mesonephros from the same embryo was treated with
the Pax2 control siRNA. This ruled out embryonic stage differences and allowed
gonad cultures to be directly compared. Pax2 siRNA (kind gift ofDr Peter
158
Chapter 6 Gene-specific Knockdown in Gonadal Organ Culture bv siRNA
Hohenstein) was used as a control since gonads do not express Pax2 and
consequently are unaffected in Pax2 knockout mice (Torres et al., 1995). Therefore,
the Pax2 siRNA treated gonad culture can be considered as the control sample in
each embryo to compare the standard level of Sox9 expression against the
corresponding Sox9 siRNA treated gonad cultures.
6.3.2 Real-time PCR Results
Wild-type El2.5 gonad cultures were incubated for 24 hours after siRNA treatment
and should therefore be approximately equivalent to El3.5 gonads. Figure 6.3 shows
a bar chart of the expression levels of Sox9 produced by gonad cultures treated with
the Sox9 siRNA cocktail and the Pax2 control siRNA. All ten embryos were
obtained from the same litter. Genotyping of each embryo revealed eight of these to
be male and two to be female. Although Sox9 is a male sex determination gene and
is not expressed in female gonads at E12.5, female littermates were included in this
primary assay to compare the differences in expression levels between the two sexes
and to assess the validity of the results against previously established data. Indeed,
in the two female gonad cultures (C97 and CI02) expression of Sox9 was
undetectable (Figure 6.3), whereas the eight male gonad cultures showed positive
levels of Sox9 expression. From these eight male gonad cultures, six showed a
reduction in Sox9 expression levels following the Sox9 siRNA cocktail treatment
when compared to their contra-lateral gonad cultures treated with the Pax2 siRNA,
which showed higher levels of Sox9 expression. However, the knockdown levels of
Sox9 varied amongst these six samples. Samples C94, C96 and CI00 showed the
greatest reduction in Sox9 expression, whereby Sox9 siRNA treated samples were
approximately 50% lower than the corresponding Pax2 control treated sample.
Samples C98 and C99 showed a 38% and 39% reduction respectively. Whereas the
Sox9 siRNA sample in CI03 only showed a 20% knockdown effect. Before
repeating these preliminary results, the phenotypic effect of the Sox9 siRNA cocktail
was investigated by X-gal staining of the gonad cultures. This will allow more
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Figure 6.3 Real-time PCR Analysis of Sox9 Expression in E12.5 Gonad Cultures
Following siRNA Treatment
Total RNA was collected from wild-type E12.5 gonads cultured for 24 hours
following Sox9 and Pax2 siRNA treatment (corresponding gonads were used). 5pg
ofRNA was reverse transcribed to produce cDNA. Real-time PCR analysis for Sox9
was performed. To control for the levels of cDNA, samples were normalised with
respect to the expression levels of GAPDH. Samples C97 and CI02 are female
gonad cultures. All other samples are male.
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concrete conclusions to be drawn and aid the decision on the approach for the next
step.
6.3.3 X-Gal Staining Results
Culturing of gonads commenced at El2.5 (stage of dissection) and was incubated for
24 hours following siRNA treatment. Therefore, the stage of the gonad culture
should have reached approximately El3.5 when culturing stopped. Normally, in
vivo, phenotypic differences between testis and ovary can be observed in El3.5
gonads. However, developmental delays are expected to occur with in vitro systems.
Thus, Sox8 mice (from Dr Michael Wegner) were used as they contain a lacZ marker
fused with the Sox8 start codon. Since Sox8 is only expressed in the developing
testis from E12 (Sock et al., 2001), following the activation of Sox9, all male gonad
cultures should be LacZ positive.
To confirm this hypothesis and to observe the growth of the gonadal organ cultures
phenotypically, El 1.5 and E12.5 male and female gonads (with mesonephroi
attached) were taken for X-gal staining (as described in section 2.8). At the same
time, from the same litter, El 1.5 and E12.5 male and female gonads were placed into
culture. After three days (E12.5) and four days (El 1.5) culturing, these explants
were also taken for X-gal staining. Figure 6.4 shows the results for the El2.5 X-gal
staining of both the gonads and the cultures. The difference in male and female
samples is clearly observed by the lacZ positive staining in male samples and the
lacZ negative staining in female samples. Although the sex cords are not formed in
an organised manner compared to normal El5.5 gonads, the structure of the sex
cords can be clearly distinguished. Figure 6.5 shows the results for the El 1.5 X-gal
staining of both the gonads and the cultures. There was no staining in either male or
female gonads. This was expected as the expression ofSox8 is not switched on until
E12 (Sock et al., 2001). However, after 3 days in culture, lacZ positive cells were
observed in XY gonad cultures but not in XX gonad cultures. This change in El 1.5






Figure 6.4 X-Gal Staining of E12.5 Gonads and Gonad Cultures
Heterozygous SoxH embryos were dissected at E12.5. The top two panels show X-gal staining of a male
gonad (left) and female gonad (right). The bottom two panels show X-gal staining ofmale (left) and female




(El 1.5 - E15.5)
Figure 6.5 X-Gal Staining of El 1.5 Gonads and Gonad Cultures
Heterozygous Sox8 embryos were dissected at El 1.5. The top two panels show X-gal staining of a male
gonad (left) and female gonad (right). The bottom two panels show X-gal staining of male (left) and female
(right) gonads cultured from El 1.5 to E15.5 (4 days).
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Although distinct sex cords could not be observed in the El 1.5 male cultures
compared to the E12.5 male cultures (as mentioned above), a clear lacZ positive stain
is found. Therefore, the male gonad cultures can be differentiated from the female
gonad cultures on the basis of lacZ staining.
To test whether Sox9 siRNA interfered with the expression of Sox8, El2.5 gonad
cultures were treated with the Sox9 siRNA cocktail (Figure 6.6). All gonad cultures
were lacZ positive. This indicated that the Sox9 siRNA cocktail was not sufficient or
could not effectively suppress the expression of Sox8 within the male E12.5 gonad
cultures. A second independent experiment gave the same results. All gonad
cultures were lacZ positive in a further three Sox9 siRNA cocktail treated male
gonad cultures (results not shown).
Taking these results and the quantitative real-time PCR result together, it was
concluded that the Sox9 siRNA cocktail does not effectively knockdown the
expression of Sox9 in gonadal organ cultures. This may be due to the fact that by
El2.5 Sox9 has already activated Sox8 and subsequently the expression levels of
Sox8 may be maintained despite the reduction of Sox9. To address this issue, we
performed the same experiments using gonad cultures from El 1.5.
6.3.4 Sox9 siRNA on El 1.5 Gonad Cultures
El 1.5 gonad cultures were incubated for 24 hours after siRNA treatment and should
therefore be approximately equivalent to E12.5 gonads. The X-gal staining
procedure revealed lacZ positive staining in Sox9 siRNA treated cultures as well as
Pax2 siRNA treated cultures (Figure 6.7). This indicated that the Sox9 siRNA
cocktail did not repress the expression of Sox9 to a sufficient extent in order to
prevent its activation of Sox8 and consequently the expression of lacZ in the gonad
cultures.
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Figure 6.6 X-Gal Staining of E12.5 Gonad Cultures Treated with Sox9 siRNA
Heterozygous SoxH embryos were dissected at E12.5 and gonads were cultured to E13.5 (24 hours).
The top two panels represent a pair of gonads from embryo 1 and the bottom two panels represent a pair
of gonads from embryo 2. Both embryos are male. Each pair of gonads was separated, one treated with
the Sox9 siRNA cocktail mix and the other with the Pax2 control siRNA. All gonad cultures were X-gal
stained under the same conditions.




Figure 6.7 X-Gal Staining of Ell.5 Gonad Cultures Treated with Sox9 siRNA
Heterozygous Sox8 embryos were dissected at E1E5 and gonads were cultured to E12.5 (24 hours).
The top two panels represent a pair of gonads from embryo 1 and the bottom two panels represent a pair
of gonads from embryo 2. Both embryos are male. Each pair of gonads was separated, one treated with
the Sox9 siRNA cocktail mix and the other with the Pax2 control siRNA. All gonad cultures were X-gal
stained under the same conditions.
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Quantitative real-time PCR results of El 1.5 gonads cultured for 24 hours to E12.5
revealed three out of the four male gonad cultures to show a decrease in Sox9
expression levels when treated with the Sox9 siRNA cocktail (Figure 6.8). The
levels of Sox9 knockdown seemed to be more successful in this case compared to the
El2.5 attempt. In the three samples that showed a reduction in Sox9 expression, the
knockdown effect was much more effective in El 1.5 than E12.5. More specifically,
sample C121 showed a 44% knockdown effect, sample CI23 showed a 72%
knockdown effect and sample CI22 showed a 77% knockdown effect. Knockdown
levels of E12.5 gonad cultures only ranged from 20% to approximately 50% (Figure
6.3). Therefore, in gonadal organ cultures, the siRNA system is more effective when
the expression levels of the target gene has not reached its peak. In addition, the
siRNAs should be applied at a time point shortly after the target gene has been
switched on, before the expression levels are too high to be repressed or knocked
down.
Given the quite promising knockdown levels of Sox9 in these El 1.5 gonad cultures,
it would be interesting to investigate the downstream effects of this Sox9 repression
in the gonadal organ culture system. Therefore, the Mis expression levels of these
El 1.5 gonad cultures were also measured by real-time PCR using sequence-specific
hybridisation probes for Mis (Appendix 2). The expression levels of Mis were
expected to be reduced in the samples where Sox9 had been knocked down as Mis
has been suggested to be a direct downstream target of Sox9 (Arango et ah, 1999; De
Santa Barbara et ah, 1998). Indeed, the three samples (C121, CI22 and CI23) that
showed a reduction in Sox9 expression also showed a reduction in Mis expression
(Figure 6.9). In particular, there was a correlation between the down regulation of
Sox9 and the down regulation ofMis. Sample C121 showed a 44% knockdown in
Sox9 expression and a 38% knockdown in Mis expression, sample CI23 showed a
72% knockdown in Sox9 expression and a 81% knockdown in Mis expression and
sample C122 showed a 77% knockdown in Sox9 expression and a 92% knockdown
in Mis expression. It should also be noted that there was no reduction of Mis
expression in the male sample CI20 in which Sox9 levels were also unaffected. This
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Figure 6.8 Real-time PCR Analysis of Sox9 Expression in E11.5 Gonad Cultures
Following siRNA Treatment
Total RNA was collected from wild-type El 1.5 gonads cultured for 24 hours
following Sox9 and Pax2 siRNA treatment (corresponding gonads were used). 5ug
of RNA was reverse transcribed to produce cDNA. Real-time PCR analysis for Sox9
was performed. To control for the levels of cDNA, samples were normalised with
respect to the expression levels ofGAPDH. All samples are male.





























Figure 6.9 Real-time PCR Analysis of MIS Expression in El 1.5 Gonad Cultures
Following Sox9 siRNA Treatment
Total RNA was collected from wild-type El 1.5 gonads cultured for 24 hours
following Sox9 and Pax2 siRNA treatment (corresponding gonads were used). 5pg
of RNA was reverse transcribed to produce cDNA. Real-time PCR analysis for MIS
was performed (same cDNA samples as previously used in Figure 6.9). To control
for the levels of cDNA, samples were normalised with respect to the expression
levels ofGAPDH. All samples are male.
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illustrates that the reduction ofMis is a result of the reduced levels of Sox9 and not
caused directly by the presence of the transfectant (oligofectamine) or the siRNA
oligonucleotides in the culturing medium. This further illustrates that the siRNA
system works to a significant extent on gonadal organ cultures as the knockdown of
the target gene reflects the in vivo results of downstream targets. More importantly,
these data demonstrate that the approach of applying siRNAs in an organ culture
system can be used to study molecular pathways.
6.4 Repression ofSry Expression by siRNA in Gonad Cultures
6.4.1 Experimental Design
Four different siRNA oligonucleotide templates were designed and produced for Sry
(as described in section 2.7.1). They are referred to as Sry(6), Sry(7), Sry(9) and
Sry(ll) (individual target sequences can be found in Appendix 3). Since Sry is not
expressed in TM4 cells (Figure 6.1), there was no system available to test for the
efficiency of each Sry siRNA. Therefore, the technique of combining all four
siRNAs in the one cocktail mix, as for Sox9, was also used for Sry. The Pax2
siRNA was again used as the control. Sox8+ + E10.5 urogenital ridges were used for
gonad cultures as the expression of Sry is switched on at E10.5, where low levels of
the Sry transcripts can be detected in XY gonads (Hacker et al., 1995; Jeske et al.,
1995). These gonad cultures were X-gal stained to analyse whether the Sry siRNA
cocktail mix would cause a phenotypic effect.
6.4.2 X-Gal Staining Results
Gonads were cultured for 48 hours (from E10.5 to approximately E12.5) before they
were removed for X-gal staining. Figure 6.10 shows the results of two pairs ofmale
gonad cultures from the same litter of embryos. The Pax2 control siRNA cultures
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Figure 6.10 X-Gal Staining of E10.5 Gonad Cultures (1) Treated with Sry siRNA
Heterozygous Sox8 embryos were dissected at E10.5 and gonads were cultured to E12.5 (48 hours).
The top two panels represent a pair of gonads from embryo 1 and the bottom two panels represent a pair
of gonads from embryo 2. Both embryos are male. Each pair of gonads was separated, one treated with
the Sry siRNA cocktail mix and the other with the Pax2 control siRNA. All gonad cultures were X-gal
stained under the same conditions.
Sry siRNA Pax2 siRNA
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Figure 6.11 X-Gal Staining of E10.5 Gonad Cultures (2) Treated with Sry siRNA
Heterozygous Sox8 embryos were dissected at E 10.5 and gonads were cultured to E12.5 (48 hours).
The top two panels represent a pair of gonads from embryo 3 and the bottom two panels represent a pair
of gonads from embryo 4. Both embryos are male. Each pair of gonads was separated, one treated with
the Sry siRNA cocktail mix and the other with the Pax2 control siRNA. All gonad cultures were X-gal
stained under the same conditions.
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clearly showed lacZ positive cells (blue staining observed), indicating that the siRNA
treatment did not significantly delay the development of these cultures and did not
interfere with the male sex determination process. In contrast, cultures treated with
Sry siRNA were lacZ negative (no blue staining observed). These data show that the
Sry siRNA cocktail mix had successfully repressed the expression of Sry in this
gonadal organ culture system, whereby no staining was observed. The fact that the
Pax2 siRNA treated corresponding cultures showed staining signifies that the Sry
siRNA treated, lacZ negative cultures were not negative due to developmental delays
in this organ culturing system where lacZ was not yet expressed. This experiment
was repeated to confirm and to assess the reproducibility of these results. Again,
only the Pax2 control siRNA cultures were stained and the Sry siRNA cocktail mix
cultures were not stained (Figure 6.11). Hypothetically, all these Sry siRNA treated
cultures could be considered to be sex-reversed as they are non-male and
phenotypically resembled female gonad cultures rather than male. In conclusion, the
Sry siRNA cocktail mix worked efficiently in this gonadal organ culture system and
successfully altered the phenotype of the male gonad cultures.
6.5 Discussion
The ability of siRNAs to silence specific genes within a biological system was only
discovered in the last few years (Fire et ah, 1998). However, it has become one of
the most promising research tools in biology. At present, when using siRNAs, it is
common to select several sequences of the target gene to test for the most effective
siRNA. As it is not efficient to conduct this in organ cultures where an excessive
number of embryos would be required, the TM4 murine Sertoli cell line (purchased
from ECACC) was used. This cell line expresses the male sex determination gene
Sox9, but did not express the sex-determining gene Sry. Therefore, only the Sox9
siRNAs could be assayed on these TM4 cells. In order to produce reliable results,
replicates of each siRNA were conducted. Although the expression of Sox9 was not
completely reduced by any of the individual siRNAs, the 15 - 45% knockdown of
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each siRNA was encouraging. Further experiments using other conditions, for
example different transfection substitutes, may allow for further optimisation.
Since none of the Sox9 siRNAs were clearly more efficient, it was decided to
combine all four siRNAs in one mix. Taking this approach may cause a greater
knockdown effect or it may prevent a particular siRNA acting more efficient.
However, following the decision to attempt this combined approach, the use of two
different siRNAs targeted against two different genes was used by Voorhoeve and
Agami (Voorhoeve and Agami, 2003). They showed that, combining the use of two
siRNA-retroviral vectors, simultaneous suppression of both pRb and p53 was
obtained in cells (Voorhoeve and Agami, 2003). Thus, it is feasible to produce a
knockdown effect by combining different siRNAs in one reaction.
In addition, recently developed dicer-based systems can be used to produce many
different siRNAs in the same reaction. This dicer system consists of a population of
several siRNAs generated by digesting long dsRNA with ribonuclease III.
Ribonuclease III cleaves dsRNA into 12-30 nucleotide dsRNA fragments with 2-3
nucleotide 3' overhangs and 5' phosphate and 3' hydroxyl termini (Byrom et ah,
2003). These overhangs and termini are similar to those produced by "dicer" in the
in vivo RNAi pathway. The success of this dicer system has been illustrated in
mouse embryos whereby dicer-siRNAs were injected into the lumen of the neural
tube at specific regions and delivered into neuroepithelial cells by directed
electroporation (Calegari et ah, 2002). These dicer-siRNAs were directed against (3-
gal and coelectroporated into neuroepithelial cells together with reporter plasmids
expressing GFP and (3-gal. Results only showed the presence of GFP, no P-gal
expression was detected (Calegari et al., 2002). This demonstrates the specificity
that can be achieved when using a number of siRNAs in the same reaction.
In gonadal organ cultures, the time point at which the siRNA is applied is important
to the efficiency of the siRNA. As measured by quantitative real-time PCR, the
Sox9 siRNA mix is almost twice more effective on El 1.5 gonad cultures than El2.5
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gonad cultures. This may be due to the presence of higher amounts ofSox9 at E12.5.
Alternatively, the amount of siRNA transfected may not have been sufficient to
suppress Sox9 efficiently. Moreover, El2.5 gonadal tissue contains more cell layers
which may have caused the siRNA not to reach deeper layers of the tissue, leading to
the siRNA not being delivered to all targeted cells. For example, the siRNA may
only affect the top layer of cells and cannot reach the cells within the central layer of
the gonad. Interestingly, although X-gal staining of Sox9 siRNA treated gonad
cultures were lacZ positive, a slight effect of the Sox9 siRNA cocktail mix may be
observed as there are fewer lacZ positive cells in the Sox9 siRNA treated samples
when compared to the corresponding Pax2 control siRNA samples. However, it
should be noted that the X-gal staining assays are a qualitative and not quantitative
method of analysis. Taking the El 1.5 and E12.5 real-time PCR results separately,
the variation in Sox9 expression levels within individual experiments may be due to
the specific developmental stage of each embryo as tail somites were not counted for
each pair of gonad cultures. Hence, the gonadal stage and the onset of genes may be
slightly different which may cause a variation in siRNA knockdown levels. Of
course, it may also be due to experimental differences as this is a sophisticated
system with many parameters involved. Therefore, siRNA work on gonadal organ
cultures must be repeated several times before conclusions can be drawn.
In contrast to Sox9, the siRNA knockdown experiments appeared to be more efficient
for Sry. All cultures treated with Sry siRNA showed a sex-reversed phenotype.
Silencing Sry may be easier than Sox9 from the aspect that it is the initial switch for
male development (Hacker et al., 1995), thus once activated, it determines the rest of
the male developmental cascade. Therefore, if repression of Sry is successful, it
should theoretically hinder further development of the male gonad cultures. In
addition, changes in sex may be due to the testis being more sensitive to a decrease in
Sry levels compared to a decrease in Sox9 levels. This is based on the fact that male
gonadal development seems to be particularly sensitive to the expression of Sry as it
has been shown that a reduction of Sry expression to less than 30% of wild-type
levels can cause male-to-female sex reversal in mice (Nagamine et al., 1999).
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Consequently, lack of or too low levels of Sry could inhibit the activation of Sox9
which would also prevent the upregulation of Sox8 and thus the expression of lacZ in
the Sox8+/T cultures. On the other hand, the expression of Sry is highly dynamic: low
levels of Sry transcripts can be detected at E10.5 (when the formation of the
bipotential gonad begins), it then reaches a peak at El 1.5 (prior to overt
differentiation), before being completely switched off by E13.0 (Elacker et al., 1995;
Jeske et al., 1995). Therefore, it is critical to choose an early time point in order to
allow the siRNA to cause an effect. In addition, as male specific expression
commences at El 1.5 and the expression of Sox9 is sufficient to cause male
development (Vidal et al., 2001), El0.5 gonad cultures had to be used for the Sry
siRNA assays.
X-gal staining results of the Sry siRNA treated El0.5 gonad cultures have shown a
repression of Sry as all these cultures were lacZ negative compared to the lacZ
positive staining of their Pax2 control siRNA treated corresponding cultures. The
successful knockdown of Sry expression levels in the Sry siRNA treated cultures
prevented the downsteam activation of Sox9, which lead to the absence of Sox8
expression and consequently no lacZ staining. These non-male gonad cultures
demonstrate that the Sry siRNA cocktail mix worked effectively in the gonadal organ
culture system and has even altered the phenotype of these male gonad cultures.
Moreover, this shows that using more than one siRNA in one transfection mix can be
efficient and successful.
However, further investigations into these non-male gonad cultures are required to
determine whether they are truly sex-reversed. More specifically, it will be
important to establish whether these non-male gonad cultures express female specific
genes. This could be examined by in-situ hybridisation using female specific
markers, such as Bmp2 (Ross et al., 2003) and Fst (Yao et al., 2004). In addition, a
Leydig cell-specific marker, such as P450scc, should be used to explore the presence
of Leydig cells within our non-male cultures. It is conceivable that the Sry siRNA
cocktail has only effected Sertoli cells within the cultures as Sry, Sox9 and Sox8 are
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all expressed in Sertoli cells. Investigations into Leydig cells will reveal the extent
of the Sry siRNA effect and will clarify whether these cultures have a truly non-male
phenotype.
In summary, the task of setting up a siRNA system to investigate the function of
novel sex determination genes has been achieved. The successful Sry siRNA
repression can be used to further investigate the male developmental pathway. For
example, the downstream targets ofSry could be deduced and confirmed by real-time
PCR analysis of their expression levels following Sry siRNA knockdown.
Subsequently, specific siRNAs for these genes can be produced and assayed on
gonadal organ cultures themselves (further discussed in chapter 7). Taking both
approaches into consideration, this siRNA gonad culture set up can be adapted and
used for many genes involved in sex determination. Using the lacZ system as an
indictor in the Sox8 mice has been helpful in setting up the technology to use siRNAs
on gonadal organ cultures. However, it should be noted that this system has to be
adjusted and adapted for other gonadal development analyses. For example, Sox8
activation occurs at early E12.5, whereas other genes act at a later stage.
Consequently, investigations into genes which are involved in sex determination of
male gonads at later stages will require a different system as Sox8 will already have
been activated, thus lacZ cannot be used as an indicator in these cases. Additionally,
although the use of this lacZ system as an indicator in the Sox8 mice is male specific,
analysis of female specific genes is also possible by using wild-type gonad cultures
and measuring their expression levels by real-time PCR. In fact, since specific gene
repression by siRNA is unlikely to be 100% complete, quantification of male and
female specific gene expression may be preferential, as it does not rely on an
absolute inactivation of the target gene. In conclusion, the siRNA gonad culture
system can be used for investigations into male and female pathways, which may
lead to a better understanding of the sex development cascades. Furthermore, RNA
isolated from siRNA-treated gonad cultures could be used on gonad-specific
microarrays, which would detect changes in gene expression. Thus, the downstream
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targets of the repressed gene would be identified and this may allow additional
elements of the sex developmental pathways to be elucidated.
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7.1 Overview ofProject
The work presented in this thesis aims to identify new genes involved in the
development of the gonad, which may lead to a better understanding of the male and
female developmental pathways. Affymetrix microarrays were used to screen for
novel candidates involved in sex determination. Differential expression patterns
were verified by whole-mount in-situ hybridisation and this thesis focused on the 3
male specific genes (Cblnl, Tpd52ll and Smoc2) that were identified. Differences in
expression levels of these transcripts were confirmed by real-time PCR analysis.
Temporal expression patterns of these potential candidates were also examined by
real-time PCR, whereby the overall trend for each gene could be monitored during
the initial stages of gonadal differentiation (early El 1.5 to late E12.5). These
temporal expression patterns allowed speculation about the factors which may
regulate these novel candidates at the early stages of male sexual development.
Extending this work, the establishment of gene-specific knockdown by siRNA in
gonadal organ cultures will allow functional analysis of candidate genes isolated
from the sex determination screen.
7.2 Future Prospects ofMicroarrays in Sex Determination
There were many potential sex differentially expressed genes within our microarray
data set. Several more potential candidates may be verified to have sexually
dimorphic expression patterns following optimisation of the whole-mount in-situ
hybridisation protocol and this may lead to identification of further novel candidates.
Advances in microarray technology now permits small amounts of total RNA to be
used. However, a well-optimised, consistent and reproducible RNA amplification
protocol is required for individual RNA samples. Once this has been achieved for
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embryonic gonadal tissue, it will allow more sex determination screens to be
performed. In particular, genes that are important in the sex development pathways
could be identified by applying RNA isolated from sex-reversed gonads to
microarrays. For example, XY homozygous knockout mice for the Sox9 gene are
completely sex reversed (Chaboissier et al., 2004). Thus, applying RNA isolated
from male, female and mutant sex-reversed gonads to microarrays will allow genes
that are involved in this male to female sex-reversed phenotype to be distinguished.
This screen may also allow a gene to be pinpointed within the sex determination
cascade and may demonstrate additional genes regulated by Sry.
7.3 Future Analyses ofCblnl, Tpd52ll and Smoc2
From our sex differential screen, the three genes that were analysed in more detail
were Cblnl, Tpd52ll and Smoc2, as they were confirmed to have a sexually
dimorphic expression pattern at El2.5 by whole-mount in-situ hybridisation (Figures
4.2, 4.3 and 4.4). Nevertheless, optimisation of the in-situ hybridisation protocol and
designing different sets of probes may improve the in-situ hybridisation results for
these genes. This may lead to a more defined staining pattern of the gonads.
Moreover, once optimisation has been achieved, analysis of sections following
whole-mount in-situ hybridisation can be conducted. These results may then reveal
the specific cell type within which each gene is expressed.
The preliminary temporal expression patterns of Cblnl, Tpd52ll and Smoc2
suggested that these genes may be regulated by an early male specifically expressed
gene, such as Sox9. To further investigate this hypothesis, the expression pattern of
these genes could be examined in Sox9 knockout mice. If these genes are not
expressed, this implies that they may be downstream targets of Sox9. Subsequently,
promoter-binding studies could be conducted to confirm the regulation of these genes
by Sox9. Consequently, the promoter regions of these genes would be checked for
the SOX9-binding site (CCCTTTGAGA) (Arango et al., 1999). If this motif is
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found within a gene, electrophoretic mobility shift assays (EMSA) and co-
transfection assays could be performed to investigate if this motif is actively
involved in the transcription of the gene. If results reveal that SOX9 can bind and
activate transcription of the gene, this indicates that Sox9 regulates the gene. In case
absolute proof is required, then this binding site could be mutated in ES cells, as
conducted forMis (Arango et al., 1999). Hence, mice with a targeted mutation of the
SOX9-binding site within the gene's promoter would be generated. Analysis of the
testes and ovaries of these mice will reveal whether mutation of the SOX9-binding
site affects the expression levels of the gene of interest. Thus, the regulation of this
gene by Sox9 will be elucidated.
7.4 Current Developments ofCblnl, Tpd52ll and Smoc2
7.4.1 Biological Profile of Cblnl
Precerebellin-1 or cerebellin 1 precursor protein {Cblnl) belongs to a larger
superfamily of several atypical collagens (Urade et al., 1991). It shares significant
amino acid homology with the globular (non-collagen) domains of the complement
components ClqA, B and C (Urade et al., 1991; Wada and Ohtani, 1991), implying
some common characteristics of structure and/or function. As the Clq complex
consists of heterotrimers of ClqA, B and C that bind to surface immunoglobulin, it
has been hypothesised that multiple precerebellins may assemble into homo- or
heteromeric complexes that bind to brain-specific members of the immunoglobulin
superfamily (Urade et al., 1991).
Molecular genetic analysis of Cblnl has determined that additional Cblnl transcripts
are derived either from alternative splicing of the 3'-untranslated region (3'-UTR) of
Cblnl or the use of different polyadenylation sites (Kavety and Morgan, 1998). To
date, four independent transcripts have been cloned from an adult mouse cerebellum
cDNA library (Kavety and Morgan, 1998). With one possible exception, these
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various processing events do not affect the amino acid sequence of precerebellin
(Kavety and Morgan, 1998).
The expression pattern of Cblnl within embryonic organs is presently unknown.
This thesis describes Cblnl expression in E12.5 forelimbs, hindlimbs, head and liver.
However, no expression was detected in the heart, lungs or kidneys (Figure 5.1). By
sex differential screens, Cblnl has been identified to be sexually dimorphically
expressed in E12.5 gonads (this thesis, Figure 4.2 and Menke and Page, 2002), which
implies that Cblnl may play a role in sex determination and gonadal development.
Although homozygous Cblnl knockout mice do not show a male-to-female sex-
reversed phenotype (personal correspondence with Dr James Morgan, St. Jude
Children's Research Hospital, Memphis), the involvement of Cblnl within the sex
development cascade should not be ruled out. For example, functional redundancy
with another gene may have occurred and thus no gonadal phenotype is observed.
Therefore, it is possible that Cblnl may still be important in the activation of male
specific genes within the testicular development pathway. Further analysis of the
homozygous Cblnl knockout gonads are required to establish a better understanding
of Cblnl in sex determination and gonadal development.
Interestingly, a novel member of the cerebellin family, Cerebellin 4 precursor protein
(iCbln4), has also been identified to be expressed in a sexually dimorphic pattern at
El2.5 ((Menke and Page, 2002). Since Cblnl and Cbln4 are both highly expressed
in El2.5 testis and given that members of this family can form ternary complexes, it
is possible that these two genes associate with each other to activate other genes
within the male development pathway. However, Cblnl seems to be localised within
the interstitial cells (this thesis, Figure 5.5 and (Menke and Page, 2002), whilst Cbln4
seems to be expressed in the testicular cords (Menke and Page, 2002). This suggests
the possibility of mutual induction signals mediated by these two molecules in the
specification of different cell types/compartments of the testes. Alternatively, the
distinct expression patterns of these two molecules correlate with distinct functions
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in these different cell types/compartments. Further investigations of these two
molecules are required to deduce their mutual or separate involvement in testicular
development.
7.4.2 Biological Profile of Tpd52ll
The tumour protein D52 family represents a conserved group of small hydrophilic
proteins, consisting ofD52 (Byrne et al., 1995), D53 (TPD52L1) (Byrne et ah, 1996)
and D54 (TPD52L2) (Nourse et al., 1998). These three D52-like proteins are coiled-
coil motif bearing proteins, indicative of protein-protein interactions, and may be
capable of hetero- and/or homodimer formation (Byrne et ah, 1996). D52-like gene
transcripts are subject to alternative splicing, with sequences encoding a region
termed insert 3 being affected in all three D52-like genes (Nourse et ah, 1998). A
14-3-3 binding motif within one of two alternatively spliced exons encoding insert 3
has recently been identified, leading to the discovery of 14-3-3 proteins as novel
heterologous partners for human D53 (Boutros et ah, 2003).
In the mouse, Tpd52ll has been mapped to chromosome 10A4-10B2 (Byrne et ah,
1998). However, little is known of its expression pattern. This thesis has shown
Tpd52ll to be strongly expressed in E12.5 forelimbs, hindlimbs and head. Plus,
moderately expressed in the heart, lungs and liver. However, no expression was
detected in the kidneys (Figure 5.1). In the gonads, Tpd52ll was found to be sex
differentially expressed by E12.5 - E14.5 (Figures 4.3 and 5.3). This suggests that
Tpd52ll may be involved in the sex determination and gonadal development
pathways. Furthermore, RNA in-situ hybridisation of E14.5 gonadal sections
indicated Tpd52ll to be expressed within Sertoli cells (Figure 5.6). The known male
specific genes Sry, Sox9 and Mis are Sertoli cell markers, thus Tpd52ll may act
within this developmental cascade. Real-time PCR analysis revealed Tpd52ll
expression to increase in male gonads between 21 tail somites (El 1.5) and 25 tail
somites (early El2.5) (Figure 5.18). More specifically, this increase occurs shortly
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after the onset of Sox9 (Figure 5.15). It would be interesting to further analyse
whether Tpd52ll is a direct downstream target ofSox9.
7.4.3 Biological Profile ofSmoc2
The secreted modular calcium-binding protein 2 (Smoc2) contains an EF-hand
calcium-binding domain homologous to that in BM-40 (Vannahme et ah, 2003). In
addition, it contains two thyroglobulin-like domains, a follistatin-like domain and a
novel domain found only in the homologous SMOC1 (Vannahme et ah, 2002).
Phylogenetic analysis of the calcium-binding domain sequences showed that SMOC1
and SMOC2 form a separate group within the BM-40 family (Vannahme et al.,
2003). Circular dichroism (CD) spectroscopy revealed SMOC2 to be a glycoprotein
with a calcium-dependent conformation (Vannahme et ah, 2003).
Northern blot analysis results from different tissues of adult mice showed a broad
expression pattern of Smoc2, whereby a prominent signal in the ovary and clear
signals in the heart, muscle and spleen were detected (Vannahme et al., 2003). RT-
PCR revealed wide-spread expression in many adult tissues, such as the brain,
thymus, lung, heart, liver, kidney, spleen, testis, ovary and skeletal muscle
(Vannahme et al., 2003). Embryonic tissue distribution of Smoc2 also exhibited
expression in E12.5 heart, lungs, kidneys, liver, forelimbs, hindlimbs and the head
(Figure 5.1). In embryonic gonads, Smoc2 has been found to be expressed in a
sexually dimorphic pattern by E12.5 - E14.5 (Figures 4.4 and 5.4). RNA in-situ
hybridisation of E14.5 gonadal sections indicated Smoc2 expression throughout the
male gonad (Figure 5.7), whereas no specific expression within a particular cell type
could be identified. As Smoc2 has now been revealed to localise in basement
membranes and is also present in the extracellular environment when calcium-bound
(Vannahme et al., 2003), it is not surprising that it is widely expressed throughout the
testis. These findings imply that the up-regulation of Smoc2 in male gonads may
only represent the formation of testicular cords. Hence, Smoc2 appears to be
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involved in the structure of the gonad rather than in the sex differentiation process.
Thus, Smoc2 is unlikely to play a role in sex determination.
7.5 Future Prospects ofsiRNA on Gonadal Organ Cultures
7.5.1 Quantitative Analysis of Sry siRNA-treated Gonad Cultures
The work in this thesis describes the application of siRNA in gonadal organ cultures.
More specifically, the successful knockdown of Sry on gonadal organ cultures by
siRNA treatment resulted in Sox8+/+ male explants to be lacZ negative, representing
the lack of expression of this male specific marker (Figures 6.10 and 6.11). It would
be interesting to perform real-time PCR analysis of these Sry siRNA-treated gonad
cultures on Sry itselfbut also on other genes. Both male and female genes should be
analysed to measure the extent of sex reversal produced by the application of siRNA.
Real-time PCR analysis of Sry will quantitatively establish the repressive effects of
siRNA against Sry. Subsequently, other genes that may be a downstream target of
Sry or act within the Sry cascade can also be examined by measurement of their
expression levels.
It would also be interesting to measure the expression levels of genes which act
within the female developmental pathway, such as Fst (Yao et al., 2004). Increased
levels of Fst within Sry siRNA-treated gonad cultures would indicate a male-to-
female sex reversed phenotype. Thus, the true extent of siRNA application on
gonadal organ cultures will also be revealed.
7.5.2 Use of Other siRNAs on Gonad Cultures
The experimental siRNA system described in this thesis is a promising method of
analysing genes involved in sex determination. Obviously, siRNA against Sry was
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conducted as a proof ofprinciple, where the successful knockdown effects have been
shown (Figures 6.10 and 6.11). The technology can now be used to study putative
sex-determining genes identified in our screen.
Investigations into potential female specific candidates are also possible by designing
siRNAs against these genes and applying them onto wild-type gonad cultures. Their
expression levels would then be quantified by real-time PCR analysis, whereby any
reductions would be measured. Of course, this system would have to be tested with
known female specific genes, such as Bmp2 (Ross et al., 2003) and Fst (Yao et ah,
2004), before assaying potential female candidates identified from the Affymetrix
sex differential microarray analysis.
7.5.3 Generation of LacZ Mice for Analysis of Later-staged Male Specific Genes
This thesis described the use of a lacZ marker fused with the Sox8 start codon (Sock
et ah, 2001) as an indicator of male specific expression. This system has aided the
set up of siRNA technology on gonadal organ cultures and allowed for the analysis
of early genes in testicular development. To investigate genes that are involved in
later stages of male gonad development, there will be a requirement for the
generation of transgenic mice carrying the lacZ marker fused with the start codon of
a male specific gene expressed at a later developmental stage.
Recently, promyelocytic leukemia zinc-finger (Plzf) has been identified as a
spermatogonia-specific transcription factor in the testis (Costoya et ah, 2004). Mice
lacking Zfpl45, encoding the transcriptional repressor Plzf, progressively lose
spermatogonia with age due to increases in apoptosis and subsequent loss of tubule
structure (Costoya et ah, 2004). However, overt differentiation defects did not occur
and supporting Sertoli cells were not lost (Costoya et ah, 2004). In wild-type mice,
expression of Plzf is first detected in the germ cells at E17.5 during development of
the testis and was found to peak in the postnatal testis at around 1 week (Costoya et
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al., 2004). Thus, a lacZ marker could be fused with the Plzf start codon to produce
transgenic mice that would serve as an indicator of phenotypically male gonad
cultures for later staged testicular specific genes. Although the onset of expression at
El7.5 may be too late and may cause problems, this system could be particularly
useful in identifying genes that are involved in germ cell maturation of the testis.
Unfortunately, there are many genes that are not suitable as they are expressed in
both male and female gonads before becoming sexually dimorphic at a later stage.
For example, Dmrtl is expressed in both sexes from E10.5 - E13.5 and only
becomes sex differentially expressed at E14.5 (De Grandi et al., 2000). Ideally, the
gene should be male specifically expressed throughout the development of the gonad
to provide a clear indication of being phenotypically male. Moreover, the onset of
the gene's expression would preferably be from E14.5 to allow later staged male
specific genes to be analysed, whilst minimising technical difficulties of culturing
gonads for prolonged periods before the lacZ marker is switched on. Currently, there
are no genes that match these criteria. However, as more male specific genes
become identified, a suitable gene may become available to allow the generation of
transgenic mice for this later staged system.
7.5.4 Alternative RNAi Approach
Although the application of siRNAs on gonadal organ cultures has been a successful
in vitro approach to analyse the function of sex-determining genes, advances in
RNAi technology can now be used in whole animal systems. A new vector, named
pDECAP (Deletion of Cap structure and poly(A)), which expresses long double-
strand RNA (ds-RNA) from an RNA polymerase II (Pol II) promoter has been
developed (Shinagawa and Ishii, 2003). Transcripts from pDECAP lack both the 5'-
cap structure and the 3'-poly(A) tail that facilitate ds-RNA export to the cytoplasm
(Shinagawa and Ishii, 2003), hence long ds-RNA from pDECAP does not induce the
interferon response. In general, Pol II transcripts are transferred to the cytosol
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immediately after transcription, where they induce interferon synthesis (Stark et ah,
1998), which leads to a block in translation and sequence-nonspecific mRNA
degradation (Elbashir et ah, 2001; Paddison et ah, 2002). However, the design of
pDECAP efficiently blocks the export of long ds-RNA to the cytosol (Shinagawa
and Ishii, 2003). Since ribonuclease(s) such as Dicer, which cleave long ds-RNA,
are localised in both the nucleus and the cytoplasm (Lee et al., 2002), the long ds-
RNA expressed from the pDECAP vector is processed into siRNA in the nucleus and
then moves to the cytosol to induce the degradation of target mRNA (Shinagawa and
Ishii, 2003). Transgenic mice embryos expressing long ds-RNA for the
transcriptional corepressor Ski from the pDECAP vector displayed similar
phenotypes to those of ^'-deficient embryos (Shinagawa and Ishii, 2003).
Adopting this novel approach, the pDECAP vector could also be used to generate
transgenic mice for the analysis of genes involved in sex determination and gonadal
development. This innovative technique would initially be assayed on known sex
determination genes, such as Sox9, to assess if similar phenotypes can be obtained.
This process would involve investigating the effect of long ds-RNA for the Sox9
gene on Sox9 protein levels. The pDECAP vector expressing ds-RNA for a
fragment of Sox9 (pDECAP-Sox9) could be cotransfected into TM4 cells (murine
Sertoli cell line expressing Sox9) together with a Sox9 expression vector.
Subsequently, Sox9 protein levels could be examined by Western blot analysis. If
levels of Sox9 protein are reduced in cotransfection of pDECAP-Sox9 and the
pDECAP-Sox9 vector alone, this indicates that the pDECAP-Sox9 vector can cause
a knockdown of Sox9 expression levels. Further investigations would be conducted
to ensure that Sox9 ds-RNA expressed from pDECAP-Sox9 does not induce the
interferon response and that endogenous levels of Sox9 mRNA are also reduced by
transfection of pDECAP-Sox9. If results obtained reveal the desired outcome, the
pDECAP-Sox9 vector can be prepared and injected into fertilised mouse oocytes for
the generation of transgenic mice. Thus, RNAi may be used to study the function of
sex determination genes by gonad specific knockdown in whole animal systems.
This in vivo RNAi method may complement and allow a more in depth functional
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analysis of sex determination genes when compared to the application of siRNA on
gonadal organ cultures. However, it does not replace the generation ofmutant mice
by homologous recombination in embryonic stem (ES) cells (Capecchi, 1989) as a
complete knockdown of the gene's expression level may not be achieved by
pDECAP.
7.6 Conclusion
Following the discovery of SRY, over a decade of study on genes involved in sex
determination and gonadal development has been conducted. Whilst several other
genes, such as WT1, SF1, DAX1 and SOX9, have been shown to play an important
part in the sex developmental process, our knowledge and understanding remains
incomplete. The utilisation of microarrays to screen for novel sex determination
candidates has been an advancement towards the elucidation of this process, yet
many other genes remain unidentified. Moreover, the functional roles of these
potential candidates are unknown. Although further work is required, the
identification of three novel sexually dimorphic expressed genes in this thesis has
been an important step forward towards unravelling the sex development cascade. In
addition, the establishment of the siRNA system on gonadal organ cultures described
in this thesis will allow the functional properties ofmany potential candidates to be
analysed, prior to the more time-consuming approaches of generating transgenic
mice. Thus, taking the microarray analysis and siRNA system together, these
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Sequences of primers used in PCR and production of riboprobes
For riboprobes, T3 and T7 promoter sequences were placed in front of 3' and 5'
primer sequences. For example, T3 promoter-3' primer and T7 promoter-5 'primer.
T3 promoter sequence: cgcaattaaccctcactaaagggaacatctaga
T7 promoter sequence: gcgtaatacgactcactatagggcgactcgag

























































































































































































Sequence-specific hybridisation probes for real-time PCR
Gapdh cDNA: 5'-attcaacggcacagtcaagg-3' and 5'-tggatgcagggatgatgttc-3',
hybridisation probes 5'-ccagaagactgtggatggcccct-x and
LC-Red640-tggaaagctgtggcgtgatggc-p.
Mis: 5'-gtcctacatctggctgaagtgat-3' and 5'-ccgagtagggcagaggttct-3',
hybridisation probes 5'-ggccctgttagtgetatactetggacc-x and
LC-Red640-gcccccaggtcacagtcacagg-p.
Sox9: 5'-gacaagcggaggcegaa-3' and 5'-ccagcttgcacgtcggtt-3',
hybridisation probes 5'-cttgcagcgccttgaagatagcattag-x and
LC-Red640-gagatgtgagtctgttccgtggcctc-p.
Sry: 5'-agcctatgtgtagttccttggte-3' and 5'-tgcataaggagtcacattttgct-3',







Anti-sense strand siRNA: aatgtgtcaggcacacagacgcctgtctc
Sense strand siRNA: aacgtctgtgtgcctgacacacctgtctc
• Sox 9
Target sequence 10: aacacccggccccaggagaac
Anti-sense strand siRNA: aacacccggccccaggagaaccctgtctc
Sense strand siRNA: aagttctcctggggccgggtgcctgtctc
Target sequence 13: aagaaggagagcgaggaagat
Anti-sense strand siRNA: aagaaggagagcgaggaagatcctgtctc
Sense strand siRNA: aaatcttcctcgctctccttccctgtctc
Target sequence 33: aagtcggtgaagaacggacaa
Anti-sense strand siRNA: aagtcggtgaagaacggacaacctgtctc
Sense strand siRNA: aattgtccgttcttcaccgaccctgtctc
Target sequence 44: aaccgacgtgcaagctggcaa
Anti-sense strand siRNA: aaccgacgtgcaagctggcaacctgtctc
Sense strand siRNA: aattgccagcttgcacgtcggcctgtctc
• Srv
Target sequence 6: aatacagagatcagcaagcag
Anti-sense strand siRNA: aatacagagatcagcaagcagcctgtctc
Sense strand siRNA: aactgcttgctgatctctgtacctgtctc
Target sequence 7: aagcagctgggatgcaggtgg
Anti-sense strand siRNA: aagcagctgggatgcaggtggcctgtctc
Sense strand siRNA: aaccacctgcatcccagctgccctgtctc
Target sequence 9: aagccttacagaagccgaaaa
Anti-sense strand siRNA: aagccttacagaagccgaaaacctgtctc
Sense strand siRNA: aattttcggcttctgtaaggccctgtctc
Target sequence 11: aaaaaaggccctttttccagg
Anti-sense strand siRNA: aaaaaaggccctttttccaggcctgtctc




(a) Male MGJU74A chip report file
(b) Female MG_U74A chip report file
(c) Male MG_U74B chip report file
(d) Female MG_U74B chip report file
(e) Male MG_U74Av2 chip report file
(f) Female MG_U74Av2 chip report file
Data for control probes (3-actin and GAPDH are highlighted in bold. Total probe sets
present on array is highlighted in red. The 3'-5' GAPDH ratio is highlighted in blue.
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(a) Male MG U74A chip report file
Filename: 01d-A_Male.CHP
Probe Array Type: MG_U7 4A






Scale Factor (SF): 0.830
TGT Value: 100
Norm Factor (NF): 1.000
Probe Mask File: C:\PROGRAM FILES\GENECHIP\LIBRARY\MG_U74A.MSK
Background:
Avg: 439.93 Std: 11.85 Min: 418.90 Max: 467.60
Noise:
Avg: 12.91 Std: 0.59 Min: 11.50 Max: 15.00
Corner+
Avg: 183 Count: 32
Corner-
Avg: 2937 Count: 32
Central-
Avg: 4073 Count: 9
The following data represents probe sets that exceed the probe pair
threshold and are not called "No Call".
Total Probe Sets: 10028
Number Present: 3162 31.5%
Number Absent: 6616 66.0%







Average Signal (All): 183.4
Housekeeping Controls:
Probe Set Sig(5') Det(5') Sig(M') Det(M')
Sig(31) Det(3') Sig(all) Sig(31/51)
B-ACTINMUR/M12481 821.1 P 1054.1 P 2762.5 P
1545.93 3.36
GAPDHMUR/M32599 2407.6 P 2378.4 P 4256.7 P
3014.24 1.77
TRANSRECMUR/X5 7349 3.7 A 23.5 A 22.3 A 16.47
6.11
PYRUCARBMUR/L 0 919 2 46.0 A 10.6 A 91.3 A 49.30
1.98
18SRNAMUR 166.3 P 1337.4 P 214.4 P 572.70
1.29
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(b) Female MG U74A chip report file
Filename: 01d-A_Female.CHP
Probe Array Type: MG_U74A






Scale Factor (SF): 1.027
TGT Value: 100
Norm Factor (NF): 1.000
Probe Mask File: C:\PROGRAM FILES\GENECHIP\LIBRARY\MG_U74A.MSK
Background:
Avg: 441.19 Std: 15.70 Min: 412.20 Max: 480.10
Noise:
Avg: 14.24 Std: 0.71 Min: 12.40 Max: 16.00
Corner+
Avg: 202 Count: 32
Corner-
Avg: 3358 Count: 32
Central-
Avg: 3816 Count: 9
The following data represents probe sets that exceed the probe pair
threshold and are not called "No Call".
Total Probe Sets: 10028
Number Present: 2855 28.5%
Number Absent: 6915 69.0%







Average Signal (All): 173.8
Housekeeping Controls:
Probe Set Sig(5') Det(5') Sig(M') Det(M')
Sig(3') Det(3') Sig(all) Sig(3'/5')
B-ACTINMUR/M12481 459.9 P 677.4 P 2262.7 P 1133.31
4.92
GAPDHMUR/M32599 1269.0 P 1952.3 P 3107.1 P
2109.46 2.45
TRANSRECMUR/X57 349 5.9 A 31.3 A 22.3 A 19.82
3 .77
PYRUCARBMUR/L09192 51.3 A 16.1 A 117.6 M 61.67
2.29
18SRNAMUR 109.9 P 576.3 P 89.6 P 258.60
0.82
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(c) Male MG U74B chip report file
Filename: 01d-B_Male.CHP
Probe Array Type: MG_U74B






Scale Factor (SF): 3.318
TGT Value: 100
Norm Factor (NF): 1.000
Probe Mask File: C:\PROGRAM FILES\GENECHIP\LIBRARY\MG_U74B.MSK
Background:
Avg: 432.24 Std: 17.09 Min: 391.30 Max: 493.30
Noise:
Avg: 10.32 Std: 0.94 Min: 8.80 Max: 13.90
Corner+
Avg: 583 Count: 32
Corner-
Avg: 45748 Count: 32
Central-
Avg: 45616 Count: 9
The following data represents probe sets that exceed the probe pair
threshold and are not called "No Call".
Total Probe Sets: 9580
Number Present: 1159 12.1%
Number Absent: 8236 86.0%







Average Signal (All): 123.2
Housekeeping Controls:
Probe Set Sig(5') Det(5') Sig(M') Det(M')
Sig(3') Det(3') Sig(all) Sig(3'/5')
B-ACTINMUR/M12481 1690.6 P 2122.0 P 7233.5 P
3682.06 4.28
GAPDHMUR/M32599 3925.6 P 6383.0 P 8697.6 P
6335.41 2.22
TRANSRECMUR/X57349 90.4 A 66.2 A 186.3 P 114.32
2 . 06
PYRUCARBMUR/L09192 15.1 A 42.7 A 181.0 A 79.61
11.98
18SRNAMUR 412.4 P 4829.2 P 513.0 P 1918.18
1.24
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Scale Factor (SF): 3.389
TGT Value: 100
Norm Factor (NF): 1.000
Probe Mask File: C:\PROGRAM FILES\GENECHIP\LIBRARY\MG_U74B.MSK
Background:
Avg: 348.53 Std: 5.74 Min: 336.20 Max: 369.30
Noise:
Avg: 9.33 Std: 0.36 Min: 8.30 Max: 10.30
Corner+
Avg: 1193 Count: 32
Corner-
Avg: 45825 Count: 32
Central-
Avg: 45823 Count: 9
The following data represents probe sets that exceed the probe pair
threshold and are not called "No Call".
Total Probe Sets: 9580
Number Present: 1407 14.7%
Number Absent: 7973 83.2%
Number Marginal: 200 2.1%
Average Signal (P): 441.8
Average Signal (A): 67.3
Average Signal (M): 212.1





























(e) Male MG_U74Av2 chip report file
Filename: Male.CHP
Probe Array Type: MG_U74Av2
Algorithm: Statistical






Scale Factor (SF): 2.099
TGT Value: 200
Norm Factor (NF): 1.000
Background:
Avg: 74.44 Std: 1.64 Min: 71.60 Max: 80.10
Noise:
Avg: 3.29 Std: 0.15 Min: 2.80 Max: 3.60
Corner+
Avg: 137 Count: 32
Corner-
Avg: 11730 Count: 32
Central-
Avg: 9620 Count: 9
The following data represents probe sets that exceed the probe pair
threshold and are not called "No Call".
Total Probe Sets: 12473
Number Presents 4900 39.3%
Number Absent: 7221 57.9%










Probe Set Sig(5') Det(5')
Sig(3') Det(3') Sig(all)
B-ACTINMUR/M12481 305.7 P 1193.8
3480.68 29.25
GAPDHMUR/M32599 110.4 P 502.0 P
60.38
TRANSRECMUR/X5 7 349 20.5 A
2 .31
PYRUCARBMUR/L 0 919 2 76.6 A
0.57


















Probe Set Sig(5') Det (5 ' ) Sig(M') Det(M
Sig (3 ' ) Det (3 ' ) Sig(all) Sig(31/51)
BIOB 153 .1 M 257 .4 P 191.9 P 200.81
BIOC 537 . 9 P 415.5 P 476.70
BIODN
5.76
479 . 9 P 2761.!3 P 1620.
CREX
1.66
5501. 5 P 9130 . . 9 P
DAPX 16.4 A 38.0 A 35 . 9 A 30.09 2.19
LYSX 5.8 A 3 . 9 A 2.7 A 4.15 0.46
PHEX 2.9 A 3.5 A 88.4 A 31.60 30.15
THRX 2.5 A 5.3 A 11.4 A 6.42 4.50
TRPNX 6.2 A 3.0 A 4.2 A 4.47 0.68
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(f) Female MG_U74Av2 chip report file
Filename: Female.CHP
Probe Array Type: MG_U7 4Av2
Algorithm: Statistical






Scale Factor (SF): 18.518
TGT Value: 200
Norm Factor (NF): 1.000
Background:
Avg: 57.13 Std: 0.73 Min: 55.60 Max: 58.70
Noise:
Avg: 1.81 Std: 0.05 Min: 1.70 Max: 1.90
Corner+
Avg: 79 Count: 32
Corner-
Avg: 11204 Count: 32
Central-
Avg: 10722 Count: 9
The following data represents probe sets that exceed the probe pair
threshold and are not called "No Call".
Total Probe Sets: 12473
Number Present: 1564 12.5%
Number Absent: 10667 85.5%
Number Marginal: 242 1.9%
Average Signal (P): 1981.9
Average Signal (A): 140.7
Average Signal (M): 462.3
Average Signal (All): 377.8
Housekeeping Controls:
Probe Set Sig(5') Det(5') Sig(M') Det(M')
Sig(3') Det(3') Sig(all) Sig(3'/5')
B-ACTINMUR/M12481 233.7 A 50.8 A 2445.0 P 909.83
10.46
GAPDHMUR/M32599 238.4 A 363.0 A 308.3 A 303.23
1.29
TRANSRECMUR/X57349 63.3 A 14.1 A 139.1 A 72.17
2.20
PYRUCARBMUR/L 0 919 2 37.3 A 21.8 A 88.7 A 49.24
2.38




Probe Set Sig (5 1 ) Det (5 1 ) Sig(M' ) Det (1







P 4471. i3 P 2559 .1
BIOC
0.76
6170. 2 P 4709 .2 P
BIODN
4.39
6125 . 4 P 26887 . 7 P
CREX
1.65
56520 .2 P 93378. 5 P
DAPX 75.6 A 113 .8 A 23 . 0 A 70.82 0.30
LYSX 94.5 A 93 . 7 A 121.3 A 103.16
PHEX 21. 6 A 25 . 8 A 24.6 A 23 . 98 1.14
THRX 46.8 A 97 . 5 A 30.9 A 58.39 0.66
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PROTEINEXPRESSEDINVE TRICLE1 (CDV-1PROTEIN). [Source:SWISSPROT;Acc:035594]
104548_at








































































































































































































































































































































































































































































116162_G_AT(Notfound) 105667_AT(Notfound) 115947_AT(Notfound) 115993_AT(Notfound) 114872_AT(Notfound) 105754_AT(Notfound) 110129_AT(Notfound) 105229_AT(Notfound) 109521_AT(Notfound) 116600_AT(Notfound)
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